
<html lang="en"     class="pb-page"  data-request-id="639775bc-3b20-48f8-8682-ec2bb22075fd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm5012676;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)" /></meta><meta name="dc.Creator" content="Thomas A.  Dineen" /></meta><meta name="dc.Creator" content="Kui  Chen" /></meta><meta name="dc.Creator" content="Alan C.  Cheng" /></meta><meta name="dc.Creator" content="Katayoun  Derakhchan" /></meta><meta name="dc.Creator" content="Oleg  Epstein" /></meta><meta name="dc.Creator" content="Joel  Esmay" /></meta><meta name="dc.Creator" content="Dean  Hickman" /></meta><meta name="dc.Creator" content="Chuck E.  Kreiman" /></meta><meta name="dc.Creator" content="Isaac E.  Marx" /></meta><meta name="dc.Creator" content="Robert C.  Wahl" /></meta><meta name="dc.Creator" content="Paul H.  Wen" /></meta><meta name="dc.Creator" content="Matthew M.  Weiss" /></meta><meta name="dc.Creator" content="Douglas A.  Whittington" /></meta><meta name="dc.Creator" content="Stephen  Wood" /></meta><meta name="dc.Creator" content="Robert T.  Fremeau, Jr." /></meta><meta name="dc.Creator" content="Ryan D.  White" /></meta><meta name="dc.Creator" content="Vinod F.  Patel" /></meta><meta name="dc.Description" content="We have previously shown that the aminooxazoline xanthene scaffold can generate potent and orally efficacious BACE1 inhibitors although certain of these compounds exhibited potential hERG liabiliti..." /></meta><meta name="Description" content="We have previously shown that the aminooxazoline xanthene scaffold can generate potent and orally efficacious BACE1 inhibitors although certain of these compounds exhibited potential hERG liabiliti..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 14, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5012676" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5012676" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5012676" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5012676" /></link>
        
    
    

<title>Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5012676" /></meta><meta property="og:title" content="Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0015.jpeg" /></meta><meta property="og:description" content="We have previously shown that the aminooxazoline xanthene scaffold can generate potent and orally efficacious BACE1 inhibitors although certain of these compounds exhibited potential hERG liabilities. In this article, we describe 4-aza substitution on the xanthene core as a means to increase BACE1 potency while reducing hERG binding affinity. Further optimization of the P3 and P2′ side chains resulted in the identification of 42 (AMG-8718), a compound with a balanced profile of BACE1 potency, hERG binding affinity, and Pgp recognition. This compound produced robust and sustained reductions of CSF and brain Aβ levels in a rat pharmacodynamic model and exhibited significantly reduced potential for QTc elongation in a cardiovascular safety model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5012676"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5012676">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5012676&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5012676&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5012676&amp;href=/doi/10.1021/jm5012676" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9811-9831</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501266w" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5010144" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+A.++Dineen">Thomas A. Dineen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kui++Chen">Kui Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+C.++Cheng">Alan C. Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katayoun++Derakhchan">Katayoun Derakhchan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oleg++Epstein">Oleg Epstein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joel++Esmay">Joel Esmay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean++Hickman">Dean Hickman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chuck+E.++Kreiman">Chuck E. Kreiman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isaac+E.++Marx">Isaac E. Marx</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+C.++Wahl">Robert C. Wahl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+H.++Wen">Paul H. Wen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+M.++Weiss">Matthew M. Weiss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+A.++Whittington">Douglas A. Whittington</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Wood">Stephen Wood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+T.++Fremeau%2C++Jr.">Robert T. Fremeau, Jr.</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryan+D.++White">Ryan D. White</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinod+F.++Patel">Vinod F. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Therapeutic Discovery, <sup>‡</sup>Neuroscience, <sup>§</sup>Molecular Structure and Characterization, <sup>∥</sup>Pharmacokinetics and Drug Metabolism, and <sup>⊥</sup>Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One Amgen Center Drive, Thousand Oaks, California 91320, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 617-444-5352. Fax: 617-621-3907. E-mail: <a href="/cdn-cgi/l/email-protection#acd8c8c5c2c9c9c2eccdc1cbc9c282cfc3c1"><span class="__cf_email__" data-cfemail="0c786865626969624c6d616b6962226f6361">[email protected]</span></a>. Address: Department of Medicinal Chemistry, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts, United States.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5012676&amp;href=/doi/10.1021%2Fjm5012676" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9811–9831</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 1, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 August 2014</li><li><span class="item_label"><b>Published</b> online</span>14 November 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 December 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5012676" title="DOI URL">https://doi.org/10.1021/jm5012676</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9811%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThomas%2BA.%2BDineen%252C%2BKui%2BChen%252C%2BAlan%2BC.%2BCheng%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D23%26contentID%3Djm5012676%26title%3DInhibitors%2Bof%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B%2528BACE1%2529%253A%2BIdentification%2Bof%2B%2528S%2529-7-%25282-Fluoropyridin-3-yl%2529-3-%2528%25283-methyloxetan-3-yl%2529ethynyl%2529-5%25E2%2580%25B2H-spiro%255Bchromeno%255B2%252C3-b%255Dpyridine-5%252C4%25E2%2580%25B2-oxazol%255D-2%25E2%2580%25B2-amine%2B%2528AMG-8718%2529%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9831%26publicationDate%3DDecember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5012676"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2039</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5012676" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibitors of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1): Identification of (S)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′H-spiro[chromeno[2,3-b]pyridine-5,4′-oxazol]-2′-amine (AMG-8718)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;A. Dineen&quot;},{&quot;first_name&quot;:&quot;Kui&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;C. Cheng&quot;},{&quot;first_name&quot;:&quot;Katayoun&quot;,&quot;last_name&quot;:&quot;Derakhchan&quot;},{&quot;first_name&quot;:&quot;Oleg&quot;,&quot;last_name&quot;:&quot;Epstein&quot;},{&quot;first_name&quot;:&quot;Joel&quot;,&quot;last_name&quot;:&quot;Esmay&quot;},{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;Hickman&quot;},{&quot;first_name&quot;:&quot;Chuck&quot;,&quot;last_name&quot;:&quot;E. Kreiman&quot;},{&quot;first_name&quot;:&quot;Isaac&quot;,&quot;last_name&quot;:&quot;E. Marx&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;C. Wahl&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;H. Wen&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;M. Weiss&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;A. Whittington&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Wood&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;T. Fremeau&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;D. White&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;F. Patel&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;9811-9831&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5012676&quot;},&quot;abstract&quot;:&quot;We have previously shown that the aminooxazoline xanthene scaffold can generate potent and orally efficacious BACE1 inhibitors although certain of these compounds exhibited potential hERG liabilities. In this article, we describe 4-aza substitution on the xanthene core as a means to increase BACE1 potency while reducing hERG binding affinity. Further optimization of the P3 and P2′ side chains resulted in the identification of 42 (AMG-8718), a compound with a balanced profile of BACE1 potency, hERG binding affinity, and Pgp recognition. This compound produced robust and sustained reductions of CSF and brain Aβ levels in a rat pharmacodynamic model and exhibited significantly reduced potential for QTc elongation in a cardiovascular safety model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5012676&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5012676" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5012676&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5012676" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5012676&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5012676" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5012676&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5012676&amp;href=/doi/10.1021/jm5012676" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5012676" /></input><a href="/doi/pdf/10.1021/jm5012676" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5012676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5012676%26sid%3Dliteratum%253Aachs%26pmid%3D25363711%26genre%3Darticle%26aulast%3DDineen%26date%3D2014%26atitle%3DInhibitors%2Bof%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B%2528BACE1%2529%253A%2BIdentification%2Bof%2B%2528S%2529-7-%25282-Fluoropyridin-3-yl%2529-3-%2528%25283-methyloxetan-3-yl%2529ethynyl%2529-5%25E2%2580%25B2H-spiro%255Bchromeno%255B2%252C3-b%255Dpyridine-5%252C4%25E2%2580%25B2-oxazol%255D-2%25E2%2580%25B2-amine%2B%2528AMG-8718%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D23%26spage%3D9811%26epage%3D9831%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292610" title="Antibiotic resistance">Antibiotic resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jmcmar.2014.57.issue-23/20141211/jmcmar.2014.57.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have previously shown that the aminooxazoline xanthene scaffold can generate potent and orally efficacious BACE1 inhibitors although certain of these compounds exhibited potential hERG liabilities. In this article, we describe 4-aza substitution on the xanthene core as a means to increase BACE1 potency while reducing hERG binding affinity. Further optimization of the P3 and P2′ side chains resulted in the identification of <b>42</b> (AMG-8718), a compound with a balanced profile of BACE1 potency, hERG binding affinity, and Pgp recognition. This compound produced robust and sustained reductions of CSF and brain Aβ levels in a rat pharmacodynamic model and exhibited significantly reduced potential for QTc elongation in a cardiovascular safety model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of dementia and is characterized by cognitive decline, changes in thinking, memory loss, and ultimately death. Although AD affects over 18 million people worldwide, there are currently no available disease-modifying therapies and the available treatments provide only limited benefit.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">A large body of evidence has implicated the formation and accumulation of amyloid β (Aβ) peptides, specifically Aβ<sub>40</sub> and Aβ<sub>42</sub>, in the brains of AD patients as critical factors in the pathogenesis of the disease.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Aβ peptides are formed in the brain via sequential proteolytic cleavage of amyloid precursor protein (APP) by the aspartyl proteases BACE1 (β-site APP cleaving enzyme) and γ-secretase.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The amyloid hypothesis suggests that inhibiting the formation and accumulation of Aβ in the brain could result in a disease-modifying effect in AD patients.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Recently published genetic evidence has provided further support for this approach, suggesting that even modest decreases in the formation of Aβ (as a result of a mutation in the gene encoding APP) may confer significant protection against the development of AD.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Since its identification in 1999,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> BACE1 has attracted a significant amount of attention as a potential target for the development of an AD therapy. BACE1 contains a long, shallow, and hydrophilic active site, and early efforts to identify BACE1 inhibitors produced large, polar compounds with unfavorable physicochemical properties and consequently poor pharmacokinetics and central nervous system (CNS) penetration.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> More recently, a number of groups have described BACE1 inhibitors that employ a 2-aminoheterocycle which engages in hydrogen bonding interactions with the catalytic aspartic acid residues of the protease.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> These heterocyclic units bind to the enzyme in an orientation that allows for further extension of a side chain into the S1 and S3 pockets. These designs have resulted in the identification of a number of potent BACE1 inhibitors with significantly improved pharmacokinetic profiles and CNS penetration compared with earlier peptidomimetic inhibitors.</div><div class="NLM_p">Our own efforts in this area led to the discovery of the aminooxazoline xanthene scaffold,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> which enabled extension of side chains into both the S3 and S2′ pockets of BACE1 and led to the identification of compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> While this compound led to robust reduction in central Aβ when dosed orally to Sprague–Dawley (SD) rats, its advancement was limited due to off-target activity on the hERG channel. Indeed, when evaluated in an anesthetized dog cardiovascular model, compound <b>1</b> caused prolongation of the QTc interval at relatively low exposure multiples over the in vivo EC<sub>50</sub> for brain Aβ reduction in a rat pharmacodynamic model. Subsequent SAR studies demonstrated that the hERG binding affinity of these compounds could be reduced by incorporating polar heteroatoms in the P2′ region of the inhibitor, albeit at the expense of increased Pgp-mediated efflux and consequently lower CNS exposure.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Further fine-tuning of physicochemical properties indicated that these increases in transporter-mediated efflux could be attenuated by reducing the PSA of the P3 group and by fluoro-substitution on the xanthene ring. The incorporation of a fluorine atom at the 4-position of the xanthene ring (e.g., <b>2</b>) also resulted in compounds with improved (5–10×) BACE1 potency.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The increased BACE1 potency within this series was attributed to a hydrogen bonding interaction between the 4-fluoro atom and Trp76 of BACE1, as observed in crystal structures of these compounds with the enzyme.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previous efforts to balance hERG inhibition and Pgp-mediated efflux.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this article, an alternative strategy is described for balancing BACE1 potency, hERG binding affinity, and Pgp-mediated efflux by incorporating a nitrogen atom into the xanthene core structure of the aminooxazoline xanthene inhibitors. Further optimization of the P3 and P2′ groups led to the identification of a metabolically stable, orally efficacious BACE1 inhibitor with a favorable balance of in vivo efficacy to off-target effects.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of inhibitors BACE1 inhibitors <b>26</b>–<b>28</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Coupling of <i>p</i>-bromophenol (<b>3</b>) with 2-fluoropyridine <b>4</b> under basic conditions in DMF, followed by ring-closure of the resulting intermediate in neat polyphosphoric acid, afforded xanthenone <b>5</b>. As described in the <a href="https://doi.org/10.1021/jm501266w">preceding article for the analogous 4-fluoroxanthenes</a>,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> the aminooxazoline unit was installed via a three-step sequence as follows. Reaction of ketone <b>5</b> with MeMgCl and subsequent HCl treatment afforded an unstable <i>exo</i>-olefin. The olefin was treated directly with in situ generated iodine isocyanate followed by a solution of ammonia in 2-propanol to yield the 2-aminooxazoline xanthene in racemic form.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Separation of the racemate through chiral supercritical fluid chromatography (SFC) afforded the (<i>S</i>)-enantiomer <b>6</b> on multigram scale. The preparation of neopentyl ether <b>8</b> was accomplished by boron tribromide-mediated demethylation of <b>6</b>, followed by cesium carbonate-promoted alkylation of intermediate phenol <b>7</b> with neopentyl iodide. Palladium catalyzed Suzuki cross-coupling reactions with the corresponding boronic acids<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> afforded the final analogues <b>26</b>–<b>28</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the P2′-Neopentyloxy 4-Azaxanthenes <b>26</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) NaH, DMF, 130 °C, 55%, (ii) PPA, 140 °C, 93%; (b) (i) MeMgCl, THF, −30 °C, HCl/Et<sub>2</sub>O, (ii) I<sub>2</sub>, AgOCN, THF, −40 °C, (iii) NH<sub>3</sub>, 23 °C; (iv) chiral SFC, 29%; (c) BBr<sub>3</sub>, DCM, 0 °C, 51%; (d) neopentyl iodide, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 63%; (e) Ar-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(AmPhos)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF–H<sub>2</sub>O, 110 °C, 72–90%.</p></p></figure><div class="NLM_p">The compounds in Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were generated via several different routes. Selected C-linked P2′ analogues (<b>31</b>, <b>32</b>, and <b>38</b>–<b>42</b>) were prepared as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> via the common dihalo intermediate <b>12</b>. Coupling of <i>p</i>-iodophenol (<b>9</b>) and 2-chloropyridine <b>10</b>, followed by acidic ring closure, gave xanthenone <b>11</b>. Formation of the 2-aminooxazoline xanthene unit and chiral separation was accomplished as described above to afford the bis-functionalized iodo-bromo intermediate <b>12</b>. Selective Suzuki cross-coupling of the aryl iodide with 2-fluoro-3-pyridineboronic acid provided the penultimate bromide <b>13</b>, which was subjected to either a second Suzuki cross-coupling or a Sonogashira cross-coupling to generate the desired compounds in good overall yield.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 4-Azaxanthenes via Late-Stage Installation of the P2′ Group<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) NaH, DMF, 130 °C, 76%, (ii) PPA, 140 °C, 85%; (b) (i) MeMgCl, THF, −30 to 0 °C, THF–CHCl<sub>3</sub>, 80 °C, (ii) I<sub>2</sub>, AgOCN, THF, −20 °C, (iii) NH<sub>3</sub>, 23 °C, (iv) chiral SFC, 13%; (c) 2-fluoro-3-pyridineboronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane–water, 70 °C, 91%; (d) R-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane–water, 80 °C, 40–59%; (e) R-CCH, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, <i>i</i>-PrNH<sub>2</sub>–DMF, 90 °C, 58–95%; (f) R-C≡C-TMS, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, TBAF, THF, 70 °C, 89% for <b>42</b>.</p></p></figure><div class="NLM_p">Alternatively, other analogues (<b>33</b>–<b>37</b>) in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> were prepared by initial coupling of the P2′ group followed by a final introduction of the 2-fluoro-3-pyridyl P3 group as described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. For these examples, phenol <b>14</b> and 2-chloropyridine <b>10</b> were converted to aminooxazoline <b>16</b> under the previously described conditions. Boron tribromide-mediated demethylation afforded bromophenol <b>17</b>, which served as a versatile intermediate for diverse Pd-catalyzed C,C and C,N cross-coupling reactions to install the P2′ group. Triflation of the phenols <b>18a</b>–<b>e</b> afforded triflates <b>19a</b>–<b>e</b>, which were subjected to a final Suzuki cross-coupling with 2-fluoro-3-pyridineboronic acid, yielding the desired compounds <b>33</b>–<b>37</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4-Azaxanthenes <b>33</b>–<b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) NaH, DMF, 140 °C, 83%, (ii) PPA, 140 °C, 66%; (b)  (i) MeMgBr, THF, −30 to 0 °C, CH<sub>3</sub>OH, 60 °C, 53%, (ii) I<sub>2</sub>, AgOCN, THF, −20 °C, (iii) NH<sub>3</sub>, 23 °C, (iv) chiral SFC, 28%; (c) BBr<sub>3</sub>, DCM, 0 °C, 62%; (d) (i) 2-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, water, 80 °C, 70%, (ii) H<sub>2</sub> (1 atm), 10% Pd/C, MeOH, 82% of <b>18a</b>; (e) R-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(AmPhos)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane–water, 75–100 °C, 34–69% for <b>18b</b>, <b>18d</b>, and <b>18e</b>; (f) morpholine, Pd<sub>2</sub>(dba)<sub>3</sub>, DavePhos, LHMDS, THF, 70 °C, 51% of <b>18c</b>; (g) PhNTf<sub>2</sub>, Et<sub>3</sub>N, DCM, 67–89%; (h) 2-fluoro-3-pyridineboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane–water, 80 °C, 34–97%.</p></p></figure><div class="NLM_p">The BACE1 inhibitor <b>30</b> was prepared via a separate route shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Xanthenone <b>21</b> was synthesized starting from bromophenol <b>3</b> and fluoropyridine <b>20</b> and was converted to bromophenol <b>22</b> via a two-step borylation-oxidation protocol. Formation of the 2-methoxy-2-methylpropoxy side chain of <b>24</b> was accomplished in four steps beginning with alkylation of the phenol with 3-bromo-2-methylpropene. The resulting alkene underwent iodo-etherification in the presence of NIS in methanol. Sequential treatment of the product with MeMgCl and lithium triethylborohydride in a single pot afforded the alcohol <b>23</b>. Exposure of <b>23</b> to acid promoted elimination of the alcohol to form the exo-olefin, which was converted to the aminooxazoline <b>24</b>. A final Suzuki cross-coupling with 2-fluoro-3-pyridineboronic acid was followed by chiral separation to furnish compound <b>30</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of BACE1 Inhibitor <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) LiTMP, THF, −10 °C, then CO<sub>2</sub>(g), <b>20</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, 140 °C, (ii) PPA, 140 °C; (b) (i) Pd(OAc)<sub>2</sub>, X-Phos, B<sub>2</sub>(pin)<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, 1,4-dioxane, 23 °C, (ii) 30% H<sub>2</sub>O<sub>2</sub>, THF, 66%; (c) (i) 3-bromo-2-methylpropene, DBU, DCM, (ii) NIS, MeOH, (iii) MeMgCl, THF, −40 °C, (iv) LiBEt<sub>3</sub>H, THF, 9% over four steps; (d) (i) HCl/1,4-dioxane, 50 °C, (ii) I<sub>2</sub>, AgOCN, THF, −20 °C, (iii) NH<sub>3</sub>, 23 °C, 16%; (e) (i) 2-fluoro-3-pyridineboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, THF–water, 110 °C, (ii) chiral SFC, 16%.</p></p></figure><div class="NLM_p">The regioisomeric azaxanthene compound <b>29</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was prepared as shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The racemic intermediate <b>16</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) was subjected to treatment with boron tribromide to give the corresponding phenol, which underwent a subsequent alkylation to form neopentyl ether <b>25</b>. Suzuki cross-coupling with 5-pyrimidyl boronic acid, followed by chiral separation, yielded the desired isomer <b>29</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of BACE1 Inhibitor <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) BBr<sub>3</sub>, DCM, 0 °C, 99%; (b) neopentyl iodide, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 48%; (c) (i) 2-fluoro-3-pyridineboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, THF–water, sealed tube, 90 °C, (ii) chiral SFC, 24%.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our previous work on aminooxazoline xanthene BACE1 inhibitors had demonstrated that incorporation of a fluorine atom in the xanthene core, especially at C(4), afforded a significant increase in enzymatic potency.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The enhanced potency was believed to arise from a favorable hydrogen-bonding interaction between the fluorine atom and NHTrp76 of the protein, and we hypothesized that a nitrogen atom at the 4-position of the xanthene could similarly engage Trp76. Furthermore, employing a nitrogen atom to exploit this interaction with the protein could not only potentially boost potency against BACE1 but at the same time reduce hERG binding affinity as a result of the increase in PSA.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> While there was a possibility that the additional PSA could result in increased transporter-mediated efflux,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> the consequential decreased exposure in the CNS could potentially be offset by increases in BACE1 potency, enabling the discovery of BACE1 inhibitors with good in vivo efficacy and improved cardiovascular safety margins.</div><div class="NLM_p">We began our investigation by preparing <b>26</b>, the 4-aza analogue of one of our initial leads, <b>1</b>. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the 4-azaxanthene core did indeed afford both greater enzymatic and functional potency than the all-carbon analogue <b>1</b>. As expected, the higher PSA led to a hERG binding <i>K</i><sub>i</sub> >10 μM in addition to a slight increase in Pgp-mediated efflux ratios to >2, indicating that compound <b>26</b> is a Pgp-substrate. Reducing the overall PSA of the molecule by changing the P3 group from a 5-pyrimidyl to a 3-pyridyl ring (<b>27</b>), isomeric with compound <b>1</b>, returned the favorable efflux properties of <b>1</b> while maintaining low hERG activity. Replacement of the P3 group with the 2-fluoro-3-pyridyl ring (<b>28</b>) generated a compound with excellent BACE1 potency in our enzymatic and functional assays, low efflux ratios, and moderate hERG binding. We also examined incorporation of a nitrogen atom at the 5-position of the xanthene. Compound <b>29</b> showed dramatically reduced BACE1 potency in the enzymatic and functional assays, suggesting an unfavorable interaction of this atom with the protein. Interestingly, incorporation of a nitrogen atom at the 4-position led to decreases in microsomal stability when coupled with either a 5-pyrimidine (<b>26</b>) or a 3-pyridly group (<b>27</b>) in P3, however, the 2-fluoro-3-pyridyl analogue (<b>28</b>) maintained the low metabolism observed with all-carbon analogue <b>1</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Evaluating Aza-substitution in the Xanthene Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values represent the mean values of at least two experiments ± SD.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Human embryonic kidney cells.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Apparent permeability measured in parental LLC-PK1 cells. Values are an average of apical to basolateral (A to B) and basolateral to apical (B to A) velocities and are reported as 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Efflux measured in LLC-PK1 cells transfected with either rat MDR1A/1B or human MDR1 and are reported as a ratio of (B to A)/(A to B).</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Rat liver microsomal (RLM) and human liver microsomal (HLM) clearance. Compound concentration = 1 μM. Microsomal protein concentration = 250 μg/mL.</p></div></div><div></div></div><div class="NLM_p">As mentioned before, compound <b>28</b> demonstrated improved BACE1 functional potency and decreased hERG activity, relative to <b>1</b>, while maintaining the high permeability, low Pgp efflux, and good microsomal stability–properties consistent with good distribution into the CNS. In an effort to further reduce hERG activity within this series, additional P2′ side chains were explored. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, a number of groups which had previously been identified as beneficial for BACE1 potency<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> were incorporated into the P2′ side chain of the 4-azaxanthene aminooxazolines. Addition of a methoxy group to the neopentyloxy P2′ side chain (<b>30</b>) resulted in a slight decrease of BACE1 enzymatic and functional potencies. Inhibitors containing a dihydropyran P2′ group (<b>31</b>, <b>32</b>, and <b>34</b>) were all approximately 2-fold less potent than <b>28</b>, and the fully saturated tetrahydropyran <b>33</b> was approximately 8-fold less potent in the functional assay. Similarly, the <i>N</i>-morpholino substituent in compound <b>35</b> resulted in reduced BACE1 activity in both the enzymatic and functional assays. While compounds with aryl groups in P2′ (<b>36</b>–<b>38</b>) maintained good potency in the BACE1 enzymatic assay, they were consistently less potent (approximately 3–6-fold) in the functional assay. Finally, alkynes <b>39</b> and <b>40</b> demonstrated no enzyme-to-cell shift and consequently produced low nanomolar inhibitors in the functional cellular assay.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. P2′ SAR of 4-Azaxanthenes</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0012.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0013.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Values represent the mean values of at least two experiments ± SD.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Human embryonic kidney cells.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Apparent permeability measured in parental LLC-PK1 cells. Values are an average of apical to basolateral (A to B) and basolateral to apical (B to A) velocities and are reported as 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Efflux measured in LLC-PK1 cells transfected with either rat MDR1A/1B or human MDR1 and are reported as a ratio of (B to A)/(A to B).</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Rat liver microsomal (RLM) and human liver microsomal (HLM) clearance. Compound concentration = 1 μM. Microsomal protein concentration = 250 μg/mL.</p></div></div><div></div></div><div class="NLM_p">Most compounds with a polar heteroatom incorporated in the P2′ side chain showed significantly decreased hERG binding affinity (<i>K</i><sub>i</sub> > 10 μM), albeit in some cases at the expense of increased human and rat Pgp recognition. For example, Pgp efflux ratios for ethereal compounds <b>30</b>, <b>31</b>, <b>33</b>, and <b>35</b> were >10. Shielding of the ethereal oxygen with methyl substitution, as in dihydropyran <b>34</b>, resulted in a favorable combination of low hERG binding affinity and low Pgp efflux ratios. The dihydropyran isomer <b>32</b> showed modest efflux when compared with close structural analogues <b>31</b> and <b>33</b>. Tolyl-substituted inhibitor <b>36</b> and aryl nitrile <b>37</b> both maintained significant hERG binding activity, while fluoropyridine <b>38</b> had hERG <i>K</i><sub>i</sub> > 10 μM. Compound <b>37</b> showed reduced Pgp efflux activity compared to compound <b>38</b>. Incorporation of a methoxy group into the <i>t</i>-butylacetylene unit of compound <b>39</b> yielded a compound with excellent BACE1 potency, low activity in hERG binding assay, and low efflux ratios (<b>40</b>).</div><div class="NLM_p">Most compounds we examined were stable in human and rat liver microsomes, with the exception of compound <b>40</b>. Given the attractive overall profile of <b>40</b>, we sought to further understand its high intrinsic clearance with the aim of generating a more metabolically stable analogue. Metabolite identification studies on a related analogue with the same P2′ side chain (data not shown), suggested that the methoxy ether of <b>40</b> may undergo oxidative demethylation to form alkynol <b>41</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In support of this hypothesis, alkynol <b>41</b> was independently synthesized and found to be stable in human and rat liver microsomes. Although this compound also showed good BACE1 potency and low activity in the hERG binding assay, it was subject to extremely high Pgp efflux (efflux ratio = >50 and 44 for human and rat, respectively), likely as a result of the additional hydrogen bond donor of the free alcohol. To combine the low intrinsic clearance of alkynol <b>41</b> with the low efflux ratios of methyl ether <b>40</b>, an inhibitor featuring a 3-methyl-3-oxetane ethynyl group in P2′ (<b>42</b>) was targeted. The oxetane group was predicted to be more stable toward oxidative dealkylation, and it was expected to be less likely a Pgp recognition element.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In fact, compound <b>42</b> (AMG-8718) exhibited good stability in human and rat liver microsomes and only modest Pgp efflux ratios. Importantly, this compound demonstrated high BACE1 potency, low activity in the hERG binding assay, and excellent permeability.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of the P2′ Alkyne</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0014.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0017.gif" alt="" id="GRAPHIC-d1012e1238-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Values represent the mean values of at least two experiments ± SD.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Human embryonic kidney cells.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Apparent permeability measured in parental LLC-PK1 cells. Values are an average of apical to basolateral (A to B) and basolateral to apical (B to A) velocities and are reported as 10<sup>–6</sup> cm/s.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Efflux measured in LLC-PK1 cells transfected with either rat MDR1A/1B or human MDR1 and are reported as a ratio of (B to A)/(A to B).</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Rat liver microsomal (RLM) and human liver microsomal (HLM) clearance. Compound concentration = 1 μM. Microsomal protein concentration = 250 μg/mL.</p></div></div><div></div></div><div class="NLM_p">An X-ray cocrystal structure of compound <b>42</b> with BACE1 is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As observed in previous cocrystallized BACE1 inhibitors, the aminooxazoline unit engages in hydrogen-bonding interactions with the catalytic aspartic acid residues of the enzyme, and the nitrogen atom of the 2-pyridyl-3-fluoro group interacts with Ser229 via a bridging water molecule in the S3 pocket. As anticipated, the nitrogen atom in the xanthene ring system engages Trp76 in a hydrogen-bonding interaction, likely resulting in the enhanced potency observed for 4-azaxanthenes relative to their all-carbon analogues. An additional hydrogen-bonding interaction in S2′ was observed between the oxetane oxygen and Arg128.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure of <b>42</b> with BACE1. (a) Interactions of <b>42</b> with the catalytic aspartic acids, Ser229, and Trp76 of BACE1. (b) Interaction of the P2′ oxetane unit with Arg128 in S2′.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A potential concern with compound <b>42</b> was the possibility of CYP inactivation as a result of oxidation of the alkynyl group to form reactive metabolites,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> however, no time-dependent inhibition of CYP activity was detected when <b>42</b> was examined in IC<sub>50</sub> shift experiments (30 min incubation).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Additionally, given the potentially reactive nature of the 2-fluoropyridine and oxetane functional groups, <b>42</b> was incubated in buffered solutions in the presence of glutathione (GSH), as well as with hepatocytes, and no incorporation of GSH was observed under these conditions.</div><div class="NLM_p">BACE inhibitors <b>34</b> and <b>42</b> possessed a good overall balance of properties (BACE1 functional potency, permeability, intrinsic stability, and Pgp efflux ratios) and were therefore evaluated in vivo for their ability reduce the concentration of CNS Aβ in a rat pharmacodynamic model. Male Sprague–Dawley rats were dosed with compounds <b>34</b> or <b>42</b> (10 mg/kg) by oral gavage, where after 4 h plasma and CSF drug levels were determined along with Aβ<sub>40</sub> concentrations in the CSF and brain.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, both compounds <b>34</b> and <b>42</b> significantly decreased Aβ<sub>40</sub> levels in the CSF at the 4 h time point (53% and 69%, respectively), however, only <b>42</b> produced a robust response in the brain (48% reduction of Aβ<sub>40</sub> levels for <b>42</b> vs 16% for <b>34</b>). The reason for this disparity is potentially due to a difference in exposure multiples for the two compounds in the brain. Although both compounds achieved similar unbound concentrations in plasma at the 4 h time point, <b>42</b> achieved an approximately 5-fold higher exposure than <b>34</b> in the CSF compartment, which may reflect a higher unbound concentration in the brain. However, it is possible that CSF concentrations may be inflated relative to unbound brain concentrations as a result of active blood-to-CSF transport by Pgp.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Reduction of CSF Aβ<sub>40</sub> in Wild-Type Sprague–Dawley Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">CSF Aβ<sub>40</sub> reduction<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center" char=".">brain Aβ<sub>40</sub> reduction<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center" char=".">[plasma]<sub>total</sub> (μM)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">[plasma]<sub>unbound</sub> (μM)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">[CSF] (μM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">[CSF]/cell IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">1.01</td><td class="colsep0 rowsep0" align="char" char=".">0.045</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">4.43</td><td class="colsep0 rowsep0" align="char" char=".">0.059</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Compounds were dosed orally at 10 mg/kg as a solution (2% HMPC, 1% Tween80) to male rats. <i>n</i> = 5 animals per group.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">CSF and brain Aβ<sub>40</sub> measured at <i>t</i> = 4 h.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Plasma drug concentration measured at <i>t</i> = 4 h.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">CSF drug concentration measured at <i>t</i> = 4 h.</p></div></div></div><div class="NLM_p">On the basis of the more significant pharmacodynamic response observed with <b>42</b>, the pharmacokinetic behavior of this compound in rat, dog, and cynomolgus monkey was evaluated. Consistent with its stability in liver microsomes, <b>42</b> showed moderate total clearance, moderate <i>V</i><sub>dss</sub>, and half-lives of ca. 5–8 h across all three species (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The clearance in cynomolgus monkey was roughly double that of rat and dog, an observation which can be partially accounted for by the larger unbound fraction in plasma for monkey relative to rat and dog. When dosed orally, bioavailability was high (70–101%) across all three species, and the compound was rapidly absorbed as indicated by <i>t</i><sub>max</sub> of 1–2 h.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Profiles and Plasma Protein Binding of <b>42</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">iv<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">po<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Cl (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">% <i>F</i></th><th class="colsep0 rowsep0" align="center" char=".">plasma protein binding (<i>F</i><sub>u</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">beagle dog</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">0.038</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">0.61</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">101</td><td class="colsep0 rowsep0" align="char" char=".">0.054</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">2 mg/kg iv dose as a solution in DMSO (rat), 1% Tween80/2% HMPC/97% water at pH = 4 (dog), or 25% HBC/75% water at pH = 4 (cynomolgus monkey).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">5 mg/kg oral dose as a solution in 1% Tween80/2% HMPC/97% water at pH = 2.</p></div></div></div><div class="NLM_p">Because <b>42</b> achieved good exposure in rats following oral administration, a dose–response relationship of this compound on CNS Aβ levels in the rat pharmacodynamic model was determined. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, <b>42</b> demonstrated dose-dependent decreases in both CSF and brain Aβ levels at 4 h time points. The reduction in Aβ levels tended to be more significant in the CSF than in the brain, although the values were generally within 2-fold and ≥70% Aβ reduction was achieved in both the CSF and brain at a dose of 30 mg/kg. The effective unbound plasma drug concentration corresponding to 50% Aβ reduction (EC<sub>50,unbound</sub>) at the 4 h time point was calculated to be 18 and 67 nM for CSF and brain, respectively. The temporal effects of <b>42</b> on CNS Aβ levels were examined in a time-course pharmacodynamic study in rat at 30 mg/kg. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, <b>42</b> demonstrated robust and sustained reduction of Aβ levels in both the CSF and brain for over 8 h. The lowest concentrations of Aβ in both compartments were observed between 4 and 5 h, and the concentrations of Aβ returned to predosing levels within 16–20 h. The changes in brain Aβ concentration tended to precede those in the CSF by a small margin. Using an indirect response PK/PD model,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which accounts for the rate of Aβ formation and clearance in the rat CNS, the in vivo plasma IC<sub>50,unbound</sub> of <b>42</b> was determined to be 62 nM. The difference between the in vivo IC<sub>50,unbound</sub> and the IC<sub>50</sub> of <b>42</b> in the BACE1 functional assay (4.4 nM) is likely due, in part, to reduced exposure in the brain as a result of Pgp efflux.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacodynamic effect of <b>42</b> on CNS Aβ in Sprague–Dawley rats. (a) CSF Aβ reduction at 4 h. (b) Brain Aβ reduction at 4 h. (c) Time-course study at 30 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The effects of <b>42</b> in an anesthetized dog cardiovascular safety model were studied. The compound was administered intravenously as a series of three 30 min infusions at doses of 2.5, 8, and 16 mg/kg to two chloralose-anesthetized dogs. The unbound plasma concentrations were assessed at the end of each infusion and determined (average) to be 0.298, 1.70, and 3.62 μM, respectively. No significant effects on the QTc interval were observed at these doses. The unbound plasma concentration at the high dose was 201-fold over the plasma EC<sub>50,unbound</sub> for CSF Aβ reduction in rats and 58-fold over the in vivo IC<sub>50,unbound</sub> as determined by the indirect response model. The margins observed in this study represent a significant improvement over compounds like <b>1</b> and <b>2</b>.</div><div class="NLM_p">Our strategy of installing a nitrogen atom at the 4-position of the xanthene to engage Trp76 resulted in the discovery of BACE1 inhibitors with increased BACE1 potency and reduced hERG binding affinity. An optimized compound from this series, <b>42</b>, showed a 5-fold improvement in BACE1 functional potency compared with <b>1</b>, an earlier lead (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Although these compounds have similar total PSA, <b>42</b> is more polar (log <i>P</i> = 2.53 for <b>42</b> vs log <i>P</i> = 5.20 for <b>1</b>), which may account for the significantly lower activity of this compound in the hERG binding assay.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The impact of increased Pgp efflux for <b>42</b> observed in the in vitro assays was mitigated by the high functional potency and permeability of this compound, resulting in robust reductions in CNS Aβ in the rat pharmacodynamic model. As a result of the balance of BACE1 potency, hERG binding affinity, and Pgp recognition for compound <b>42</b>, significantly higher safety margins for elongation of the QTc interval in the dog cardiovascular model relative the EC<sub>50</sub> and IC<sub>50</sub> measured in the rat pharmacodynamic model were achieved.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of BACE Inhibitors <b>1</b> and <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Aspartyl Protease Selectivity of <b>1</b> and <b>42</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">protease IC<sub>50</sub> (μM)/selectivity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">BACE1</th><th class="colsep0 rowsep0" align="center">BACE2</th><th class="colsep0 rowsep0" align="center">renin</th><th class="colsep0 rowsep0" align="center">pepsin</th><th class="colsep0 rowsep0" align="center">cathepsin D</th><th class="colsep0 rowsep0" align="center">cathepsin E</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0023</td><td class="colsep0 rowsep0" align="left">0.015 (7×)</td><td class="colsep0 rowsep0" align="left">>3 (1300×)</td><td class="colsep0 rowsep0" align="left">9.5 (4130×)</td><td class="colsep0 rowsep0" align="left">1.1 (478×)</td><td class="colsep0 rowsep0" align="left">0.32 (139×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0007</td><td class="colsep0 rowsep0" align="left">0.005 (7×)</td><td class="colsep0 rowsep0" align="left">>1 (1429×)</td><td class="colsep0 rowsep0" align="left">>1 (1429×)</td><td class="colsep0 rowsep0" align="left">2.3 (3285×)</td><td class="colsep0 rowsep0" align="left">>1 (1429×)</td></tr></tbody></table></div></div><div class="NLM_p last">Finally, compounds <b>1</b> and <b>42</b> were tested against a panel of other aspartyl proteases. Both compounds demonstrated limited selectivity for BACE1 over homologue BACE2, and the high selectivity for BACE1 over both renin and pepsin observed with <b>1</b> was preserved with <b>42</b>. Although <b>1</b> showed only modest selectivity for BACE1 against cathepsins D and E (478× and 139×, respectively), <b>42</b> was very selective (3285× and 1429×, respectively), a result of both increased BACE1 potency and lower cathepsin activity for this compound.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A novel series of potent BACE1 inhibitors was discovered by incorporating a nitrogen atom into the 4-position of the aminooxazoline xanthene scaffold. The nitrogen atom led to improved BACE1 potency, reduced hERG binding affinity, and elevated Pgp efflux ratios. Optimization of the P3 group and exploration of the P2′ group resulted in several compounds with improved in vitro profiles. An oxetane-containing P2′ group was designed to balance Pgp efflux and microsomal turnover, and this effort culminated in the identification of inhibitor <b>42</b>. Although this compound was a moderate Pgp substrate, it led to robust and sustained reductions of CSF and brain Aβ in a rat pharmacodynamic model. In accordance with low hERG binding affinity, <b>42</b> did not result in elongation of the QTc interval at plasma concentrations exceeding 108-fold and 31-fold over the plasma EC<sub>50,unbound</sub> for CSF Aβ reduction and the vivo plasma IC<sub>50,unbound</sub>, respectively. Further studies detailing pharmacodynamic and toxicology studies of this compound will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58340" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58340" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> BACE1 Enzymatic Assay</h3><div class="NLM_p last">BACE1 enzymatic activity was determined by the enhancement of fluorescence intensity upon enzymatic cleavage of the fluorescence resonance energy transfer substrate according to a previously published procedure.<a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">(6p)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cell-Based Assay</h3><div class="NLM_p last">BACE 1 cellular activity was determined in human embryonic kidney cells (HEK293) stably expressing APP<sub>SW</sub>. After incubation overnight with the test compounds, the conditioned media was collected and the Aβ40 levels were determined using a sandwich ELISA as described previously.<a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">(6p)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Permeability Assay</h3><div class="NLM_p last">Permeability and efflux ratios were determined in the wild-type cell line LLC-PK1 (porcine renal epithelial cells, WT-LLC-PK1) transfected with human <i>MDR1</i> gene (hMDR1-LLC-PK1) and rat <i>mdr1a</i> gene (rMdr1a-LLC-PK1) as described previously.<a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">(6p)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Microsomal Stability Assay</h3><div class="NLM_p last">Compounds (1 μM) were incubated with liver microsomes from human and rat for 30 min at 37 °C, and the samples were analyzed according to published procedure.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> hERG Binding Assay</h3><div class="NLM_p last">A stable HEK293 cell line expressing the hERG channel was established in house. Compounds were tested in the [<sup>3</sup>H]-dofetilide binding assay with cell membranes prepared from this cell line by using the method of Finlayson with some modifications.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Briefly, filtration assays were carried out in 194 μL of binding buffer (10 mM HEPES, pH 7.4, 60 mM KCl, 71.5 mM NaCl, 1 mM CaCl<sub>2</sub>, 2 mM MgCl<sub>2</sub>) with 10 μg/well membrane (based on membrane protein) and [<sup>3</sup>H]-dofetilide (8 nM), 6 μL of compound dissolved in 100% DMSO. Nonspecific binding was determined by using 10 μM cold dofetilide (∼1000-fold molar excess over hot ligand). The entire assay was conducted in 96-well Whatman Unifilter plates at room temperature for 90 min. The binding assay was terminated by washing the plates four times on a Millipore vacuum filtration manifold with 100 μL/well of ice-cold wash buffer (10 mM HEPES, pH 7.4, 131.5 mM NaCl, 1 mM CaCl<sub>2</sub>, 2 mM MgCl<sub>2</sub>). The bound radioisotope was quantified using a Packard TopCount NTS liquid scintillation counter with scintillation fluid.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Pharmacodynamic Assay</h3><div class="NLM_p last">Male Sprague–Dawley rats (175–200 g) were administered compound by oral gavage at the appropriate dose. Samples of plasma, CSF, and brain were analyzed according to previously reported procedures.<a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">(6p)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div class="NLM_p">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from Aldrich or EM Science and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. All microwave assisted reactions were conducted with a Smith synthesizer from Personal Chemistry, Uppsala, Sweden. Silica gel chromatography was performed using either glass columns packed with silica gel (230–400 mesh, EMD Chemicals, Gibbstown, NJ) or prepacked silica gel cartridges (Biotage or ISCO). <sup>1</sup>H NMR spectra were recorded on a Bruker AV-400 (400 MHz) spectrometer at ambient temperature or on a Varian 400 MHz spectrometer. Chemical shifts are reported in parts per million (ppm, δ units) downfield from tetramethylsilane. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and number of protons. Purity for final compounds was greater than 95% unless otherwise noted and was measured using Agilent 1100 series high performance liquid chromatography (HPLC) systems with UV detection at 254 nm (system A, Agilent Zorbax Eclipse XDB-C8 4.6 mm × 150 mm, 5 μm, 5–100% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 15 min at 1.5 mL/min; system B, Waters Xterra 4.6 mm × 150 mm, 3.5 μm, 5–95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 15 min at 1.0 mL/min). Exact mass confirmation was performed on an Agilent 1100 series high performance liquid chromatography (HPLC) system (Santa Clara, CA, U.S.) by flow injection analysis, eluting with a binary solvent system A and B (A, water with 0.1% FA; B, ACN with 0.1% FA) under isocratic conditions (50% A/50% B) at 0.2 mL/min with MS detection by an Agilent G1969A time-of-flight (TOF) mass spectrometer (Santa Clara, CA, U.S.).</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 7-Bromo-3-methoxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (<b>5</b>)</h4><div class="NLM_p">Step 1: 2-(4-Bromophenoxy)-5-methoxynicotinic acid. To a slurry of sodium hydride (60% dispersion) (5.14 g, 129 mmol) in DMF (106 mL, 58.4 mmol) at 0 °C was added 4-bromophenol (11.12 g, 64.3 mmol), resulting in the evolution of hydrogen gas. The mixture was stirred at 0 °C for 2 min then for an additional 5 min at room temperature. 2-Fluoro-5-methoxynicotinic acid (10.0 g, 58.4 mmol) was added portionwise over 1 min. The resulting slurry was heated to 130 °C for 20 h, then heated to 140 °C for another 3 h. The reaction mixture was cooled to room temperature and poured onto 500 g of ice. Acetic acid (16.73 mL, 292 mmol) was added, and the resulting taffy was stirred vigorously for 2 h, resulting in the formation of a fine off-white precipitate. The slurry was filtered, and the collected solid was washed with methanol, washed ether, and then dried to give 2-(4-bromophenoxy)-5-methoxynicotinic acid (10.5 g, 55% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.42 (br s, 1 H), 8.06 (d, <i>J</i> = 3.1 Hz, 1 H), 7.81 (d, <i>J</i> = 3.1 Hz, 1 H), 7.60–7.50 (m, 2 H), 7.01–6.94 (m, 2 H), 3.85 (s, 3 H). MS <i>m</i>/<i>z</i> = 324.0 [M + H]<sup>+</sup>. Calcd for C<sub>13</sub>H<sub>11</sub>BrNO<sub>4</sub>: 324.0. </div><div class="NLM_p last">Step 2: 7-Bromo-3-methoxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one. 2-(4-Bromophenoxy)-5-methoxynicotinic acid (8.00 g, 24.68 mmol) was added to a round-bottom flask containing polyphosphoric acid (115% H<sub>3</sub>PO<sub>4</sub>) (75 g, 24.68 mmol) that had been warmed to 140 °C. The resulting mixture was stirred at this temperature for 3.5 h. The reaction mixture was allowed to cool to 100 °C and then poured into 500 mL of ice–water. The resulting thick taffy was stirred vigorously, leading to the formation of a fine white precipitate. Stirring was continued for 1 h, at which point the mixture was filtered. The collected solid was washed with MeOH (2 × 100 mL), washed with diethyl ether (3 × 100 mL), and dried to give 7-bromo-3-methoxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (7.05 g, 93% yield) as a fine-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.71 (d, <i>J</i> = 3.3 Hz, 1 H), 8.35 (d, <i>J</i> = 2.4 Hz, 1 H), 8.20–8.12 (m, 2 H), 7.86 (d, <i>J</i> = 8.9 Hz, 1 H), 4.07 (s, 3 H).</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-7-Bromo-3-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>6</b>)</h4><div class="NLM_p">To a slurry of 7-bromo-3-methoxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (23 g, 75 mmol) in THF (751 mL, 75 mmol) at −40 °C was added methylmagnesium chloride (3 M solution in THF, 88 mL, 263 mmol) over 2 min, such that the temperature did not rise above −35 °C. The resulting red slurry was maintained at −30 °C. After 1 h, the reaction mixture was quenched by the addition of EtOAc (50 mL). The solution was then carefully quenched with 800 mL of a 50% aq ammonium chloride solution. The mixture was poured into a separatory funnel containing ethyl acetate (100 mL). The layers were separated, and the organic layer was washed with brine, dried over sodium sulfate, filtered, and concentrated. The aqueous layer was extracted with ethyl acetate (3 × 500 mL). The combined organic layers were washed with water and then brine, dried over sodium sulfate, filtered, and combined with the first lot of residue. This organic solution was washed with brined, dried over sodium sulfate, fitlered, and concentrated to provide a yellow solid which was used directly in the next reaction. </div><div class="NLM_p">Step 2: To a solution of 7-bromo-3-methoxy-5-methyl-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-ol (23.5 g, 72.9 mmol, from step 1) in THF (729 mL, 72.9 mmol) was added HCl (1 M in ether) (0.729 mL, 0.729 mmol). After heating at 45 °C for 10 min, more HCl (1 M in ether) (0.729 mL, 0.729 mmol) was added. The reaction was heated at 45 °C for a total of 30 min, at which point TLC indicated complete conversion to olefin. This light-yellow solution was cooled to −25 °C and added to the slurry generated below.</div><div class="NLM_p last">To a solution of iodine (20.37 g, 80 mmol) and THF (400 mL) at −15 °C was added silver cyanate (32.8 g, 219 mmol). The resulting slurry was maintained at −40 °C for 25 min, and then the olefin solution (generated above) was added via cannula over 15 min, maintaining the temperature below −35 °C. The derived slurry was maintained at −30 °C for 1 h and then was filtered through a pad of Celite, washing well with 200 mL of THF. The derived brown solution was cooled to −20 °C and treated with ammonia (2.0 M in 2-propanol, 219 mL, 438 mmol). The resulting solution was allowed to slowly warm to room temperature overnight. To the reaction was added 10% aq sodium thiosulfate solution (700 mL), and the resulting light-orange solution was stirred for 10 min before being poured into a separatory funnel containing EtOAc (250 mL). The layers were separated, and the organic layer was washed with brine and concentrated in vacuo to provide an orange mixture still containing a considerable amount of water. This mixture was combined with the organic extracts obtained below.The aqueous layer was extracted with ethyl acetate (2 × 500 mL). These organics were combined with the organics obtained and poured into a separatory funnel. The layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 100 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to provide 25 g of racemic 7-bromo-3-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine as a brown solid. This material was dissolved in DCM (200 mL) and MeOH (200 mL). The solution was purified by chromatography, using 6 mL injections on a 5 μm, 5 cm × 15 cm Chiralpak AD column with 50% MeOH/0.2% diethylamine/50% CO<sub>2</sub> at a flow rate of 250 mL/min to afford peak 1, (<i>R</i>)-7-bromo-3-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (8.235 g, 22.74 mmol, 31.2% yield), and peak 2, (<i>S</i>)-7-bromo-3-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (7.53 g, 20.79 mmol, 28.5% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.30–8.22 (m, 1 H), 7.66 (d, <i>J</i> = 2.2 Hz, 1 H), 7.17 (d, <i>J</i> = 9.0 Hz, 1 H), 6.96 (dd, <i>J</i> = 3.0, 8.9 Hz, 1 H), 6.83 (d, <i>J</i> = 3.0 Hz, 1 H), 6.55 (br s, 2 H), 5.50 (s, 1 H), 4.29–4.10 (m, 2 H), 3.76 (s, 3 H). MS <i>m</i>/<i>z</i> = 362.0 [M + H]<sup>+</sup>. Calcd for C<sub>15</sub>H<sub>13</sub>BrN<sub>3</sub>O: 362.0.</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-2′-Amino-7-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-3-ol (<b>7</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-7-bromo-3-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>6</b>) (6.0 g, 16.57 mmol) in DCM (166 mL) at 0 °C was added boron tribromide (9.40 mL, 99 mmol). This led to the immediate formation of a light-orange precipitate. The resulting slurry was removed from the ice bath and allowed to stir at room temperature for 12 h. The mixture was cooled to −20 °C and treated with methanol (6.70 mL, 166 mmol), followed immediately by saturated aq sodium bicarbonate (1 L). DCM (500 mL) was added, and the mixture was warmed to room temperature. The layers were separated, and the aqueous layer was extracted with methylene chloride (500 mL). The combined organic layers were washed with brine and dried over sodium sulfate. The aqueous layer was then extracted with ethyl acetate (2 × 500 mL). The combined organics were washed with brine, dried over sodium sulfate, and combined with the organic solution obtained above. The aqueous layer was then stirred overnight with 500 mL of ethyl acetate. The organic layer was removed, washed with brine, dried over sodium sulfate, and filtered. This solution was combined with the organic layers above and concentrated in vacuo to provide an orange solid. This solid was taken up in 10 mL of DCM and purified by silica gel chromatography (0–10% MeOH/DCM with 0.1% ammonium hydroxide) to provide (<i>S</i>)-2′-amino-7-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-3-ol (2.95 g, 8.47 mmol, 51.1% yield) as a light-orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.88 (br s, 1 H), 7.81 (d, <i>J</i> = 2.7 Hz, 1 H), 7.59–7.44 (m, 2 H), 7.28–7.12 (m, 2 H), 4.31 (br s, 2 H), 4.06 (q, <i>J</i> = 5.2 Hz, 1 H), 3.18 (s, 1 H), 3.16 (s, 1 H).</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-7-Bromo-3-(neopentyloxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>8</b>)</h4><div class="NLM_p last">To a solution of (<i>S</i>)-2′-amino-7-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-3-ol (0.900 g, 2.59 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (10.34 mL, 2.59 mmol) at rt was added cesium carbonate (2.106 g, 6.46 mmol). The mixture was stirred for a 1 min, and then 1-iodo-2,2-dimethylpropane (0.514 mL, 3.88 mmol) was added. The mixture was heated to 100 °C for 3 h. After cooling to room temperature, the reaction mixture was diluted with water (250 mL) and poured into a separatory funnel containing ethyl acetate (250 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (3 × 200 mL). The combined organic layers were washed with water and then brine, dried over sodium sulfate, filtered, and concentrated. The aq layer was then extracted with DCM (4 × 150 mL). The combined organics were washed with brine, dried over sodium sulfate, filtered, and concentrated. The two residues were combined, and the combined residue was purified by chromatography on silica gel (0–10% MeOH/DCM 0.1% ammonium hydroxide). The resulting material was purified again by chromatography on silica gel (0–100% EtOAc/DCM) to provide (<i>S</i>)-7-bromo-3-(neopentyloxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (680 mg, 1.626 mmol, 62.9% yield) as an orange solid. MS <i>m</i>/<i>z</i> = 418.0 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>21</sub>BrN<sub>3</sub>O<sub>3</sub>: 418.0.</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 3-Bromo-7-iodo-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (<b>11</b>)</h4><div class="NLM_p">Step 1: 5-Bromo-2-(4-iodophenoxy)nicotinic acid, a round-bottom flask under N<sub>2</sub>(g) was charged with sodium hydride (22.40 g, 560 mmol) and DMF (540 mL). The slurry was cooled to 0 °C and carefully treated with 4-iodophenol (58.6 g, 266 mmol) portionwise, resulting in bubbling. After the bubbling had subsided, 5-bromo-2-chloronicotinic acid (60.2 g, 255 mmol) was then added to slurry portionwise and the resulting mixture was heated to 115 °C overnight. The mixture was cooled to room temperature then diluted with water (240 mL). Acetic acid (ca. 60 mL) was added until the mixture achieved pH of 4–5. Water (1260 mL) was added via addition funnel, and the resulting mixture was cooled in an ice-bath for 1.5 h. The mixture was filtered, and the collected solid was washed with water and dried on the filter overnight to give 5-bromo-2-(4-iodophenoxy)nicotinic acid (80.9 g, 76%) as a light-brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.56 (br s, 1 H), 8.40 (dd, <i>J</i> = 2.6, 13.4 Hz, 2 H), 7.82–7.60 (m, 2 H), 7.05–6.80 (m, 2 H). MS <i>m</i>/<i>z</i> = 420.0 [M + H]<sup>+</sup>. Calcd for C<sub>12</sub>H<sub>8</sub>BrINO<sub>3</sub>: 419.9.</div><div class="NLM_p last">Step 2: 3-Bromo-7-iodo-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one, 5-bromo-2-(4-iodophenoxy)nicotinic acid (80.9 g, 193 mmol) was added portionwise to a round-bottom flask containing polyphosphoric acid at 110 °C. When the addition was complete, the mixture was stirred at 110 °C overnight and then at 140 °C for 1.5 h. The mixture was cooled to 35 °C and then added slowly to ice-cold water (1.2 L). The resulting slurry was stirred for 1 h at room temperature, and then the solid was filtered. The collected solid was washed with water (2×), washed with 2-PrOH, and dried under vacuum to give 3-bromo-7-iodo-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (65.9 g, 85%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.95 (d, <i>J</i> = 2.6 Hz, 1 H), 8.71 (d, <i>J</i> = 2.5 Hz, 1 H), 8.39 (d, <i>J</i> = 2.2 Hz, 1 H), 8.20 (dd, <i>J</i> = 2.2, 8.8 Hz, 1 H), 7.59 (d, <i>J</i> = 8.8 Hz, 1 H).</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-3-Bromo-7-iodo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>12</b>)</h4><div class="NLM_p">Step 1: A mixture of 3-bromo-7-iodo-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (33.0 g, 82 mmol) and THF (1642 mL, 82 mmol) in a 3 L three-neck flask was cooled to −40 °C. To this slurry was added methylmagnesium bromide (1 M in butyl ether) (164 mL, 164 mmol) via an addition funnel over 10 min. The internal temperature rose to −30 °C during the addition. The flask was maintained in the cooling bath and slowly allowed to warm to 0 °C over the course of 2 h. The reaction mixture was diluted with saturated aq ammonium chloride (1 L) and poured into a separatory funnel containing ethyl acetate (250 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 250 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo (maintained on the rotovap at 80 °C for 30 min) to provide the tertiary alcohol as a light-yellow solid. The derived alcohol was taken up in 150 mL of THF and 50 mL of chloroform and maintained at 80 °C for 30 min. The yellow solid was concentrated under reduced pressure to give the crude olefin as an orange solid. The material was used directly in next step. </div><div class="NLM_p last">Step 2: A 2 L round-bottom flask charged with iodine (19.99 g, 79 mmol) and 600 mL of THF was cooled in a dry ice acetone bath until an internal temperature of −25 °C was maintained, at which point silver cyanate (33.7 g, 225 mmol) was added in one portion. During this addition, the internal temperature rose to −20 °C. The resulting slurry was maintained at between −25 and −20 °C for 20 min, at which point a solution of the crude 3-bromo-7-iodo-5-methylene-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridine (30.0 g, 75.0 mmol) in 500 mL of THF was added via cannula over the course of 5 min. The internal temperature rose to −10 °C during this addition. The flask was recooled to −20 °C and maintained between −20 and −10 °C for 1.5 h. The reaction mixture was filtered through a plug of Celite (500 g) with the aid of diethyl ether (until the filtrate was colorless). The filtrate was concentrated in vacuo, and the resulting brown oily residue was taken up in THF (1 L). The resulting mixture was cooled to 0 °C and treated with ammonia (2 M in 2-propanol, 225 mL, 450 mmol). Following the addition, the flask was removed from the ice bath and maintained stirred for 8 h. The reaction mixture was diluted with 10% aq sodium thiosulfate solution (1 L) and poured into a separatory funnel containing ethyl acetate (500 mL) and brine (250 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 500 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to provide a brown residue. The residue was dried further by concentration from toluene (3 × 100 mL). The residue was then triturated with DCM/MeOH (600 mL/300 mL) and cooled to 0 °C overnight. The mixture was then filtered. The solid was collected and the filtrate was concentrated, and the trituration procedure was repeated twice more. The collected solids were combined, and the filtrate was further purified by chromatography on silica gel (0–10% MeOH/DCM with 0.1% ammonium hydroxide). The product thus obtained was combined with solid to give 21.9 g of racemic (<i>S</i>)-3-bromo-7-iodo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine. A portion of this material (16 g) was dissolved in a mixture of DCM (150 mL), MeOH (150 mL), and DMSO (25 mL). The solution was purified by SFC, using 6 mL injections on a 5 μm, 5 cm × 15 cm Chiralpak AD column with 35% MeOH/0.2% diethylamine/65% CO<sub>2</sub> at a flow rate of 250 mL/min. This afforded peak 1, (<i>R</i>)-3-bromo-7-iodo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (4.50 g, 9.82 mmol, 13.10% yield), and peak 2, (<i>S</i>)-3-bromo-7-iodo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (4.45 g, 9.72 mmol, 12.95% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.40 (d, <i>J</i> = 2.55 Hz, 1 H), 7.87 (d, <i>J</i> = 2.54 Hz, 1 H), 7.70 (dd, <i>J</i> = 8.56, 2.20 Hz, 1 H), 7.58 (d, <i>J</i> = 2.05 Hz, 1 H), 7.08 (d, <i>J</i> = 8.51 Hz, 1 H), 6.63 (s, 2 H), 4.16–4.30 (m, 2 H).</div></div><div id="sec4_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-3-Bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>13</b>)</h4><div class="NLM_p last">A 50 mL round-bottom flask was charged with (<i>S</i>)-3-bromo-7-iodo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (2.56 g, 5.59 mmol), 2-fluoro-3-pyridineboronic acid (1.103 g, 7.82 mmol), potassium carbonate (2.317 g, 16.77 mmol), and 1,1′-bis(diphenylphosphino)ferrocene-palladium dichloride (0.228 g, 0.279 mmol). The flask was flushed with Ar(g), and then 1,4-dioxane (11.18 mL) and water (5.5 mL) were added in sequence. The flask was fitted with a reflux condenser and heated to 70 °C for 40 min. The mixture was cooled to room temperature and diluted with EtOAc (20 mL) and water (20 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (20 mL). The organic layers were combined, and the combined solution was dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–100% EtOAc/heptane) to give (<i>S</i>)-3-bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (2.172 g, 5.08 mmol, 91% yield) as an orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.42 (d, <i>J</i> = 2.4 Hz, 1 H), 8.29–8.21 (m, 1 H), 8.12 (ddd, <i>J</i> = 2.0, 7.4, 10.4 Hz, 1 H), 7.88 (d, <i>J</i> = 2.4 Hz, 1 H), 7.67–7.61 (m, 1 H), 7.57 (t, <i>J</i> = 1.8 Hz, 1 H), 7.49 (ddd, <i>J</i> = 2.0, 4.9, 7.5 Hz, 1 H), 7.38 (d, <i>J</i> = 8.6 Hz, 1 H), 6.58 (s, 2 H), 4.36–4.21 (m, 2 H). MS <i>m</i>/<i>z</i> = 427.0 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>13</sub>BrFN<sub>4</sub>O<sub>2</sub>: 427.0.</div></div><div id="sec4_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-Bromo-7-methoxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (<b>15</b>)</h4><div class="NLM_p">Step 1: To a round-bottom flask charged with sodium hydride (60% dispersion in oil, 26.6 g, 666 mmol) was added <i>N</i>,<i>N</i>-dimethylformamide (634 mL, 317 mmol). The slurry was cooled to 0 °C and carefully treated with 4-methoxyphenol (39.4 g, 317 mmol) portionwise over 7 min, resulting in the evolution of a large amount of hydrogen gas. The mixture was stirred for 2 min, and then the ice bath was removed. After another 5 min of stirring, 5-bromo-2-chloronicotinic acid (75 g, 317 mmol) was slowly added portionwise over 5 min. After the addition was complete, the solution was heated to 140 °C for 1 h. The reaction mixture was cooled to room temperature and diluted with ice–water (750 mL). The brown mixture was acidified with acetic acid (91 mL, 1586 mmol), and then concentrate hydrochloric acid (93 mL, 1110 mmol) was added, resulting in the formation of a white precipitate. The pink slurry was stirred at room temperature for 2 h before being filtered to provide an off-white solid. This white solid contained residual DMF and was further dried under vacuum at 80 °C for 1 h to provide 5-bromo-2-(4-methoxyphenoxy)nicotinic acid (85.10 g, 263 mmol, 83% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ = 8.58 (d, <i>J</i> = 2.5 Hz, 1 H), 8.35 (d, <i>J</i> = 2.6 Hz, 1 H), 7.16–7.06 (m, 2 H), 7.02–6.92 (m, 2 H), 3.84 (s, 3 H).</div><div class="NLM_p last">Step 2: 5-Bromo-2-(4-methoxyphenoxy)nicotinic acid (85 g, 262 mmol) was added to a round-bottom flask containing polyphosphoric acid (900 g, 262 mmol) which had been heated to 140 °C. The mixture was maintained at 140 °C for 2 h and then cooled for 15 min. The partially cooled reaction mixture was poured onto 750 g of ice. The resulting mixture was then carefully adjusted with 10 M aq NaOH solution to a pH of 9–10 (during this quench the internal temperature rose to 100 °C). The mixture was cooled to room temperature and filtered. This material was taken up in DCM (200 mL), MeOH (200 mL), and benzene (100 mL). The mixture was concentrated in vacuo. The residue was taken up in DCM (400 mL) and MeOH (400 mL), and the resulting orange slurry was heated to 65 °C for 1 h, and then the hot solution was filtered. The filtrate was concentrated to afford 3-bromo-7-methoxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (53.3 g, 174 mmol, 66.4% yield) as an orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.94 (d, <i>J</i> = 2.6 Hz, 1 H), 8.72 (d, <i>J</i> = 2.6 Hz, 1 H), 7.77–7.70 (m, 1 H), 7.61–7.50 (m, 2 H), 3.90 (s, 3 H). MS <i>m</i>/<i>z</i> = 306.0 [M + H]<sup>+</sup>. Calcd for C<sub>13</sub>H<sub>9</sub>BrNO<sub>3</sub>: 306.0.</div></div><div id="sec4_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-3-Bromo-7-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>16</b>)</h4><div class="NLM_p">Step 1: A three-neck 5 L flask equipped with an addition funnel and overhead stirrer was charged with 3-bromo-7-methoxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (52.00 g, 170 mmol). THF (1.7 L) was added, and the reaction vessel was cooled in an ice bath. When the internal temperature reached 5 °C, methylmagnesium bromide (1 M in butyl ether) (340 mL, 340 mmol) was added dropwise via an addition funnel over the course of 15 min. The red slurry was removed from the ice bath and stirred at rt for 1.5 h. The reaction was carefully quenched with saturated aq ammonium chloride solution (1.2 L). DCM (1 L) was added, and the yellow mixture was stirred for 30 min. The layers were separated, and the aqueous layer was extracted with DCM (3 × 500 mL). The organic layers were each individually washed with brine and then combined. The combined solution was dried over sodium sulfate, filtered, and concentrated in vacuo at 75 °C provide an orange solid. The solid was suspended in MeOH (700 mL) and heated to 60 °C. The warm slurry was filtered to give 21.5 g of a light-yellow solid. The filtrate was concentrated, and the residue was purified by chromatgraphy on silica gel (eluting with DCM) to afford another 6.0 g of solid. The two solids were combined and dried under vacuum to give 3-bromo-7-methoxy-5-methylene-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridine (27.5 g, 53% yield) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.60 (d, <i>J</i> = 2.3 Hz, 1 H), 8.38 (d, <i>J</i> = 2.4 Hz, 1 H), 7.34 (d, <i>J</i> = 2.9 Hz, 1 H), 7.20 (d, <i>J</i> = 9.0 Hz, 1 H), 7.02 (dd, <i>J</i> = 2.9, 9.0 Hz, 1 H), 5.95 (d, <i>J</i> = 1.1 Hz, 1 H), 5.90 (d, <i>J</i> = 1.0 Hz, 1 H), 3.82 (s, 3 H),</div><div class="NLM_p last">Step 2: A round-bottom flask was charged with iodine (18.49 g, 72.8 mmol) and THF (347 mL, 69.4 mmol). The resulting solution was cooled to −15 °C and treated in one portion with silver isocyanate (31.2 g, 208 mmol). The temperature, which rose to −12 °C during the addition, was lowered to −20 °C and maintained for 15 min. A solution of 3-bromo-7-methoxy-5-methylene-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridine (21.10 g, 69.4 mmol) in THF (347 mL, 69.4 mmol) was added, and the resulting mixture was maintained at −20  to −10 °C for 1 h. The yellow slurry was diluted with ether (250 mL) and filtered through a pad of celilte, washing well with ether and THF. The resulting brown filtrate was concentrated under reduced pressure, with minimal heating. The derived brown oil was taken up in THF (347 mL, 69.4 mmol), cooled to 0 °C, and treated with ammonia (2 M in 2-PrOH) (104 mL, 208 mmol). The solution was maintained at 0 °C for 15 min then warmed to room temperature, where it was maintained for 10 h. The reaction was diluted with 10% aq sodium thiosulfate solution (1 L) and poured into a separatory funnel containing EtOAc (250 mL). The layers were separated, and the aq layer was extracted with EtOAc (3 × 250 mL). The combined organic extracts were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was purified by silical gel chromatography (0–100% EtOAc/hexanes) to provide <i>rac</i>-3-bromo-7-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (17.5 g, 48.3 mmol, 69.6% yield) as a yellow solid. This material was dissolved in 1:1 DCM/MeOH (300 mL), and the resulting solution was purified by SFC, using 4 mL injections on a 5 cm × 25 cm Chiralpak AD-H column with 35% MeOH/0.2% diethylamine/65% CO<sub>2</sub> at a flow rate of 250 mL/min to give peak 1, (<i>R</i>)-3-bromo-7-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (6.47 g), and peak 2, (<i>S</i>)-3-bromo-7-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (7.12 g, 28% yield). Data for peak 2: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.37 (d, <i>J</i> = 2.5 Hz, 1 H), 7.83 (d, <i>J</i> = 2.4 Hz, 1 H), 7.18 (d, <i>J</i> = 8.9 Hz, 1 H), 6.96 (dd, <i>J</i> = 3.1, 8.9 Hz, 1 H), 6.81 (d, <i>J</i> = 2.9 Hz, 1 H), 6.58 (br s, 2 H), 4.32–4.12 (m, 2 H), 3.76 (s, 3 H).</div></div><div id="sec4_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-2′-Amino-3-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (<b>17</b>)</h4><div class="NLM_p last">A 250 mL round-bottom flask was charged with a solution of (<i>S</i>)-3-bromo-7-methoxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (1.832 g, 5.06 mmol) in DCM (50.6 mL). The flask was cooled in an ice-bath for 10 min, and then BBr<sub>3</sub> (1.913 mL, 20.23 mmol) was added over 30 s, slightly faster than dropwise. The mixture was stirred for 5 min, and then the ice-bath was removed. The mixture was stirred for 5 h at room temperature and then was diluted with saturated aq sodium bicarbonate solution (75 mL). A solid formed, so THF (30 mL) was added and the mixture was stirred overnight. The layers were separated, and the aqueous layer was extracted with DCM (3 × 50 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated to give an orange solid. The solid was taken up in DCM (50 mL), and the resulting mixture was sonicated for 10 min. The mixture was then cooled in an ice-bath for 20 min. The solid was filtered, washed with cold DCM (30 mL), and dried under vacuum to give give (<i>S</i>)-2′-amino-3-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (1.089 g, 3.13 mmol, 61.8% yield) as a cream-colored solid. MS <i>m</i>/<i>z</i> = 347.8 [M + H]<sup>+</sup>. Calcd for C<sub>14</sub>H<sub>11</sub>BrN<sub>3</sub>O<sub>3</sub>: 348.0.</div></div><div id="sec4_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-Bromo-7-hydroxy-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (<i>rac</i>-<b>17</b>)</h4><div class="NLM_p last">To a solution of <i>rac</i>-3-bromo-7-methoxy-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (2300 mg, 6350 μmol) in DCM (12.7 mL 6.35 mmol) at 0 °C was added BBr<sub>3</sub> (1.8 mL, 19 mmol). Immediately a thick precipitate formed. The resulting red slurry was stirred at 0 °C for 10 min, at which point the ice bath was removed and the mixture was allowed to warm to rt and stirred at rt for 1 h. Another portion of BBr<sub>3</sub> (1 mL) at 23 °C, and the mixture was stirred for 1 h. The reaction was cooled to 0 °C and carefully quenched with saturated aq sodium bicarbonate solution (250 mL) and then poured into DCM (250 mL). The layers were separated, and the aqueous layer was extracted with DCM (3 × 300 mL). The organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The extraction process was repeated with DCM. All organic layers were combined and concentrated under reduced pressure to provide 3-bromo-7-hydroxy-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (2.2 g, 99% yield) as a brown solid. MS <i>m</i>/<i>z</i> = 348.0 [M + H]<sup>+</sup>. Calcd for C<sub>14</sub>H<sub>11</sub>BrN<sub>3</sub>O<sub>3</sub>: 348.0.</div></div><div id="sec4_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-2′-Amino-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (<b>18a</b>)</h4><div class="NLM_p">Step 1: A vial was charged with (<i>S</i>)-2′-amino-3-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (380 mg, 1.091 mmol), potassium carbonate (754 mg, 5.46 mmol), 2-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (688 mg, 3.27 mmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (126 mg, 0.109 mmol), DMF (5457 μL), and water (2.5 mL). The vial was sealed and heated to 80 °C overnight. The mixture was diluted with water (35 mL) and extracted with EtOAc (3 × 15 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–100% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to give give (<i>S</i>)-2′-amino-3-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (267.7 mg, 0.762 mmol, 69.8% yield) as an orange solid. MS <i>m</i>/<i>z</i> = 352.0 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>18</sub>N<sub>3</sub>O<sub>4</sub>: 352.1.</div><div class="NLM_p last">Step 2: A 25 mL flask was charged with (<i>S</i>)-2′-amino-3-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (211 mg, 0.601 mmol) and MeOH (7.5 mL). The mixture was sonicated for 1 min to give an opaque mixture. 10% Pd/C (63.9 mg, 0.060 mmol) was added, and H<sub>2</sub>(g) was bubbled through the mixture for 1 min. The mixture was stirred further under a balloon of H<sub>2</sub>(g) for 24 h. H<sub>2</sub>(g) was again bubbled in for 1 min, and the mixture was stirred for 2 days under a H<sub>2</sub>(g) balloon. The mixture was filtered through Celite with the aid of methanol. The filtrate was evaporated, and the residue was purified by chromatography on silica gel (0–100% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH) to give (<i>S</i>)-2′-amino-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (201.8 mg, 0.698 mmol, 82% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.31 (s, 1 H), 8.13 (d, <i>J</i> = 2.3 Hz, 1 H), 7.60 (d, <i>J</i> = 2.4 Hz, 1 H), 7.09–6.97 (m, 1 H), 6.81–6.68 (m, 2 H), 6.48 (s, 2 H), 4.16–4.08 (m, 2 H), 3.95 (dd, <i>J</i> = 1.9, 9.5 Hz, 2 H), 3.48–3.38 (m, 2 H), 2.91–2.78 (m, 1 H), 1.77–1.56 (m, 4 H). MS <i>m</i>/<i>z</i> = 354.0 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>20</sub>N<sub>3</sub>O<sub>4</sub>: 354.2.</div></div><div id="sec4_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-2′-Amino-3-(6,6-dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (<b>18b</b>)</h4><div class="NLM_p last">A microwave reaction vial was charged with (<i>S</i>)-2′-amino-3-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (0.850 g, 2.441 mmol), 2-(2,2-dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (as a 1.5:1 mixture of olefin isomers, 0.930 g, 3.91 mmol), potassium carbonate (1.012 g, 7.32 mmol) and PdCl<sub>2</sub>(AmPhos)<sub>2</sub> (0.086 g, 0.122 mmol), 1,4-dioxane (14.24 mL), and water (2.035 mL). The vial was sealed and heated in microwave reactor for 1 h at 100 °C. The reaction mixture was diluted with water and washed with EtOAc. The aqueous layer was extracted with EtOAc, and the combined organic layers were dried with sodium sulfate, filtered, and concentrated. The residue was purified via column chromatography on silica gel (0–80% of a 90:10:1 mixture of DCM/MeOH/NH<sub>4</sub>OH in DCM). The resulting material was repurified to collect the title regiosomer as the first eluting peak to afford (<i>S</i>)-2′-amino-3-(6,6-dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (0.604 g, 1.592 mmol, 65.2% yield) as a tan solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.35 (br s, 1 H), 8.31 (d, <i>J</i> = 2.4 Hz, 1 H), 7.73 (d, <i>J</i> = 2.4 Hz, 1 H), 7.08–7.00 (m, 1 H), 6.83–6.69 (m, 2 H), 6.50 (s, 2 H), 6.17 (t, <i>J</i> = 1.5 Hz, 1 H), 4.14 (s, 2 H), 3.83 (t, <i>J</i> = 5.4 Hz, 2 H), 2.40–2.32 (m, 2 H), 1.27 (s, 3 H), 1.27 (s, 3 H). MS <i>m</i>/<i>z</i> = 380.2 [M + H]<sup>+</sup>. Calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>: 380.2.</div></div><div id="sec4_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-2′-Amino-3-morpholino-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (<b>18c</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-2′-amino-3-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (0.647 g, 1.858 mmol), DavePhos (0.088 g, 0.223 mmol), and tris(dibenzylideneacetone)dipalladium(0) (0.085 g, 0.093 mmol). The vessel was flushed with Ar(g), and then lithium bis(trimethylsilyl)amide (1.0 M in THF) (9.29 mL, 9.29 mmol) and morpholine (0.486 mL, 5.58 mmol) were added in sequence. The vial was sealed and heated at 70 °C for 1 h. The mixture was diluted with water and saturated aq ammoniom chloride solution. The mixture was extracted with DCM (3 × 30 mL) and EtOAc (3×). The combined organic extracts were combined, dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–10% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to afford (<i>S</i>)-2′-amino-3-morpholino-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (0.336 g, 0.948 mmol, 51.0% yield) as an orange solid. MS <i>m</i>/<i>z</i> = 355.2 [M + H]<sup>+</sup>. Calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O<sub>4</sub>: 355.1.</div></div><div id="sec4_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-2′-Amino-3-(<i>p</i>-tolyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (<b>18d</b>)</h4><div class="NLM_p last">A vial was charged (<i>S</i>)-2′-amino-3-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (282 mg, 0.809 mmol), <i>p</i>-tolylboronic acid (220 mg, 1.618 mmol), potassium carbonate (559 mg, 4.04 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (46.7 mg, 0.040 mmol). The vial was flushed with Ar(g), and then 1,4-dioxane (4 mL) and water (2 mL) were added in sequence. The vial was sealed and heated to 80 °C for 1.5 h. The mixture was partitioned between brine and 10% iPrOH/EtOAc. The layers were separated, and the aqueous layer was extracted with EtOAc. The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–80% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to give (<i>S</i>)-2′-amino-3-<i>p</i>-tolyl-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (259.36 mg, 0.722 mmol, 89% yield) as an orange solid. MS <i>m</i>/<i>z</i> = 360.0 [M + H]<sup>+</sup>. Calcd for C<sub>21</sub>H<sub>18</sub>N<sub>3</sub>O<sub>3</sub>: 360.1.</div></div><div id="sec4_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-4-(2′-Amino-7-hydroxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-3-yl)benzonitrile (<b>18e</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-2′-amino-3-bromo-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (247 mg, 0.711 mmol), 4-cyanophenylboronic acid (313 mg, 2.132 mmol), potassium carbonate (491 mg, 3.55 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (82 mg, 0.071 mmol). The vial was flushed with Ar(g), and then 1,4-dioxane (3553 μL) and water (1.8 mL) were added in sequence. The vial was sealed and heated to 80 °C overnight. The next morning, the mixture was diluted with water (40 mL) and extracted with EtOAc (3 × 20 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–9% MeOH/DCM) to give (<i>S</i>)-4-(2′-amino-7-hydroxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-3-yl)benzonitrile (181.62 mg, 0.490 mmol, 69.0% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.39 (s, 1 H), 8.65 (d, <i>J</i> = 2.5 Hz, 1 H), 8.05 (d, <i>J</i> = 2.4 Hz, 1 H), 8.00–7.86 (m, 4 H), 7.14–7.03 (m, 1 H), 6.81–6.70 (m, 2 H), 6.50 (br s, 2 H), 4.31–4.25 (m, 1 H), 4.23–4.18 (m, 1 H). MS <i>m</i>/<i>z</i> = 371.0 [M + H]<sup>+</sup>. Calcd for C<sub>21</sub>H<sub>15</sub>N<sub>4</sub>O<sub>3</sub>: 371.1.</div></div><div id="sec4_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-2′-Amino-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-yl Trifluoromethanesulfonate (<b>19a</b>)</h4><div class="NLM_p last">A 25 mL round-bottom flask was charged with (<i>S</i>)-2′-amino-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-oland triethylamine (194 μL, 1.392 mmol) in DCM (2.5 mL) to give an opaque mixture. <i>N</i>-Phenyltrifluoromethanesulfonimide (261 mg, 0.731 mmol) was added, and the resulting mixture was stirred for 24 h. An additional portion of <i>N</i>-phenyltrifluoromethanesulfonimide (50 mg) was added, and the mixture was stirred for an additional 4 h. The reaction mixture was diluted with DCM (20 mL) and saturated aq sodium bicarbonate solution (20 mL). The layers were separated, and the aqueous layer was extracted with DCM (2 × 10 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–7% MeOH/DCM) to give (<i>S</i>)-2′-amino-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (280.69 mg, 0.578 mmol, 83% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.22 (d, <i>J</i> = 2.3 Hz, 1 H), 7.68 (br s, 1 H), 7.57–7.50 (m, 1 H), 7.46–7.41 (m, 1 H), 7.36 (br s, 1 H), 4.24 (br s, 2 H), 3.96 (dd, <i>J</i> = 1.7, 11.2 Hz, 2 H), 3.44 (tt, <i>J</i> = 2.5, 11.2 Hz, 2 H), 2.96–2.81 (m, 1 H), 1.75–1.59 (m, 4 H). MS <i>m</i>/<i>z</i> = 485.8 [M + H]<sup>+</sup>. Calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>3</sub>O<sub>6</sub>S: 486.1.</div></div><div id="sec4_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>S</i>)-2′-Amino-3-(6,6-dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-yl Trifluoromethanesulfonate (<b>19b</b>)</h4><div class="NLM_p last">(<i>S</i>)-2′-Amino-3-(6,6-dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (0.231 g, 0.609 mmol) and triethylamine (0.255 mL, 1.827 mmol) were combined in DCM (12.18 mL). 1,1,1-Trifluoro-<i>N</i>-phenyl-<i>N</i>-(trifluoromethylsulfonyl)methanesulfonamide (0.239 g, 0.670 mmol) was added, and the solution was stirred at room temperature overnight. In the morning, the solution purified directly by chromatography on silica gel (0–60% of a 90:10:1 mixture of DCM/MeOH/NH<sub>4</sub>OH in DCM) to afford (<i>S</i>)-2′-amino-3-(6,6-dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (0.258 g, 0.504 mmol, 83% yield) as a off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.38 (d, <i>J</i> = 2.4 Hz, 1 H), 7.78 (s, 1 H), 7.54 (dd, <i>J</i> = 3.0, 9.0 Hz, 1 H), 7.48–7.40 (m, 1 H), 7.32 (br s, 1 H), 6.65 (br s, 2 H), 6.23 (s, 1 H), 4.33–4.12 (m, 2 H), 3.84 (t, <i>J</i> = 5.4 Hz, 2 H), 2.41–2.34 (m, 2 H), 1.28 (s, 6 H). MS <i>m</i>/<i>z</i> = 512.1 [M + H]<sup>+</sup>. Calcd for C<sub>22</sub>H<sub>21</sub>F<sub>3</sub>N<sub>3</sub>O<sub>6</sub>S: 512.1.</div></div><div id="sec4_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>S</i>)-2′-Amino-3-morpholino-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-yl Trifluoromethanesulfonate (<b>19c</b>)</h4><div class="NLM_p last">A 25 mL round-bottom flask was charged with cesium carbonate (0.371 g, 1.138 mmol), (<i>S</i>)-2′-amino-3-morpholino-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (0.336 g, 0.948 mmol), and DMF (4.74 mL). The resulting mixture was stirred for 10 min, and then the flask was submerged in an ice bath for 5 min. <i>N</i>-Phenyltrifluoromethanesulfonimide (0.373 g, 1.043 mmol) was added as a single portion, and the reaction was stirred overnight, during which the ice bath was allowed to melt. In the morning, the mixture was cooled to 0 °C, and additional portions of cesium carbonate (150 mg) and <i>N</i>-phenyltrifluoromethanesulfonimide were added in sequence. The mixture was stirred for an additional 1 h and then was diluted with water and extracted with EtOAc (2×). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–70% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to afford (<i>S</i>)-2′-amino-3-morpholino-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (0.309 g, 0.635 mmol, 67% yield) as an off-white solid. The material was about 80% pure as determined by LCMS and was used directly in the next reaction. MS <i>m</i>/<i>z</i> = 487.2 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>18</sub>F<sub>3</sub>N<sub>4</sub>O<sub>6</sub>S: 487.1.</div></div><div id="sec4_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>S</i>)-2′-Amino-3-(<i>p</i>-tolyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-yl Trifluoromethanesulfonate (<b>19d</b>)</h4><div class="NLM_p last">A 25 mL flask was charged with (<i>S</i>)-2′-amino-3-<i>p</i>-tolyl-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-ol (259.36 mg, 0.722 mmol) in DCM (7217 μL) to give an clear, orange solution. Triethylamine (201 μL, 1.443 mmol) and 1,1,1-trifluoro-<i>N</i>-phenyl-<i>N</i>-(trifluoromethylsulfonyl)methanesulfonamide (271 mg, 0.758 mmol) were added in sequence. The resulting mixture was stirred for 3 h and then was purified directly by chromatography on silica gel (0–5% MeOH/DCM) to give (<i>S</i>)-2′-amino-3-<i>p</i>-tolyl-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (317.34 mg, 0.646 mmol, 89% yield) as a cream-colored solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.58 (d, <i>J</i> = 2.4 Hz, 1 H), 7.96 (d, <i>J</i> = 2.4 Hz, 1 H), 7.64–7.52 (m, 2 H), 7.49–7.43 (m, 1 H), 7.37–7.30 (m, 2 H), 6.66 (br s, 2 H), 4.40–4.16 (m, 2 H), 2.36 (s, 3 H). MS <i>m</i>/<i>z</i> = 492.0 [M + H]<sup>+</sup>. Calcd for C<sub>22</sub>H<sub>17</sub>F<sub>3</sub>N<sub>3</sub>O<sub>5</sub>S: 492.0.</div></div><div id="sec4_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>S</i>)-2′-Amino-3-(4-cyanophenyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-7-yl Trifluoromethanesulfonate (<b>19e</b>)</h4><div class="NLM_p last">A round-bottom flask was charged with (<i>S</i>)-4-(2′-amino-7-hydroxy-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-3-yl)benzonitrile (181.62 mg, 0.490 mmol) and DCM (4904 μL) to give a suspension. Triethylamine (137 μL, 0.981 mmol) was added, and the starting material dissolved after a few minutes of stirring. <i>N</i>-Phenyl-bis(trifluoromethanesulfonimide) (184 mg, 0.515 mmol) was added, and the mixture was stirred overnight. In the morning, the reaction mixture was diluted with saturated aq sodium bicarbonate solution (20 mL). The layers were separated, and the aqueous layer was extracted with DCM (2 × 20 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–5% MeOH/DCM) to give (<i>S</i>)-2′-amino-3-(4-cyanophenyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (186.48 mg, 0.371 mmol, 76% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.71 (d, <i>J</i> = 2.5 Hz, 1 H), 8.10 (d, <i>J</i> = 2.4 Hz, 1 H), 8.03–7.89 (m, 4 H), 7.59–7.53 (m, 1 H), 7.51–7.45 (m, 1 H), 7.34 (d, <i>J</i> = 2.9 Hz, 1 H), 6.65 (s, 2 H), 4.38 (d, <i>J</i> = 8.8 Hz, 1 H), 4.27 (d, <i>J</i> = 8.8 Hz, 1 H). MS <i>m</i>/<i>z</i> = 502.8 [M + H]<sup>+</sup>. Calcd for C<sub>22</sub>H<sub>14</sub>F3N<sub>4</sub>O<sub>5</sub>S: 503.1.</div></div><div id="sec4_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 7-Bromo-3-iodo-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (<b>21</b>)</h4><div class="NLM_p">Step 1: 2-(4-Bromophenoxy)-5-iodonicotinic acid. A solution of 2,2,6,6-tetramethylpiperidine (45.7 mL, 269 mmol) in THF (400 mL) was cooled to −10 °C and then treated with <i>n</i>-butyllithium (103 mL, 257 mmol). After stirring for 10 min, the reaction mixture was cooled to −78 °C. The cooled solution was treated with a solution of 2-fluoro-5-iodopyridine (54.6 g, 245 mmol) in THF (200 mL). The reaction mixture was stirred for 40 min, and then CO<sub>2</sub> (g) gas was bubbled through for 10 min via syringe. The reaction mixture was placed in a 0 °C bath, and CO<sub>2</sub>(g) was bubbled through for an additional 10 min. 4-Bromophenol (46.6 g, 269 mmol) and potassium carbonate (42.3 g, 306 mmol) were added in sequence. The reaction mixture was concentrated in vacuo, and the residue was suspended in DMF (500 mL). The resulting mixture was heated to 140 °C overnight. In the morning, the mixture was cooled to room temperature and then poured into 1N aq HCl. The resulting suspension was filtered, washed with 1:1 water/acetone, and dried to give 2-(4-bromophenoxy)-5-iodonicotinic acid (92.60 g, 220 mmol, 90% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ = 8.52 (d, <i>J</i> = 2.3 Hz, 1 H), 8.42 (d, <i>J</i> = 2.3 Hz, 1 H), 7.58–7.52 (m, 2 H), 7.08–7.04 (m, 2 H). MS <i>m</i>/<i>z</i> = 419.8 [M + H]<sup>+</sup>. Calcd for C<sub>12</sub>H<sub>8</sub>BrINO: 419.9. </div><div class="NLM_p last">Step 2: 7-Bromo-3-iodo-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one. A flask charged with 2-(4-bromophenoxy)-5-iodonicotinic acid (93 g, 220 mmol) and polyphosphoric acid 115% (926 g, 220 mmol) was heated to 120 °C overnight. In the morning, starting material persisted, so the reaction mixture was heated to 140 °C for 3 h. The reaction mixture was then cooled to room temperature and poured into water. The water slurry was stirred for 2 h and then filtered. The collected solid was washed with 1N aq NaOH, water, and 2-PrOH, then dried under air to yield 7-bromo-3-iodo-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (63.48 g, 158 mmol, 71.6% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ = 8.98 (d, <i>J</i> = 2.4 Hz, 1 H), 8.94 (d, <i>J</i> = 2.4 Hz, 1 H), 8.44 (d, <i>J</i> = 2.4 Hz, 1 H), 7.89 (dd, <i>J</i> = 2.4, 8.9 Hz, 1 H), 7.53 (d, <i>J</i> = 9.0 Hz, 1 H). MS <i>m</i>/<i>z</i> = 401.7 [M + H]<sup>+</sup>. Calcd for C<sub>12</sub>H<sub>6</sub>BrINO<sub>2</sub>: 401.7.</div></div><div id="sec4_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 7-Bromo-3-hydroxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (<b>22</b>)</h4><div class="NLM_p last">A flask charged with Pd(OAc)<sub>2</sub> (1.773 g, 7.90 mmol), X-Phos (11.29 g, 23.69 mmol), 7-bromo-3-iodo-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (63.5 g, 158 mmol), bis(pinacolato)diboron (42.1 g, 166 mmol), and potassium phosphate (101 g, 474 mmol) was diluted with 1,4-dioxane (600 mL), and the resulting mixture was stirred at room temperature overnight. The reaction mixture was filtered through a plug of Celite, and the filtrate was diluted with THF (500 mL) and a 6N aq sodium hydroxide solution (132 mL, 790 mmol). The resulting mixture was cooled to 0 °C, and hydrogen peroxide 30% (58.1 mL, 1895 mmol) was added dropwise. The resulting mixture was stirred for 5 h and then diluted with MeOH (500 mL). A 6N aq hydrochloric acid solution (150 mL) and a 10% aq sodium thiosulfate solution (300 mL) were added in sequence. The mixture was then concentrated in vacuo to remove the volatiles, and the resulting suspension was filtered. The collected solid was washed with 1:1 water/acetone and dried. The resulting dark-brown solid was triturated with warm diethyl ether then hot acetonitrile and then filtered to give 7-bromo-3-hydroxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (30.39 g, 104 mmol, 65.9% yield). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ = 8.43 (d, <i>J</i> = 2.2 Hz, 1 H), 8.32 (d, <i>J</i> = 2.8 Hz, 1 H), 8.03 (d, <i>J</i> = 2.7 Hz, 1 H), 7.83 (dd, <i>J</i> = 2.4, 8.8 Hz, 1 H), 7.54–7.47 (m, 1 H), 7.00 (s, 1 H). MS <i>m</i>/<i>z</i> = 291.9 [M + H]<sup>+</sup>. Calcd for C<sub>12</sub>H<sub>7</sub>BrNO<sub>3</sub>: 291.9.</div></div><div id="sec4_7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>rac</i>-7-Bromo-3-(2-methoxy-2-methylpropoxy)-5-methyl-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-ol (<b>23</b>)</h4><div class="NLM_p">Step 1: A solution of 7-bromo-3-hydroxy-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (15.00 g, 51.4 mmol) in DCM (100 mL) was treated with DBU (9.68 mL, 64.2 mmol) and stirred for 10 min. 3-Bromo-2-methylpropene (5.44 mL, 53.9 mmol) was added, and the resulting mixture was stirred for an additional hour. The reaction mixture was quenched with 0.5 N aq citric acid solution (200 mL) and concentrated in vacuo to remove the volatiles. The resulting suspension was filtered, and the collected solid was washed with 1:1 water/acetone and dried. The solid was purified by chromatography on silica gel (0–50% EtOAc/hexane), yielding 7-bromo-3-(2-methylallyloxy)-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (4.50 g, 13.00 mmol, 25.3% yield). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ = 8.51 (d, <i>J</i> = 3.2 Hz, 1 H), 8.34 (d, <i>J</i> = 2.5 Hz, 1 H), 8.06 (d, <i>J</i> = 3.3 Hz, 1 H), 7.95 (dd, <i>J</i> = 2.5, 8.9 Hz, 1 H), 7.59 (d, <i>J</i> = 8.9 Hz, 1 H), 5.15 (d, <i>J</i> = 0.7 Hz, 1 H), 5.06 (d, <i>J</i> = 1.6 Hz, 1 H), 4.67 (s, 2 H), 1.85 (d, <i>J</i> = 0.5 Hz, 3 H). MS <i>m</i>/<i>z</i> = 346.0 [M + H]<sup>+</sup>. Calcd for C<sub>16</sub>H<sub>13</sub>BrNO<sub>3</sub>: 346.0. </div><div class="NLM_p">Step 2: A suspension of 7-bromo-3-((2-methylallyl)oxy)-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (2.420 g, 6.99 mmol) in MeOH (100 mL) was treated with <i>N</i>-iodosuccinimide (7.86 g, 35.0 mmol), and the resulting mixture was stirred at room temperature for 36 h. The crude product was purified by chromatography on silica gel (0–100% EtOAc/hexane) to give 7-bromo-3-(3-iodo-2-methoxy-2-methylpropoxy)-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (2.33 g, 4.62 mmol, 66.1% yield) as an oil. <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ = 8.52 (d, <i>J</i> = 3.3 Hz, 1 H), 8.34 (d, <i>J</i> = 2.4 Hz, 1 H), 8.13–8.10 (m, 1 H), 7.95 (dd, <i>J</i> = 2.5, 8.9 Hz, 1 H), 7.60 (d, <i>J</i> = 9.0 Hz, 1 H), 4.24–4.07 (m, 2 H), 3.62–3.52 (m, 2 H), 3.27 (s, 3 H), 1.45 (s, 3 H). MS <i>m</i>/<i>z</i> = 503.9 [M + H]<sup>+</sup>. Calcd for C<sub>17</sub>H<sub>16</sub>BrINO<sub>4</sub>: 503.9. </div><div class="NLM_p last">Step 3: A solution of 7-bromo-3-(3-iodo-2-methoxy-2-methylpropoxy)-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-one (4.10 g, 8.13 mmol) in THF (100 mL) cooled to −40 °C was treated with methylmagnesium chloride (5.42 mL of 3 M solution in diethyl ether, 16.27 mmol). After stirring for 2 h, the reaction mixture was allowed to warm to room temperature. Lithium triethylborohydride (40.7 mL of a 1 M solution in THF, 40.7 mmol) was added added over 5 min. After stirring for an additional 2 h at room temperature, the reaction mixture was cooled to 0 °C and was quenched with MeOH. The reaction mixture was poured into saturated aq ammonium chloride solution and extracted with EtOAc. The organic layer was washed with water and brine, dried over MgSO<sub>4</sub>, and concentrated, yielding crude 7-bromo-3-(2-methoxy-2-methylpropoxy)-5-methyl-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-ol (1.80 g, 4.57 mmol, 56.1% yield). This material was used directly in the next reaction. MS <i>m</i>/<i>z</i> = 394.0 [M + H]<sup>+</sup>. Calcd for C<sub>18</sub>H<sub>21</sub>BrNO<sub>4</sub>: 394.0.</div></div><div id="sec4_7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>rac</i>-7-Bromo-3-(2-methoxy-2-methylpropoxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>24</b>)</h4><div class="NLM_p last">A solution of 7-bromo-3-(2-methoxy-2-methylpropoxy)-5-methyl-5<i>H</i>-chromeno[2,3-<i>b</i>]pyridin-5-ol (1.780 g, 4.51 mmol) in THF (50 mL) was treated with a 4 M HCl solution in 1,4-dioxane (0.113 mL, 0.451 mmol), and the resulting mixture was heated to 50 °C for 1 h to afford a solution containing the corresponding olefin. The solution was cooled to 0 °C. Separately, silver cyanate (1.692 g, 11.29 mmol) was added in one portion to a solution of iodine (1.260 g, 4.97 mmol) in THF (50 mL) maintained at −40 °C. The resulting was stirred for 1 h at −40 °C, and then the solution of olefin was via cannula. After an additional hour of stirring, ammonia (13.54 mL of 2 M solution in 2-PrOH) was added in one portion. The mixture was warmed to room temperature and stirred for a further 3 h. The reaction mixture was quenched with a 10% aq sodium thiosulfate solution, and the resulting biphasic mixture was stirred at room temperature for 1 h. The organic layer was separated, washed with water, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by chromatography on silica gel (0–10% MeOH/DCM) to give <i>rac</i>-bromo-3-(2-methoxy-2-methylpropoxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.319 g, 0.735 mmol, 16.27% yield) as an off-white solid. MS <i>m</i>/<i>z</i> = 434.0 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>21</sub>BrN<sub>3</sub>O<sub>4</sub>: 434.0.</div></div><div id="sec4_7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-Bromo-7-(2,2-dimethylpropoxy)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (<i>rac</i>-<b>25</b>)</h4><div class="NLM_p last">To a solution of 3-bromo-7-hydroxy-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (650 mg, 1867 μmol) and DMF (7468 μL, 1867 μmol) in a microwave vial were added cesium carbonate (1521 mg, 4668 μmol) and 1-iodo-2,2-dimethylpropane (0.495 mL, 3.74 mmol). The mixture was heated in a microwave at 100 °C for 1 h. An additional portion of 1-iodo-2,2-dimethylpropane (0.4 mL) was added, and the mixture was heated in the microwave at 100 °C for another 1 h. The reaction was diluted with water (5 mL) and EtOAc (5 mL) and stirred for 5 min until homogeneous. The resulting mixture was poured into 10 mL of ethyl acetate and 25 mL of saturated ammonium chloride, and the layers were separated. The aqueous layer was extracted with ethyl acetate (3 × 20 mL). The aqueous layer was then extracted with DCM (3 × 15 mL). The organic layers were each washed with brine, combined, dried over sodium sulfate, filtered, and concentrated. The resulting oil was purified by silica gel chromatography (0–100% EtOAc/hexanes) to provide 3-bromo-7-(2,2-dimethylpropoxy)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (375 mg, 48% yield) as a yellow solid. MS <i>m</i>/<i>z</i> = 418.2 [M + H]<sup>+</sup>. Calcd for C<sub>19</sub>H<sub>21</sub>BrN<sub>3</sub>O<sub>3</sub>: 418.1.</div></div><div id="sec4_7_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>S</i>)-3-(Neopentyloxy)-7-(pyrimidin-5-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>26</b>)</h4><div class="NLM_p last">A sealable tube was charged with (<i>S</i>)-7-bromo-3-(neopentyloxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (75 mg, 0.179 mmol), pyrimidin-5-ylboronic acid (89 mg, 0.717 mmol), potassium carbonate (124 mg, 0.897 mmol), PdCl<sub>2</sub>(AmPhos)<sub>2</sub> (6.35 mg, 8.97 μmol), THF (1793 μL), and water (1 mL). The tube was flushed with Ar(g), sealed, and heated to 110 °C for 1 h. The reaction was diluted with water (25 mL) and poured into a separatory funnel containing ethyl acetate (25 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 10 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to provide a brown foam. This residue was purified by silica gel chromatography (0–10% MeOH/DCM with 0.1% ammonium hydroxide) to provide a tan solid. This solid was purified further by chromatography on silica gel (0–100% EtOAc/DCM) to provide (<i>S</i>)-3-(neopentyloxy)-7-(pyrimidin-5-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (54 mg, 0.129 mmol, 72.1% yield) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.19 (s, 1 H), 9.10 (s, 2 H), 8.01 (d, <i>J</i> = 2.9 Hz, 1 H), 7.79 (dd, <i>J</i> = 2.3, 8.5 Hz, 1 H), 7.67 (d, <i>J</i> = 2.2 Hz, 1 H), 7.36 (d, <i>J</i> = 8.5 Hz, 1 H), 7.30 (d, <i>J</i> = 3.0 Hz, 1 H), 6.51 (br s, 2 H), 4.32 (s, 2 H), 3.79–3.65 (m, 2 H), 1.02 (s, 9 H). MS <i>m</i>/<i>z</i> = 418.2 [M + H]<sup>+</sup>. Calcd for C<sub>23</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>: 418.2.</div></div><div id="sec4_7_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>S</i>)-3-(Neopentyloxy)-7-(pyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>27</b>)</h4><div class="NLM_p last">A sealable tube was charged with (<i>S</i>)-7-bromo-3-(neopentyloxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (150 mg, 0.359 mmol), 3-pyridylboronic acid (132 mg, 1.076 mmol), potassium carbonate (248 mg, 1.793 mmol), tetrakis(triphenylphosphine)palladium(0) (20.72 mg, 0.018 mmol), THF (3586 μL), and water (0.5 mL). The tube was flushed with Ar(g), sealed, and heated to 110 °C for 1 h. The reaction was diluted with water (25 mL) and poured into a separatory funnel containing ethyl acetate (50 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 10 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to provide a brown foam. This residue was purified by silica gel chromatography (0–10% MeOH/DCM with 0.1% ammonium hydroxide) to provide (<i>S</i>)-3-(neopentyloxy)-7-(pyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (116 mg, 0.279 mmol, 78% yield) as a light-yellow foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.85 (d, <i>J</i> = 1.9 Hz, 1 H), 8.57 (dd, <i>J</i> = 1.6, 4.8 Hz, 1 H), 8.06–7.95 (m, 2 H), 7.71 (dd, <i>J</i> = 2.3, 8.5 Hz, 1 H), 7.58 (d, <i>J</i> = 2.2 Hz, 1 H), 7.50 (dd, <i>J</i> = 4.8, 7.9 Hz, 1 H), 7.35–7.29 (m, 2 H), 6.52 (s, 2 H), 4.35–4.22 (m, 2 H), 3.77–3.65 (m, 2 H), 1.02 (s, 9 H). MS <i>m</i>/<i>z</i> = 417.2 [M + H]<sup>+</sup>. Calcd for C<sub>24</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>: 417.2.</div></div><div id="sec4_7_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-(neopentyloxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>28</b>)</h4><div class="NLM_p last">A sealable tube was charged with (<i>S</i>)-7-bromo-3-(neopentyloxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (104822–28) (75 mg, 0.179 mmol), 2-fluoropyridin-3-ylboronic acid (76 mg, 0.538 mmol), potassium carbonate (124 mg, 0.897 mmol), PdCl<sub>2</sub>(AmPhos)<sub>2</sub> (6.35 mg, 8.97 μmol), THF (1793 μL), and water (1 mL). The tube was flushed with Ar(g), sealed, and heated to 110 °C for 1 h. The reaction was diluted with water (25 mL) and poured into a separatory funnel containing ethyl acetate (25 mL). The layers were separated, and the aqueous layer was extracted with ethyl acetate (2 × 10 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo to provide a brown foam. This residue was purified by silica gel chromatography (0–10% MeOH/DCM with 0.1% ammonium hydroxide) to provide (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-(neopentyloxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (70 mg, 0.161 mmol, 90% yield) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.24 (d, <i>J</i> = 4.7 Hz, 1 H), 8.15–8.07 (m, 1 H), 8.00 (d, <i>J</i> = 3.0 Hz, 1 H), 7.61 (d, <i>J</i> = 8.9 Hz, 1 H), 7.54 (s, 1 H), 7.49 (ddd, <i>J</i> = 1.9, 5.0, 7.2 Hz, 1 H), 7.35–7.27 (m, 2 H), 6.53 (s, 2 H), 4.30–4.20 (m, 2 H), 3.78–3.66 (m, 2 H), 1.02 (s, 9 H). MS <i>m</i>/<i>z</i> = 435.0 [M + H]<sup>+</sup>. Calcd for C<sub>24</sub>H<sub>24</sub>FN<sub>4</sub>O<sub>3</sub>: 435.1.</div></div><div id="sec4_7_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>S</i>)-7-(2,2-Dimethylpropoxy)-3-(5-pyrimidinyl)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (<b>29</b>)</h4><div class="NLM_p last">A sealable tube was charged with 3-bromo-7-(2,2-dimethylpropoxy)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (0.120 g, 287 μmol), pyrimidin-5-ylboronic acid (98 mg, 789 μmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (33 mg, 29 μmol), THF (8 mL), and an aqueous solution of potassium carbonate (1 M) (1434 μL, 1434 μmol). The tube was sealed and heated at 90 °C for 2.5 h. The reaction was cooled to room temperature and diluted with water (15 mL). The organics were removed, and the aqueous layer was extracted with ethyl acetate (3 × 45 mL). The combined organics were washed with brine, dried over sodium sulfate, filtered, and concentrated to provide a residue which was purified by chromatography on silica gel (0–10% MeOH/DCM) to provide <i>rac</i>-7-(2,2-dimethylpropoxy)-3-(5-pyrimidinyl)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine as a yellow solid. MS <i>m</i>/<i>z</i> = 418.2 [M + H]<sup>+</sup>. Calcd for C<sub>23</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>: 418.2. Chiral separation of racemic 7-(2,2-dimethylpropoxy)-3-(5-pyrimidinyl)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine: Racemic 7-(2,2-dimethylpropoxy)-3-(5-pyrimidinyl)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (69 mg) was subjected to SFC using 15:85:0.1 MeOH:CO<sub>2</sub>:DEA at 70 mL/min on a 2 cm × 15 cm, 5 μm ChiralPak AD-H column and 100 bar system pressure. The first peak (RT = 3.2 min) provided (<i>S</i>)-7-(2,2-dimethylpropoxy)-3-(5-pyrimidinyl)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (29 mg, 24% yield, >99% ee), and the second peak (RT = 6.8 min) provided (<i>R</i>)-7-(2,2-dimethylpropoxy)-3-(5-pyrimidinyl)-spiro[chromeno[2,3-<i>b</i>]pyridine]-5,4′-[1,3]oxazole]-2′-amine (>99% ee). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 9.22 (s, 1 H), 9.18 (s, 2 H), 8.69 (d, <i>J</i> = 2.4 Hz, 1 H), 8.15 (d, <i>J</i> = 2.4 Hz, 1 H), 7.19 (d, <i>J</i> = 8.9 Hz, 1 H), 6.98 (dd, <i>J</i> = 3.0, 8.9 Hz, 1 H), 6.81 (d, <i>J</i> = 2.9 Hz, 1 H), 6.52 (s, 2 H), 4.35–4.22 (m, 2 H), 3.62 (q, <i>J</i> = 8.6 Hz, 2 H), 1.01 (s, 9 H).</div></div><div id="sec4_7_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-(2-methoxy-2-methylpropoxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>30</b>)</h4><div class="NLM_p last">A vial was charged with 2-fluoropyridin-3-ylboronic acid (0.156 g, 1.105 mmol), tetrakis(triphenylphosphine)palladium(0) (0.043 g, 0.037 mmol), potassium carbonate (0.255 g, 1.842 mmol), <i>rac</i>-7-bromo-3-(2-methoxy-2-methylpropoxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.160 g, 0.368 mmol), THF (3 mL), and water (0.5 mL). The resulting mixture was heated to 110 °C for 2 h. The reaction mixture was cooled to room temperature and extracted with EtOAc. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by chromatography on silica gel (0–10% MeOH/DCM) to give <i>rac</i>-7-(2-fluoropyridin-3-yl)-3-(2-methoxy-2-methylpropoxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.072 g, 0.160 mmol, 43.4% yield). This material was dissolved in methanol, and the resulting solution was purified by SFC, using 1.5 mL injections on a 5 μm, 3 cm × 15 cm Chiralpak IC column with 40% MeOH/0.2% diethylamine/60% CO<sub>2</sub> at a flow rate of 100 mL/min. This afforded peak 1, (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-(2-methoxy-2-methylpropoxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.026 g, 0.058 mmol, 15.67% yield), and peak 2, (<i>R</i>)-7-(2-fluoropyridin-3-yl)-3-(2-methoxy-2-methylpropoxy)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.026 g, 0.058 mmol, 15.67% yield). Data for the title compound. <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ = 8.18 (td, <i>J</i> = 1.6, 4.8 Hz, 1 H), 8.00 (ddd, <i>J</i> = 1.9, 7.5, 10.2 Hz, 1 H), 7.96 (d, <i>J</i> = 2.9 Hz, 1 H), 7.60–7.58 (m, 1 H), 7.57–7.55 (m, 1 H), 7.41–7.35 (m, 2 H), 7.28 (dd, <i>J</i> = 0.7, 8.2 Hz, 1 H), 5.08 (br s, 2 H), 4.32 (d, <i>J</i> = 1.8 Hz, 2 H), 3.93 (d, <i>J</i> = 1.0 Hz, 2 H), 3.23 (s, 3 H), 1.27 (s, 6 H). MS <i>m</i>/<i>z</i> = 451.2 [M + H]<sup>+</sup>. Calcd for C<sub>24</sub>H<sub>24</sub>FN<sub>4</sub>O<sub>4</sub>: 451.2.</div></div><div id="sec4_7_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>S</i>)-3-(3,6-Dihydro-2<i>H</i>-pyran-4-yl)-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>31</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-3-bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.150 g, 0.351 mmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.020 g, 0.018 mmol), potassium carbonate (0.243 g, 1.756 mmol), 1,4-dioxane (1.756 mL), and water (0.585 mL). The vial was flushed with argon, sealed, and heated overnight at 80 °C. The mixture was cooled to room temperature and then diluted water and extracted with ethyl acetate (2×). The combined organic extracts were dried with sodium sulfate, filtered, and concentrated. The residue was purified by chromatography on silica gel (0–6% MeOH/DCM0 to afford (<i>S</i>)-3-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.089 g, 0.207 mmol, 58.9% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.39 (d, <i>J</i> = 2.4 Hz, 1 H), 8.25 (td, <i>J</i> = 1.5, 4.9 Hz, 1 H), 8.12 (ddd, <i>J</i> = 1.9, 7.5, 10.3 Hz, 1 H), 7.79 (d, <i>J</i> = 2.4 Hz, 1 H), 7.62 (td, <i>J</i> = 1.9, 8.5 Hz, 1 H), 7.56 (t, <i>J</i> = 1.8 Hz, 1 H), 7.49 (ddd, <i>J</i> = 1.9, 5.0, 7.3 Hz, 1 H), 7.37 (d, <i>J</i> = 8.5 Hz, 1 H), 6.51 (s, 2 H), 6.31 (t, <i>J</i> = 1.5 Hz, 1 H), 4.28 (s, 2 H), 4.25 (q, <i>J</i> = 2.6 Hz, 2 H), 3.85 (t, <i>J</i> = 5.5 Hz, 2 H). MS <i>m</i>/<i>z</i> = 431.1 [M + H]<sup>+</sup>. Calcd for C<sub>24</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>3</sub>: 431.1.</div></div><div id="sec4_7_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>S</i>)-3-(5,6-Dihydro-2<i>H</i>-pyran-3-yl)-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>32</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-3-bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (129 mg, 0.302 mmol), 2-(5,6-dihydro-2<i>H</i>-pyran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (307 mg, 0.453 mmol), potassium carbonate (209 mg, 1.510 mmol), and PdCl<sub>2</sub>(dppf)–CH<sub>2</sub>Cl<sub>2</sub> (12.33 mg, 0.015 mmol). The vial was flushed with Ar(g), and then 1,4-dioxane (1510 μL) and water (0.5 mL) were added in sequence. The vial was sealed and heated to 70 °C for 40 min. The mixture was diltued with EtOAc (15 mL) and water (15 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (15 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–50% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to give ca. 60 mg of a brown solid. The solid was dissolved in MeOH, and the resulting solution was loaded onto a 2-g SCX acidic ion exchange column. The column was eluted with MeOH, then with 2N ammonia in methanol. The basic fraction was concentrated to give (<i>S</i>)-3-(5,6-dihydro-2<i>H</i>-pyran-3-yl)-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (52.48 mg, 0.122 mmol, 40.4% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.30 (d, <i>J</i> = 2.4 Hz, 1 H), 8.25 (td, <i>J</i> = 1.5, 4.8 Hz, 1 H), 8.11 (ddd, <i>J</i> = 2.0, 7.5, 10.3 Hz, 1 H), 7.73 (d, <i>J</i> = 2.4 Hz, 1 H), 7.62 (td, <i>J</i> = 1.7, 8.8 Hz, 1 H), 7.56 (t, <i>J</i> = 1.8 Hz, 1 H), 7.49 (ddd, <i>J</i> = 1.9, 5.0, 7.2 Hz, 1 H), 7.36 (d, <i>J</i> = 8.5 Hz, 1 H), 6.53 (br s, 2 H), 6.32 (td, <i>J</i> = 2.2, 3.9 Hz, 1 H), 4.45 (qd, <i>J</i> = 2.3, 6.6 Hz, 2 H), 4.28 (s, 2 H), 3.76 (t, <i>J</i> = 5.5 Hz, 2 H), 2.28 (qd, <i>J</i> = 2.7, 6.8 Hz, 2 H). MS <i>m</i>/<i>z</i> = 431.0 [M + H]<sup>+</sup>. Calcd for C<sub>24</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>3</sub>: 431.1.</div></div><div id="sec4_7_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>33</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-2′-amino-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (70.0 mg, 0.144 mmol), 2-fluoropyridin-3-ylboronic acid (61.0 mg, 0.433 mmol), potassium carbonate (100 mg, 0.721 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (8.33 mg, 7.21 μmol). The vial was flushed with Ar(g), and then 1,4-dioxane (721 μL) and water (0.3 mL) were added in sequence. The vial was sealed and heated to 80 °C for 50 min. The mixture was diluted with brine (20 mL) and extracted with EtOAc (2 × 15 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–70% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to give (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-(tetrahydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (60.4 mg, 0.140 mmol, 97% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.24 (d, <i>J</i> = 4.8 Hz, 1 H), 8.20 (d, <i>J</i> = 2.2 Hz, 1 H), 8.11 (ddd, <i>J</i> = 1.9, 7.7, 10.1 Hz, 1 H), 7.66 (d, <i>J</i> = 2.2 Hz, 1 H), 7.61 (d, <i>J</i> = 8.6 Hz, 1 H), 7.56 (s, 1 H), 7.49 (ddd, <i>J</i> = 1.8, 5.0, 7.2 Hz, 1 H), 7.35 (d, <i>J</i> = 8.5 Hz, 1 H), 6.51 (s, 2 H), 4.28–4.21 (m, 2 H), 4.00–3.93 (m, 2 H), 3.50–3.39 (m, 2 H), 2.95–2.84 (m, 1 H), 1.79–1.60 (m, 4 H). MS <i>m</i>/<i>z</i> = 433.0 [M + H]<sup>+</sup>. Calcd for C<sub>24</sub>H<sub>22</sub>FN<sub>4</sub>O<sub>3</sub>: 433.2.</div></div><div id="sec4_7_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>S</i>)-3-(6,6-Dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>34</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-2′-amino-3-(6,6-dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (0.130 g, 0.254 mmol), 2-fluoropyridin-3-ylboronic acid (0.107 g, 0.763 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.015 g, 0.013 mmol). The vial was purged with Ar(g), and then DMF (1.271 mL) and potassium carbonate (0.635 mL, 1.271 mmol) (as a 2.0 M aq solution) were added in sequence. The vial was sealed and stirred at 70 °C overnight. In the morning, the reaction was diluted with ethyl acetate and washed with water. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were dried with sodium sulfate, filtered, and concentrated. The material was purified via chromatography on silica gel (0–5% MeOH/DCM) afford 30 mg of product as an off-white solid. The impure fractions were combined and repurified via chromatography on silica gel (0–5% MeOH/DCM). Fractions containing clean desired product were combined with the previously isolated material and concentrated to afford (<i>S</i>)-3-(6,6-dimethyl-3,6-dihydro-2<i>H</i>-pyran-4-yl)-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.044 g, 0.096 mmol, 37.8% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.37 (d, <i>J</i> = 2.4 Hz, 1 H), 8.25 (td, <i>J</i> = 1.5, 4.8 Hz, 1 H), 8.11 (ddd, <i>J</i> = 1.9, 7.5, 10.3 Hz, 1 H), 7.78 (d, <i>J</i> = 2.5 Hz, 1 H), 7.62 (td, <i>J</i> = 1.7, 8.8 Hz, 1 H), 7.56 (t, <i>J</i> = 1.8 Hz, 1 H), 7.49 (ddd, <i>J</i> = 2.0, 5.0, 7.3 Hz, 1 H), 7.36 (d, <i>J</i> = 8.5 Hz, 1 H), 6.52 (s, 2 H), 6.22 (t, <i>J</i> = 1.4 Hz, 1 H), 4.28 (s, 2 H), 3.84 (t, <i>J</i> = 5.4 Hz, 2 H), 2.41–2.35 (m, 2 H), 1.28 (s, 6 H). MS <i>m</i>/<i>z</i> = 459.3 [M + H]<sup>+</sup>. Calcd for C<sub>26</sub>H<sub>24</sub>FN<sub>4</sub>O<sub>3</sub>: 459.2.</div></div><div id="sec4_7_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-morpholino-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>35</b>)</h4><div class="NLM_p last">A vial was charged (<i>S</i>)-2′-amino-3-morpholino-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (0.060 g, 0.123 mmol), 2-fluoropyridin-3-ylboronic acid (0.052 g, 0.370 mmol), potassium carbonate (0.085 g, 0.617 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (7.13 mg, 6.17 μmol). The vial was flushed with Ar(g) and then 1,4-dioxane (0.617 mL) and water (0.36 mL). The vial was sealed and heated at 75 °C for 1 h. The reaction mixture was diluted with ethyl acetate and washed with water. The aqueous layer was extracted with ethyl acetate, and the combined organic extracts were washed with brine, dried over sodium sulfate, filtered, and concentrated. The material was purified via chromatography on silica gel (0–10% MeOH/DCM) to give partially purified material. This material was purified further by reverse-phase HPLC (20–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA). Fractions containing clean desired product were combined, and the combined solution was partitioned between DCM and saturated aq sodium bicarbonate solution. The aqueous layer was extracted with DCM, and the combined organic extracts were dried with sodium sulfate, filtered, and concentrated to afford (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-morpholino-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (0.018 g, 0.042 mmol, 33.7% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.24 (td, <i>J</i> = 1.6, 4.8 Hz, 1 H), 8.10 (ddd, <i>J</i> = 1.9, 7.5, 10.4 Hz, 1 H), 8.00 (d, <i>J</i> = 2.9 Hz, 1 H), 7.60 (td, <i>J</i> = 1.7, 8.8 Hz, 1 H), 7.53 (t, <i>J</i> = 1.8 Hz, 1 H), 7.49 (ddd, <i>J</i> = 1.9, 5.0, 7.3 Hz, 1 H), 7.35–7.28 (m, 2 H), 6.50 (s, 2 H), 4.24 (s, 2 H), 3.77 (t, <i>J</i> = 4.8 Hz, 4 H), 3.16–3.08 (m, 4 H). MS <i>m</i>/<i>z</i> = 434.4 [M + H]<sup>+</sup>. Calcd for C<sub>23</sub>H<sub>21</sub>FN<sub>5</sub>O<sub>3</sub>: 434.2.</div></div><div id="sec4_7_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-(p-tolyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>36</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-2′-amino-3-<i>p</i>-tolyl-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (45.0 mg, 0.092 mmol), 2-fluoropyridin-3-ylboronic acid (38.7 mg, 0.275 mmol), potassium carbonate (229 μL, 0.458 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (5.29 mg, 4.58 μmol). The vial was flushed with Ar(g), and then 1,4-dioxane (1 mL) and water (0.5 mL) were added in sequence. The vial was sealed and heated to 80 °C for 1 h. The mixture was diluted with EtOAc, washed with brine, dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–5% MeOH/DCM) to give (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-<i>p</i>-tolyl-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (29.53 mg, 0.067 mmol, 73.6% yield) as a tan solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.57 (d, <i>J</i> = 2.4 Hz, 1 H), 8.25 (td, <i>J</i> = 1.6, 4.8 Hz, 1 H), 8.13 (ddd, <i>J</i> = 1.9, 7.5, 10.3 Hz, 1 H), 7.97 (d, <i>J</i> = 2.4 Hz, 1 H), 7.67–7.56 (m, 4 H), 7.50 (ddd, <i>J</i> = 1.9, 5.0, 7.3 Hz, 1 H), 7.39 (d, <i>J</i> = 8.5 Hz, 1 H), 7.33 (d, <i>J</i> = 7.8 Hz, 2 H), 6.54 (s, 2 H), 4.41–4.25 (m, 2 H), 2.36 (s, 3 H). MS <i>m</i>/<i>z</i> = 439.0 [M + H]<sup>+</sup>. Calcd for C<sub>26</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>2</sub>: 439.2.</div></div><div id="sec4_7_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (S<i>S</i>)-4-(2′-Amino-7-(2-fluoropyridin-3-yl)-5′H-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-3-yl)benzonitrile (<b>37</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-2′-amino-3-(4-cyanophenyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-7-yl trifluoromethanesulfonate (50 mg, 0.100 mmol), 2-fluoropyridin-3-ylboronic acid (42.1 mg, 0.299 mmol), potassium carbonate (68.8 mg, 0.498 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (5.75 mg, 4.98 μmol). The vial was flushed with Ar(g), and then 1,4-dioxane (498 μL) and water (0.25 mL) were added in sequence. The vial was sealed and heated to 80 °C for 2.5 h. The mixture was diluted with EtOAc (20 mL), washed with water (15 mL), dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–100% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to give (<i>S</i>)-4-(2′-amino-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazole]-3-yl)benzonitrile (35.91 mg, 0.080 mmol, 80% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.70 (d, <i>J</i> = 2.4 Hz, 1 H), 8.28–8.23 (m, 1 H), 8.17–8.07 (m, 2 H), 8.02–7.89 (m, 4 H), 7.67–7.62 (m, 1 H), 7.58 (t, <i>J</i> = 1.8 Hz, 1 H), 7.50 (ddd, <i>J</i> = 2.0, 4.9, 7.4 Hz, 1 H), 7.41 (d, <i>J</i> = 8.5 Hz, 1 H), 6.54 (s, 2 H), 4.45–4.26 (m, 2 H). MS <i>m</i>/<i>z</i> = 450.0 [M + H]<sup>+</sup>. Calcd for C<sub>26</sub>H<sub>17</sub>FN<sub>5</sub>O<sub>2</sub>: 450.1.</div></div><div id="sec4_7_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-(2-fluoropyridin-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>38</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-3-bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (70 mg, 0.164 mmol), 2-fluoropyridin-4-ylboronic acid (69.3 mg, 0.492 mmol), potassium carbonate (113 mg, 0.819 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (9.47 mg, 8.19 μmol). The vial was flushed with Ar(g), and then 1,4-dioxane (819 μL) and water (1 mL) were added in sequence. The vial was sealed and heated to 80 °C for 3 h. The mixture was cooled and diluted with EtOAc (15 mL) and brine (15 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (15 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–70% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to afford (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-(2-fluoropyridin-4-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (31.26 mg, 0.070 mmol, 43.0% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.81 (d, <i>J</i> = 2.4 Hz, 1 H), 8.36 (d, <i>J</i> = 5.4 Hz, 1 H), 8.26 (td, <i>J</i> = 1.5, 4.8 Hz, 1 H), 8.23 (d, <i>J</i> = 2.4 Hz, 1 H), 8.16–8.10 (m, 1 H), 7.76 (td, <i>J</i> = 1.8, 5.3 Hz, 1 H), 7.68–7.63 (m, 2 H), 7.57 (t, <i>J</i> = 1.8 Hz, 1 H), 7.50 (ddd, <i>J</i> = 1.9, 5.0, 7.3 Hz, 1 H), 7.42 (d, <i>J</i> = 8.5 Hz, 1 H), 6.52 (s, 2 H), 4.45–4.41 (m, 1 H), 4.39–4.36 (m, 1 H). MS <i>m</i>/<i>z</i> = 444.0 [M + H]<sup>+</sup>. Calcd for C<sub>24</sub>H<sub>16</sub>F<sub>2</sub>N<sub>5</sub>O<sub>2</sub>: 444.1.</div></div><div id="sec4_7_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>S</i>)-3-(3,3-Dimethylbut-1-yn-1-yl)-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>39</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-3-bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (80 mg, 0.187 mmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (21.64 mg, 0.019 mmol), CuI (3.57 mg, 0.019 mmol), THF (0.75 mL), and DMF (0.75 mL). <i>N</i>,<i>N</i>-Diisopropylamine (525 μL, 3.75 mmol) and 3,3-dimethylbut-1-yne (115 μL, 0.936 mmol) were added in sequence. The vial was flushed with Ar(g), sealed, and heated to 110 °C for 3 h. The mixture was partitioned between water (10 mL) and EtOAc (10 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (2 × 10 mL). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–70% of a 90:10:1 mixture of DCM/MeOH/NH<sub>4</sub>OH in DCM) to give 80 mg of a solid. This solid was dissolved in MeOH and purified further by reverse-phase HPLC (10–90% CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA). The fractions containing product were combined in saturated aq sodium bicarbonate solution with the aid of methanol and extracted with DCM (3×). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated to give (<i>S</i>)-3-(3,3-dimethylbut-1-ynyl)-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (46.61 mg, 0.109 mmol, 58.1% yield) as a white powder. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.27 (d, <i>J</i> = 2.2 Hz, 1 H), 8.25 (td, <i>J</i> = 1.4, 4.8 Hz, 1 H), 8.12 (ddd, <i>J</i> = 1.9, 7.5, 10.3 Hz, 1 H), 7.67 (d, <i>J</i> = 2.3 Hz, 1 H), 7.65–7.61 (m, 1 H), 7.58–7.56 (m, 1 H), 7.49 (ddd, <i>J</i> = 1.8, 5.0, 7.2 Hz, 1 H), 7.36 (d, <i>J</i> = 8.5 Hz, 1 H), 6.55 (s, 2 H), 4.30–4.27 (m, 1 H), 4.25–4.22 (m, 1 H), 1.32 (s, 9 H). MS <i>m</i>/<i>z</i> = 429.0 [M + H]<sup>+</sup>. Calcd for C<sub>25</sub>H<sub>22</sub>FN<sub>4</sub>O<sub>2</sub>: 429.2.</div></div><div id="sec4_7_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-(3-methoxy-3-methylbut-1-yn-1-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>40</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-3-bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (169 mg, 0.396 mmol), CuI (7.53 mg, 0.040 mmol), and Pd(Ph<sub>3</sub>P)<sub>4</sub> (45.7 mg, 0.040 mmol). DMF (791 μL), <i>i</i>-Pr<sub>2</sub>NH (0.8 mL), and 3-methoxy-3-methylbut-1-yne (143 μL, 1.187 mmol) were added in sequence, and the vial was sealed and heated to 90 °C for 3.5 h. The reaction mixture was diluted with water and extracted with EtOAc (2×). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated under vacuum. The residue was purified by chromatography on silica gel (0–100% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to give a yellow oil. This oil was dissolved in MeOH and loaded onto a 5-g SCX-2 acidic ion exchange column. The column was eluted with methanol, then with 2N ammonia in methanol. The basic fraction was concentrated under vacuum to give (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-(3-methoxy-3-methylbut-1-ynyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (167.79 mg, 0.378 mmol, 95% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.38 (d, <i>J</i> = 2.2 Hz, 1 H), 8.25 (td, <i>J</i> = 1.5, 3.3 Hz, 1 H), 8.17–8.08 (m, 1 H), 7.76 (d, <i>J</i> = 2.2 Hz, 1 H), 7.64 (td, <i>J</i> = 1.7, 8.6 Hz, 1 H), 7.57 (d, <i>J</i> = 1.7 Hz, 1 H), 7.49 (ddd, <i>J</i> = 1.9, 5.1, 7.3 Hz, 1 H), 7.38 (d, <i>J</i> = 8.5 Hz, 1 H), 6.58 (br s, 2 H), 4.34–4.29 (m, 1 H), 4.28–4.22 (m, 1 H), 3.33 (s, 3 H), 1.50 (s, 6 H). MS <i>m</i>/<i>z</i> = 445.0 [M + H]<sup>+</sup>. Calcd for C<sub>25</sub>H<sub>22</sub>FN<sub>4</sub>O<sub>3</sub>: 445.2.</div></div><div id="sec4_7_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>S</i>)-4-(2′-Amino-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-3-yl)-2-methylbut-3-yn-2-ol (<b>41</b>)</h4><div class="NLM_p last">A vial was charged with (<i>S</i>)-3-bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (101 mg, 0.237 mmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (27.4 mg, 0.024 mmol), CuI (4.51 mg, 0.024 mmol), THF (0.95 mL), and DMF (0.95 mL). <i>N</i>,<i>N</i>-Diisopropylamine (664 μL, 4.74 mmol) and 2-methylbut-3-yn-2-ol (116 μL, 1.184 mmol) were added in sequence. The vial was flushed with Ar(g), sealed, and heated at 110 °C for 2.5 h. The reaction mixture was diluted with water and extracted with EtOAc (3×). The combined organic extracts were dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–100% of a 90:10:1 mixture of DCM/MeOH/NH<sub>4</sub>OH) to give (<i>S</i>)-4-(2′-amino-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-3-yl)-2-methylbut-3-yn-2-ol (36.4 mg, 60% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.31 (d, <i>J</i> = 2.2 Hz, 1 H), 8.25 (td, <i>J</i> = 1.5, 4.8 Hz, 1 H), 8.12 (ddd, <i>J</i> = 2.0, 7.5, 10.4 Hz, 1 H), 7.71 (d, <i>J</i> = 2.2 Hz, 1 H), 7.63 (td, <i>J</i> = 1.7, 8.8 Hz, 1 H), 7.58 (t, <i>J</i> = 1.8 Hz, 1 H), 7.49 (ddd, <i>J</i> = 2.0, 5.0, 7.3 Hz, 1 H), 7.37 (d, <i>J</i> = 8.5 Hz, 1 H), 6.58 (s, 2 H), 5.54 (s, 1 H), 4.32–4.28 (m, 1 H), 4.23 (d, <i>J</i> = 8.7 Hz, 1 H), 1.49 (s, 6 H). MS <i>m</i>/<i>z</i> = 431.0 [M + H]<sup>+</sup>. Calcd for C<sub>24</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>3</sub>: 431.2.</div></div><div id="sec4_7_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Preparation of Trimethyl((3-methyloxetan-3-yl)ethynyl)silane for the Synthesis of <b>42</b></h4><div class="NLM_p">Step 1: Pyridinium chlorochromate (10.13 g, 47.0 mmol) and silica gel (10 g) were combined and ground with a mortar and pestle until a fine, light-orange powder resulted. The powder was transferred to a 500 mL round-bottom flask and suspended in DCM (157 mL). 3-Methyl-3-oxetanemethanol (3.87 mL, 39.2 mmol) was added in one portion via syringe, and the resulting mixture was stirred for 24 h. The reaction the mixture was filtered through a pad of silica gel, and the filter pad was washed with DCM (2×). The filtrate was carefully evaporated, but not to dryness, to give 5.8193 g of a greenish solution that corresponded to 32 wt % of the 3-methyloxetane-3-carbaldehyde in DCM (as determined by <sup>1</sup>H NMR analysis). This solution was used directly in the next reaction. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ = 9.96 (s, 1 H), 4.88 (d, <i>J</i> = 6.3 Hz, 2 H), 4.51 (d, <i>J</i> = 6.4 Hz, 2 H), 1.49 (s, 3 H).</div><div class="NLM_p">Step 2: A 500 mL round-bottom flask was charged with triphenylphosphine (19.51 g, 74.4 mmol) and DCM (93 mL) to give a clear solution. The flask was cooled in an ice bath for 10 min, and then carbon tetrabromide (12.34 g, 37.2 mmol) was added in one portion. After 30 min of stirring, 3-methyloxetane-3-carbaldehyde (5.8193 g, 32 wt % in DCM, 18.60 mmol) was added dropwise to the thick, orange mixture via a pipet (with a 5 mL DCM flask-wash). The resulting mixture was slowly warmed to room temperature over 1 h, then was diluted with hexane (300 mL). The mixture was stirred for 10 min, resulting in the formation of a precipitate. The supernatant was decanted onto a pad of silica gel and filtered. The remaining solid was washed with 10% EtOAc/hexane (3 × 100 mL), each time filtering through the silica gel pad. The combined filtrates were evaporated to give 3-(2,2-dibromovinyl)-3-methyloxetane (3.539 g, 13.83 mmol, 74.3% yield) as a clear oil. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ = 6.70 (s, 1 H), 4.82 (d, <i>J</i> = 5.8 Hz, 2 H), 4.39 (d, <i>J</i> = 6.1 Hz, 2 H), 1.61 (s, 3 H).</div><div class="NLM_p last">Step 3: A 250 mL round-bottom flask was charged with 3-(2,2-dibromovinyl)-3-methyloxetane (2.177 g, 8.51 mmol) in THF (85 mL) to give a clear solution. The flask was cooled in a dry ice/acetone bath for 15 min, and then <i>n</i>-butyllithium (7.83 mL, 19.56 mmol) (as a 2.5 M solution in hexane) was added dropwise over 5 min. The resulting mixture was stirred for 45 min, and then trimethylchlorosilane (3.81 mL, 29.8 mmol) was added dropwise. The cooling bath was removed, and the mixture was stirred at room temperature for 30 min. The reaction mixture was diluted with water (50 mL) and ether (50 mL). The layers were separated, and the aqueous layer was extracted with ether (25 mL). The combined organic extracts were dried over magnesium sulfate, filtered, and evaporated. The residue was dissolved in a small amount of ether and filtered through a silica gel pad. The filtrate was evaporated to give trimethyl((3-methyloxetan-3-yl)ethynyl)silane (1.344 g, 7.99 mmol, 94% yield) as a pale-yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 5.75 (s, 1 H), 4.61 (d, <i>J</i> = 5.3 Hz, 2 H), 4.33 (d, <i>J</i> = 5.6 Hz, 3 H), 0.14 (s, 9 H).</div></div><div id="sec4_7_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>S</i>)-7-(2-Fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (<b>42</b>)</h4><div class="NLM_p last">A round-bottom flask was charged with (<i>S</i>)-3-bromo-7-(2-fluoropyridin-3-yl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (5.04 g, 11.80 mmol), copper(i) iodide (0.112 g, 0.590 mmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (0.682 g, 0.590 mmol), and tetrabutylammonium fluoride trihydrate (4.63 g, 17.70 mmol). The flask was flushed with Ar(g), and then THF (23.60 mL) and trimethyl((3-methyloxetan-3-yl)ethynyl)silane (3.35 mL, 17.70 mmol) were added in sequence. The flask was fitted with a reflux condenser and heated to 70 °C for 2 h. The mixture was cooled to room temperature, then poured into a separatory funnel with the aid of EtOAc (25 mL). The organic solution was washed with water (2 × 25 mL), and the aquoeus washes were extracted with EtOAc (25 mL). The organic extracts were combined, and the combined solution was washed with brine (30 mL), dried over sodium sulfate, filtered, and evaporated. The residue was purified by chromatography on silica gel (0–50% of a 90:10:1 mix of DCM/MeOH/NH<sub>4</sub>OH in DCM) to give to (<i>S</i>)-7-(2-fluoropyridin-3-yl)-3-((3-methyloxetan-3-yl)ethynyl)-5′<i>H</i>-spiro[chromeno[2,3-<i>b</i>]pyridine-5,4′-oxazol]-2′-amine (4.655 g, 10.52 mmol, 89% yield) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.36 (d, <i>J</i> = 2.2 Hz, 1 H), 8.25 (td, <i>J</i> = 1.6, 4.8 Hz, 1 H), 8.12 (ddd, <i>J</i> = 1.9, 7.5, 10.4 Hz, 1 H), 7.76 (d, <i>J</i> = 2.2 Hz, 1 H), 7.66–7.61 (m, 1 H), 7.57 (t, <i>J</i> = 1.8 Hz, 1 H), 7.49 (ddd, <i>J</i> = 1.9, 4.9, 7.4 Hz, 1 H), 7.39–7.35 (m, 1 H), 6.56 (s, 2 H), 4.78 (d, <i>J</i> = 5.5 Hz, 2 H), 4.45 (d, <i>J</i> = 5.6 Hz, 2 H), 4.32–4.28 (m, 1 H), 4.27–4.22 (m, 1 H), 1.66 (s, 3 H). MS <i>m</i>/<i>z</i> = 443.2 [M + H]<sup>+</sup>. Calcd for C<sub>25</sub>H<sub>20</sub>FN<sub>4</sub>O<sub>3</sub>: 443.2.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68"><a href="/doi/suppl/10.1021/jm5012676">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">General information, experimental data and characterization, X-ray crystal structure information. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5012676/suppl_file/jm5012676_si_001.pdf">jm5012676_si_001.pdf (509.29 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession code for the X-ray cocrystal of BACE1 + compound <b>42</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RCD">4RCD</a>.</p><div class="testing" data-doi="10.1021/jm5012676" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas A. Dineen</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#196d7d70777c7c775978747e7c77377a7674"><span class="__cf_email__" data-cfemail="bfcbdbd6d1dadad1ffded2d8dad191dcd0d2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kui Chen</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan C. Cheng</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katayoun Derakhchan</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oleg Epstein</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joel Esmay</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean Hickman</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chuck E. Kreiman</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isaac E. Marx</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert C. Wahl</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul H. Wen</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew M. Weiss</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas A. Whittington</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Wood</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert T. Fremeau</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan D. White</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod F. Patel</span> - <span class="hlFld-Affiliation affiliation">†Departments of Therapeutic
Discovery, ‡Neuroscience, §Molecular Structure and Characterization, ∥Pharmacokinetics
and Drug Metabolism, and ⊥Comparative Biology and Safety Sciences, Amgen, Inc., 360 Binney Street, Cambridge, Massachusetts 02142, and One
Amgen Center Drive, Thousand Oaks, California 91320, United
States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i73" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i73"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid</p></td></tr><tr><td class="NLM_term">HEA</td><td class="NLM_def"><p class="first last">hydroxythethyl amine</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">β-site APP cleaving enzyme</p></td></tr><tr><td class="NLM_term">Pgp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54423" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54423" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Small, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span> </span><span class="NLM_article-title">Alois Alzheimer and Alzeimer’s Disease: A Centennial Perspective</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1111%2Fj.1471-4159.2006.04212.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=17076655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=708-710&author=D.+H.+Smallauthor=R.+Cappai&title=Alois+Alzheimer+and+Alzeimer%E2%80%99s+Disease%3A+A+Centennial+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Alois Alzheimer and Alzheimer's disease: a centennial perspective</span></div><div class="casAuthors">Small, David H.; Cappai, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-710</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The year 2006 is the centenary of the famous presentation of Alois Alzheimer which first described the neuropathol. of Alzheimer's disease (AD).  Since this presentation, enormous progress has been made in understanding the biol. of AD.  The central role of the β-amyloid protein (Aβ) in the pathogenesis of AD and the relationship between plaque and tangle pathol. is now much better understood.  In this article, we review the current status of the amyloid hypothesis of AD and its role in the development of future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHVyze5z1W7Vg90H21EOLACvtfcHk0lgWbhhYDDr2ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE&md5=27564c272b2bc577bbf4d568ffb7a079</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04212.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04212.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DCappai%26aufirst%3DR.%26atitle%3DAlois%2520Alzheimer%2520and%2520Alzeimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Centennial%2520Perspective%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D708%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A century of Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Marum, R. J.</span><span> </span><span class="NLM_article-title">Current and future therapy in Alzheimer’s Disease</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1111%2Fj.1472-8206.2008.00578.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=18485144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=265-274&author=R.+J.+Van+Marum&title=Current+and+future+therapy+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Current and future therapy in Alzheimer's disease</span></div><div class="casAuthors">van Marum, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-274</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized as one of the most important medical problems in the elderly.  As most pharmacol. research within the field of dementia is focused on Alzheimer's dementia (AD), this review will focus on pharmacol. interventions in AD.  Most disease-modifying therapies are based on the amyloid hypothesis.  In this hypothesis, the pathol. accumulation of Aβ in the brain leads to oxidative stress, neuronal destruction and finally the clin. syndrome of AD.  Following this hypothesis, secondary prevention of AD can be made by: decreasing the prodn. of Aβ, stimulation of clearance of Aβ formed or prevention of aggregation of Aβ into amyloid plaques.  First a short overview on current approved therapies for AD is given.  The main part of the review will focus on potential disease-modifying therapies for AD that are currently being studied in phase I to phase III trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYSu96SxTqLVg90H21EOLACvtfcHk0lgWbhhYDDr2ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D&md5=0813e575e9440a3e1ffc0e0ee79c5e7a</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2008.00578.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2008.00578.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMarum%26aufirst%3DR.%2BJ.%26atitle%3DCurrent%2520and%2520future%2520therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D22%26spage%3D265%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">100 Years and counting: prospects for defeating Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=781-784&author=E.+D.+Robersonauthor=L.+Mucke&title=100+Years+and+counting%3A+prospects+for+defeating+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3D100%2520Years%2520and%2520counting%253A%2520prospects%2520for%2520defeating%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D781%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Catalano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henze, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafft, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span> </span><span class="NLM_article-title">The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer’s Disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.2174%2F156802606776743066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=16712494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVOmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=597-608&author=S.+Catalanoauthor=E.+C.+Dodsonauthor=D.+A.+Henzeauthor=J.+G.+Joyceauthor=G.+A.+Krafftauthor=G.+G.+Kinney&title=The+role+of+amyloid-beta+derived+diffusible+ligands+%28ADDLs%29+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease</span></div><div class="casAuthors">Catalano, Susan M.; Dodson, Elizabeth C.; Henze, Darrell A.; Joyce, Joseph G.; Krafft, Grant A.; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid-β (Aβ) cascade hypothesis of Alzheimer's disease (AD) has dominated research and subsequent therapeutic drug development for over two decades.  Central to this hypothesis is the observation that Aβ is elevated in AD patients and that the disease is ultimately characterized by the central deposition of insol. senile plaques.  More recent evidence, however, suggests that the presence or absence of plaque is insufficient to fully account for the deleterious role of elevated Aβ in AD.  Such studies support the basis for an alternate interpretation of the Aβ cascade hypothesis.  Namely, that sol. oligomers of Aβ (i.e., ADDLs) accumulate and cause functional deficits prior to overt neuronal cell death or plaque deposition.  Accordingly, the following review focuses on research describing the prepn. and functional activity of ADDLs in vitro and in vivo.  These studies provide the basis for an alternate, ADDL-based, view of the Aβ cascade hypothesis and accounts for the disconnect between plaque burden and cognitive deficits.  Possible therapeutic approaches aimed at lowering ADDLs in AD patients are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXQlT7tzCPc7Vg90H21EOLACvtfcHk0lhepreRV4fPZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVOmsbY%253D&md5=fc371b4b30370dce13f04afebe292872</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F156802606776743066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743066%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DS.%26aulast%3DDodson%26aufirst%3DE.%2BC.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJoyce%26aufirst%3DJ.%2BG.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DThe%2520role%2520of%2520amyloid-beta%2520derived%2520diffusible%2520ligands%2520%2528ADDLs%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pimplikar, S. W.</span><span> </span><span class="NLM_article-title">Reassessing the Amyloid Cascade Hypothesis of Alzheimer’s Disease</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2Fj.biocel.2008.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=19124085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1261-1268&author=S.+W.+Pimplikar&title=Reassessing+the+Amyloid+Cascade+Hypothesis+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessing the amyloid cascade hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Pimplikar, Sanjay W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-1268</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since its inception, the amyloid cascade hypothesis has dominated the field of Alzheimer's disease (AD) research and has provided the intellectual framework for therapeutic intervention.  Although the details of the hypothesis continue to evolve, its core principle has remained essentially unaltered.  It posits that the amyloid-β peptides, derived from amyloid precursor protein (APP), are the root cause of AD.  Substantial genetic and biochem. data support this view, and yet a no. of findings also run contrary to its tenets.  The presence of familial AD mutations in APP and presenilins, demonstration of Aβ toxicity, and studies in mouse models of AD all support the hypothesis, whereas the presence of Aβ plaques in normal individuals, the uncertain nature of the pathogenic Aβ species, and repeated disappointments with Aβ-centered therapeutic trials are inconsistent with the hypothesis.  The current state of knowledge does not prove nor disprove the amyloid hypothesis, but rather points to the need for its reassessment.  A view that Aβ is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZoitUBRzaLVg90H21EOLACvtfcHk0lhepreRV4fPZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D&md5=e33973b5f125c34d95cb3f1b477d3ced</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPimplikar%26aufirst%3DS.%2BW.%26atitle%3DReassessing%2520the%2520Amyloid%2520Cascade%2520Hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D1261%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">beta-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=beta-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3Dbeta-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE1%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as beta-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lg55eKw42NMyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520beta-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashier, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membraned-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashierauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membraned-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+beta-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashier%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembraned-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sinha%2C+S.%3B+Anderson%2C+J.+P.%3B+Barbour%2C+R.%3B+Basi%2C+G.+S.%3B+Caccavello%2C+R.%3B+Davis%2C+D.%3B+Doan%2C+M.%3B+Dovey%2C+H.+F.%3B+Frigon%2C+N.%3B+Hong%2C+J.%3B+Jacobson-Croak%2C+K.%3B+Jewett%2C+N.%3B+Keim%2C+P.%3B+Knops%2C+J.%3B+Lieberburg%2C+I.%3B+Power%2C+M.%3B+Tan%2C+H.%3B+Tatsuno%2C+G.%3B+Tung%2C+J.%3B+Schenk%2C+D.%3B+Seubert%2C+P.%3B+Suomensaari%2C+S.+M.%3B+Wang%2C+S.%3B+Walker%2C+D.%3B+Zhao%2C+J.%3B+McConlogue%2C+L.%3B+John%2C+V.Nature+1999%2C+402%2C+537%E2%80%93540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span> </span><span class="NLM_article-title">Inhibition of BACE1 for therapeutic use in Alzheimer’s Disease</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=20661410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFagtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=618-628&author=X.+Luoauthor=R.+Yan&title=Inhibition+of+BACE1+for+therapeutic+use+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BACE1 for therapeutic use in Alzheimer's disease</span></div><div class="casAuthors">Luo, Xiaoyang; Yan, Riqiang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-628</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Since BACE1 was reported as the β-secretase in Alzheimer's disease (AD) over ten years ago, encouraging progress has been made toward understanding the cellular functions of BACE1.  Genetic studies have further confirmed that BACE1 is essential for processing amyloid precursor protein (APP) at the β-secretase site.  Only after this cleavage can the membrane-bound APP C-terminal fragment be subsequently cleaved by γ-secretase to release so-called AD-causing Aβ peptides.  Hence, in the past decade, a wide variety of BACE1 inhibitors have been developed for AD therapy.  This review will summarize the major historical events during the evolution of BACE1 inhibitors designed through different strategies of drug discovery.  Although BACE1 inhibitors are expected to be safe in general, careful titrn. of drug dosage to avoid undesirable side effects in BACE1-directed AD therapy is also emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUFz1x-AF9XbVg90H21EOLACvtfcHk0li-3pU0u2jxOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFagtbo%253D&md5=0cf2745b97b31229b1de6b7db04911e2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520BACE1%2520for%2520therapeutic%2520use%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2010%26volume%3D3%26spage%3D618%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Johnsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jönsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span> </span><span class="NLM_article-title">A mutation in <i>APP</i> protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Johnssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Johnssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+B.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottir&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJohnsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BB.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermolieff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Design of potent inhibitors for human brainmemapsin 2 (β-secretase)</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">3522</span><span class="NLM_x">–</span> <span class="NLM_lpage">3523</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja000300g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=3522-3523&author=A.+K.+Ghoshauthor=D.+Shinauthor=D.+Downsauthor=G.+Koelschauthor=X.+Linauthor=J.+Ermolieffauthor=J.+Tang&title=Design+of+potent+inhibitors+for+human+brainmemapsin+2+%28%CE%B2-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fja000300g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja000300g%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DErmolieff%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520potent%2520inhibitors%2520for%2520human%2520brainmemapsin%25202%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D3522%26epage%3D3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span> </span><span class="NLM_article-title">Design and development of BACE-1 inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=536-556&author=J.+N.+Cummingauthor=U.+Iserlohauthor=M.+E.+Kennedy&title=Design+and+development+of+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26atitle%3DDesign%2520and%2520development%2520of%2520BACE-1%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2004%26volume%3D7%26spage%3D536%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Durham, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, T. A.</span><span> </span><span class="NLM_article-title">Progress toward the discovery and development of efficacious BACE inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=776-791&author=T.+B.+Durhamauthor=T.+A.+Shepherd&title=Progress+toward+the+discovery+and+development+of+efficacious+BACE+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DShepherd%26aufirst%3DT.%2BA.%26atitle%3DProgress%2520toward%2520the%2520discovery%2520and%2520development%2520of%2520efficacious%2520BACE%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D776%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Potent pyrrolidine- and piperidine-based BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2Fj.bmcl.2007.10.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=18023580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1Wgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=414-417&author=U.+Iserlohauthor=Y.+Wuauthor=J.+N.+Cummingauthor=J.+Panauthor=L.+Y.+Wangauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=X.+Chenauthor=E.+M.+Parkerauthor=C.+Stricklandauthor=J.+Voigt&title=Potent+pyrrolidine-+and+piperidine-based+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Potent pyrrolidine- and piperidine-based BACE-1 inhibitors</span></div><div class="casAuthors">Iserloh, U.; Wu, Y.; Cumming, J. N.; Pan, J.; Wang, L. Y.; Stamford, A. W.; Kennedy, M. E.; Kuvelkar, R.; Chen, X.; Parker, E. M.; Strickland, C.; Voigt, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">414-417</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Based on lead compd. 1 identified from the patent literature, the authors developed novel patentable BACE-1 inhibitors by introducing a cyclic amine scaffold.  Extensive SAR studies on both pyrrolidines and piperidines ultimately led to inhibitor (I), one of the most potent inhibitors synthesized to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAchFs1p0DSrVg90H21EOLACvtfcHk0lgalfyRMKUJbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1Wgtg%253D%253D&md5=39db058f22f5ff8f12735456a6f7b70e</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.116%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DPotent%2520pyrrolidine-%2520and%2520piperidine-based%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D414%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Discovery of an orally efficacious 4-phenoxypyrrolidine-based BACE-1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=418-422&author=U.+Iserlohauthor=J.+Panauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=Q.+Zhangauthor=L.+Zhangauthor=E.+M.+Parkerauthor=N.+A.+McHughauthor=L.+Favreauauthor=C.+Stricklandauthor=J.+Voigt&title=Discovery+of+an+orally+efficacious+4-phenoxypyrrolidine-based+BACE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DMcHugh%26aufirst%3DN.%2BA.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520efficacious%25204-phenoxypyrrolidine-based%2520BACE-1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D418%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacPherson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanway, S.</span><span> </span><span class="NLM_article-title">BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1017-1022&author=B.+Clarkeauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=A.+Fallerauthor=J.+Hawkinsauthor=I.+Hussainauthor=D.+MacPhersonauthor=G.+Maileauthor=R.+Maticoauthor=P.+Milnerauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=D.+Riddellauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Stanway&title=BACE-1+inhibitors+part+2%3A+identification+of+hydroxy+ethylamines+%28HEAs%29+with+reduced+peptidic+character"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMacPherson%26aufirst%3DD.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMilner%26aufirst%3DP.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DStanway%26aufirst%3DS.%26atitle%3DBACE-1%2520inhibitors%2520part%25202%253A%2520identification%2520of%2520hydroxy%2520ethylamines%2520%2528HEAs%2529%2520with%2520reduced%2520peptidic%2520character%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1017%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6g"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3664</span><span class="NLM_x">–</span> <span class="NLM_lpage">3668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3664-3668&author=N.+Charrierauthor=B.+Clarkeauthor=L.+Cutlerauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=C.+Howesauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors.+Part+1%3A+The+need+for+improved+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors.%2520Part%25201%253A%2520The%2520need%2520for%2520improved%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3664%26epage%3D3668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6h"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors part 2: optimization of the non-prime side substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3669</span><span class="NLM_x">–</span> <span class="NLM_lpage">3673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3669-3673&author=N.+Charrierauthor=B.+Clarkeauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors+part+2%3A+optimization+of+the+non-prime+side+substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors%2520part%25202%253A%2520optimization%2520of%2520the%2520non-prime%2520side%2520substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3669%26epage%3D3673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6i"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors part 3: towards non-hydroxyethylamine transition state mimetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3674</span><span class="NLM_x">–</span> <span class="NLM_lpage">3678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3674-3678&author=N.+Charrierauthor=B.+Clarkeauthor=L.+Cutlerauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=C.+Howesauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors+part+3%3A+towards+non-hydroxyethylamine+transition+state+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors%2520part%25203%253A%2520towards%2520non-hydroxyethylamine%2520transition%2520state%2520mimetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3674%26epage%3D3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6j"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Stachel, S. J.</span><span> </span><span class="NLM_article-title">Progess toward the development of a viable BACE1 inhibitor</span> <span class="citation_source-journal">Drug. Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=101-110&author=S.+J.+Stachel&title=Progess+toward+the+development+of+a+viable+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26atitle%3DProgess%2520toward%2520the%2520development%2520of%2520a%2520viable%2520BACE1%2520inhibitor%26jtitle%3DDrug.%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references therein.</p></div><div class="NLM_citation" id="cit6k"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Al-Tel, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Qawasmeh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Aboudi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabri, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voelter, W.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of potent dibenzazepine motifs as β-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6484</span><span class="NLM_x">–</span> <span class="NLM_lpage">6488</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9008482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6484-6488&author=T.+H.+Al-Telauthor=R.+A.+Al-Qawasmehauthor=M.+F.+Schmidtauthor=A.+Al-Aboudiauthor=S.+N.+Raoauthor=S.+S.+Sabriauthor=W.+Voelter&title=Rational+design+and+synthesis+of+potent+dibenzazepine+motifs+as+%CE%B2-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1021%2Fjm9008482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9008482%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Tel%26aufirst%3DT.%2BH.%26aulast%3DAl-Qawasmeh%26aufirst%3DR.%2BA.%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DAl-Aboudi%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DSabri%26aufirst%3DS.%2BS.%26aulast%3DVoelter%26aufirst%3DW.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520potent%2520dibenzazepine%2520motifs%2520as%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6484%26epage%3D6488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Cumming, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgur, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saionz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2837</span><span class="NLM_x">–</span> <span class="NLM_lpage">2842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2837-2842&author=J.+Cummingauthor=S.+Babuauthor=Y.+Huangauthor=C.+Carrolauthor=X.+Chenauthor=L.+Favreauauthor=W.+Greenleeauthor=T.+Guoauthor=M.+Kennedyauthor=R.+Kuvelkarauthor=T.+Leauthor=G.+Liauthor=N.+McHughauthor=P.+Orthauthor=L.+Ozgurauthor=E.+Parkerauthor=K.+Saionzauthor=A.+Stamfordauthor=C.+Stricklandauthor=D.+Tadesseauthor=J.+Voigtauthor=L.+Zhangauthor=Q.+Zhang&title=Piperazine+sulfonamide+BACE1+inhibitors%3A+design%2C+synthesis%2C+and+in+vivo+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCarrol%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLe%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMcHugh%26aufirst%3DN.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DOzgur%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DSaionz%26aufirst%3DK.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DPiperazine%2520sulfonamide%2520BACE1%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2837%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Al-Tel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semreen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Qawasmeh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Awadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaarour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Agnaf, O.</span><span> </span><span class="NLM_article-title">Design, synthesis, and qualitative structure–activity evaluations of novel β-secretase inhibitors as potential Alzheimer’s drug leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8873</span><span class="NLM_x">–</span> <span class="NLM_lpage">8385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8873-8385&author=T.+Al-Telauthor=M.+H.+Semreenauthor=R.+A.+Al-Qawasmehauthor=M.+F.+Schmidtauthor=R.+El-Awadiauthor=M.+Ardahauthor=R.+Zaarourauthor=S.+N.+Raoauthor=O.+El-Agnaf&title=Design%2C+synthesis%2C+and+qualitative+structure%E2%80%93activity+evaluations+of+novel+%CE%B2-secretase+inhibitors+as+potential+Alzheimer%E2%80%99s+drug+leads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Tel%26aufirst%3DT.%26aulast%3DSemreen%26aufirst%3DM.%2BH.%26aulast%3DAl-Qawasmeh%26aufirst%3DR.%2BA.%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DEl-Awadi%26aufirst%3DR.%26aulast%3DArdah%26aufirst%3DM.%26aulast%3DZaarour%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DEl-Agnaf%26aufirst%3DO.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520qualitative%2520structure%25E2%2580%2593activity%2520evaluations%2520of%2520novel%2520%25CE%25B2-secretase%2520inhibitors%2520as%2520potential%2520Alzheimer%25E2%2580%2599s%2520drug%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8873%26epage%3D8385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6n"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span> </span><span class="NLM_article-title">A potent and orally efficacious, hydroxyethylamine-based inhibitor of beta-secretase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3000148" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=886-891&author=M.+R.+Kallerauthor=S.+S.+Harriedauthor=B.+Albrechtauthor=P.+Amaranteauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=R.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+Dunnauthor=R.+Graceffaauthor=D.+Hickmanauthor=T.+Juddauthor=C.+Kreimanauthor=D.+Laauthor=P.+Lopezauthor=Y.+Luoauthor=C.+Masseauthor=H.+Monenscheinauthor=T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=T.+Williamsonauthor=S.+Woodauthor=M.+Xueauthor=B.+Yangauthor=J.+Zhangauthor=V.+Patelauthor=W.+Zhongauthor=S.+Hitchcock&title=A+potent+and+orally+efficacious%2C+hydroxyethylamine-based+inhibitor+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=10.1021%2Fml3000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000148%26sid%3Dliteratum%253Aachs%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DAlbrecht%26aufirst%3DB.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDunn%26aufirst%3DR.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DLa%26aufirst%3DD.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMasse%26aufirst%3DC.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DHitchcock%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520orally%2520efficacious%252C%2520hydroxyethylamine-based%2520inhibitor%2520of%2520beta-secretase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D886%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and preparation of a potent series of β-secretase inhibitors that demonstrate robust reduction of central β-amyloid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9009</span><span class="NLM_x">–</span> <span class="NLM_lpage">9024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300119p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9009-9024&author=M.+M.+Weissauthor=T.+Williamsonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=T.+A.+Dineenauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=C.+Rattanauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+preparation+of+a+potent+series+of+%CE%B2-secretase+inhibitors+that+demonstrate+robust+reduction+of+central+%CE%B2-amyloid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6o&amp;dbid=16384&amp;doi=10.1021%2Fjm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520a%2520potent%2520series%2520of%2520%25CE%25B2-secretase%2520inhibitors%2520that%2520demonstrate%2520robust%2520reduction%2520of%2520central%2520%25CE%25B2-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9009%26epage%3D9024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, orally efficacious hydroxyethylamine derived β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9025</span><span class="NLM_x">–</span> <span class="NLM_lpage">9044</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6p&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9025-9044&author=T.+A.+Dineenauthor=M.+M.+Weissauthor=T.+Williamsonauthor=P.+Actonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+T.+Dunnauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+synthesis+of+potent%2C+orally+efficacious+hydroxyethylamine+derived+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6pR"><div class="casContent"><span class="casTitleNuber">6p</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors</span></div><div class="casAuthors">Dineen, Thomas A.; Weiss, Matthew M.; Williamson, Toni; Acton, Paul; Babu-Khan, Safura; Bartberger, Michael D.; Brown, James; Chen, Kui; Cheng, Yuan; Citron, Martin; Croghan, Michael D.; Dunn, Robert T.; Esmay, Joel; Graceffa, Russell F.; Harried, Scott S.; Hickman, Dean; Hitchcock, Stephen A.; Horne, Daniel B.; Huang, Hongbing; Imbeah-Ampiah, Ronke; Judd, Ted; Kaller, Matthew R.; Kreiman, Charles R.; La, Daniel S.; Li, Vivian; Lopez, Patricia; Louie, Steven; Monenschein, Holger; Nguyen, Thomas T.; Pennington, Lewis D.; San Miguel, Tisha; Sickmier, E. Allen; Vargas, Hugo M.; Wahl, Robert C.; Wen, Paul H.; Whittington, Douglas A.; Wood, Stephen; Xue, Qiufen; Yang, Bryant H.; Patel, Vinod F.; Zhong, Wenge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9025-9044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords compds. (e.g., 1, I) with sufficient bioavailability and pharmacokinetic profiles to reduce central amyloid-β peptide (Aβ) levels in wild-type rats following oral dosing.  In this article, we describe further modifications of the Ph ring of the hydroxyethylamine series to afford potent, dual BACE1/CYP 3A4 inhibitors which demonstrate improved penetration into the CNS.  Several of these compds. caused robust redn. of Aβ levels in rat CSF and brain following oral dosing, and compd. II exhibited an improved cardiovascular safety profile relative to 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqApKWBnTeHErVg90H21EOLACvtfcHk0lhGkjFemna7GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOnsbg%253D&md5=1c6ad4a5aa1583864bd778715e1453ea</span></div><a href="/servlet/linkout?suffix=cit6p&amp;dbid=16384&amp;doi=10.1021%2Fjm300118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300118s%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DActon%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520orally%2520efficacious%2520hydroxyethylamine%2520derived%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9025%26epage%3D9044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Ng, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailunas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konradi, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dappen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zmolek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bova, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yednock, T. A.</span><span> </span><span class="NLM_article-title">Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4674</span><span class="NLM_x">–</span> <span class="NLM_lpage">4679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6q&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2Fj.bmcl.2013.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6q&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=23856050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6q&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSgsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4674-4679&author=R.+A.+Ngauthor=+Sunauthor=S.+Minguaauthor=S.+Bowersauthor=R.+K.+Homauthor=G.+D.+Probstauthor=V.+Johnauthor=L.+Y.+Fangauthor=M.+Maillardauthor=A.+Gailunasauthor=L.+Brogleyauthor=R.+J.+Neitzauthor=J.+S.+Tungauthor=M.+A.+Pleissauthor=A.+W.+Konradiauthor=H.+L.+Shamauthor=M.+S.+Dappenauthor=M.+Adlerauthor=N.+Yaoauthor=W.+Zmolekauthor=D.+Nakamuraauthor=K.+P.+Quinnauthor=J.-M.+Sauerauthor=M.+P.+Bovaauthor=L.+Ruslimauthor=D.+R.+Artisauthor=T.+A.+Yednock&title=Design+and+synthesis+of+hydroxyethylamine+%28HEA%29+BACE-1+inhibitors%3A+prime+side+chromane-containing+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6qR"><div class="casContent"><span class="casTitleNuber">6q</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: Prime side chromane-containing inhibitors</span></div><div class="casAuthors">Ng, Raymond A.; Sun, Minghua; Bowers, Simeon; Hom, Roy K.; Probst, Gary D.; John, Varghese; Fang, Lawrence Y.; Maillard, Michel; Gailunas, Andrea; Brogley, Louis; Neitz, R. Jeffrey; Tung, Jay S.; Pleiss, Michael A.; Konradi, Andrei W.; Sham, Hing L.; Dappen, Michael S.; Adler, Marc; Yao, Nanhua; Zmolek, Wes; Nakamura, David; Quinn, Kevin P.; Sauer, John-Michael; Bova, Michael P.; Ruslim, Lany; Artis, Dean R.; Yednock, Ted A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4674-4679</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The structure activity relationship of the prime region of conformationally restricted hydroxyethylamine (HEA) BACE inhibitors is described.  Variation of the P1' region provided selectivity over Cat-D with a series of 2,2-dioxo-isothiochromanes and optimization of the P2' substituent of chromane-HEA(s) with polar substituents provided improvements in the compd.'s in vitro permeability.  Significant potency gains were obsd. with small aliph. substituents such as Me, Pr, and cyclopropyl when placed at the C-2 position of the chromane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUSWYKJenCb7Vg90H21EOLACvtfcHk0lhgv92g39wvEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSgsrzI&md5=e851a0654e076d7cc032f2adc58af570</span></div><a href="/servlet/linkout?suffix=cit6q&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DR.%2BA.%26aulast%3DSun%26aulast%3DMingua%26aufirst%3DS.%26aulast%3DBowers%26aufirst%3DS.%26aulast%3DHom%26aufirst%3DR.%2BK.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DJohn%26aufirst%3DV.%26aulast%3DFang%26aufirst%3DL.%2BY.%26aulast%3DMaillard%26aufirst%3DM.%26aulast%3DGailunas%26aufirst%3DA.%26aulast%3DBrogley%26aufirst%3DL.%26aulast%3DNeitz%26aufirst%3DR.%2BJ.%26aulast%3DTung%26aufirst%3DJ.%2BS.%26aulast%3DPleiss%26aufirst%3DM.%2BA.%26aulast%3DKonradi%26aufirst%3DA.%2BW.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DDappen%26aufirst%3DM.%2BS.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DZmolek%26aufirst%3DW.%26aulast%3DNakamura%26aufirst%3DD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSauer%26aufirst%3DJ.-M.%26aulast%3DBova%26aufirst%3DM.%2BP.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DYednock%26aufirst%3DT.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520hydroxyethylamine%2520%2528HEA%2529%2520BACE-1%2520inhibitors%253A%2520prime%2520side%2520chromane-containing%2520inhibitors%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4674%26epage%3D4679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061197u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1124-1132&author=M.+Congreveauthor=D.+Aharonyauthor=J.+Albertauthor=O.+Callaghanauthor=J.+Campbellauthor=R.+A.+E.+Carrauthor=G.+Chessariauthor=S.+Cowanauthor=P.+D.+Edwardsauthor=M.+Fredericksonauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+the+discovery+of+aminopyridines+as+inhibitors+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Fjm061197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061197u%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DJ.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520the%2520discovery%2520of%2520aminopyridines%2520as%2520inhibitors%2520of%2520beta-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1124%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baxter, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braeken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruinzeel, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenneman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, A. B.</span><span> </span><span class="NLM_article-title">2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): use of structure based design to convert a micromolar hit into a nanomolar lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4261</span><span class="NLM_x">–</span> <span class="NLM_lpage">4264</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0705408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4261-4264&author=E.+W.+Baxterauthor=K.+A.+Conwayauthor=L.+Kennisauthor=F.+Bischoffauthor=M.+H.+Merckenauthor=H.+L.+Winterauthor=C.+H.+Reynoldsauthor=B.+A.+Toungeauthor=C.+Luoauthor=M.+K.+Scottauthor=Y.+Huangauthor=M.+Braekenauthor=S.+M.+Pietersauthor=D.+J.+Berthelotauthor=S.+Masureauthor=W.+D.+Bruinzeelauthor=A.+D.+Jordanauthor=M.+H.+Parkerauthor=R.+E.+Boydauthor=J.+Quauthor=R.+S.+Alexanderauthor=D.+E.+Brennemanauthor=A.+B.+Reitz&title=2-Amino-3%2C4-dihydroquinazolines+as+inhibitors+of+BACE-1+%28beta-site+APP+cleaving+enzyme%29%3A+use+of+structure+based+design+to+convert+a+micromolar+hit+into+a+nanomolar+lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm0705408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0705408%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DE.%2BW.%26aulast%3DConway%26aufirst%3DK.%2BA.%26aulast%3DKennis%26aufirst%3DL.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DMercken%26aufirst%3DM.%2BH.%26aulast%3DWinter%26aufirst%3DH.%2BL.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DM.%2BK.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DBraeken%26aufirst%3DM.%26aulast%3DPieters%26aufirst%3DS.%2BM.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%26aulast%3DMasure%26aufirst%3DS.%26aulast%3DBruinzeel%26aufirst%3DW.%2BD.%26aulast%3DJordan%26aufirst%3DA.%2BD.%26aulast%3DParker%26aufirst%3DM.%2BH.%26aulast%3DBoyd%26aufirst%3DR.%2BE.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DBrenneman%26aufirst%3DD.%2BE.%26aulast%3DReitz%26aufirst%3DA.%2BB.%26atitle%3D2-Amino-3%252C4-dihydroquinazolines%2520as%2520inhibitors%2520of%2520BACE-1%2520%2528beta-site%2520APP%2520cleaving%2520enzyme%2529%253A%2520use%2520of%2520structure%2520based%2520design%2520to%2520convert%2520a%2520micromolar%2520hit%2520into%2520a%2520nanomolar%2520lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4261%26epage%3D4264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Barrow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1002%2Fcmdc.200700038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=17458843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVyktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=995-999&author=J.+Barrowauthor=K.+Rittleauthor=P.+Ngoauthor=H.+Selnickauthor=S.+Grahamauthor=S.+Pitzenbergerauthor=G.+McGaugheyauthor=D.+Colussiauthor=M.-T.+Laiauthor=Q.+Huangauthor=K.+Tugushevaauthor=A.+Espesethauthor=A.+Simonauthor=S.+Munshiauthor=J.+Vacca&title=Design+and+synthesis+of+2%2C3%2C5-substituted+imidazolidin-4-one+inhibitors+of+BACE-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1</span></div><div class="casAuthors">Barrow, James C.; Rittle, Kenneth E.; Ngo, Phung L.; Selnick, Harold G.; Graham, Samuel L.; Pitzenberger, Steven M.; McGaughey, Georgia B.; Colussi, Dennis; Lai, Ming-Tain; Huang, Qian; Tugusheva, Katherine; Espeseth, Amy S.; Simon, Adam J.; Munshi, Sanjeev K.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">995-999</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2,3,5-Substituted imidazolidin-4-ones (e.g. I (R1 = Me, H; R2 = Bn)) were prepd. and tested as BACE-1 inhibitors.  The illustrated I are the most potent inhibitors.  The crystal and mol. structures of I (R1 = Me; R2 = Me) in the active site of BACE-1 were detd. by x-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgoCprsegvBLVg90H21EOLACvtfcHk0lgYvoSjAvdzyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVyktLc%253D&md5=e04a29f0ada03e808cbe5a10e8e57d0e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700038%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%26aulast%3DRittle%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DP.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DPitzenberger%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202%252C3%252C5-substituted%2520imidazolidin-4-one%2520inhibitors%2520of%2520BACE-1%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D995%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichau, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichau&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichau%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lgvEdFk37Vjxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBell, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lhKX1zLND2crA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Swahn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S. v.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.+Swahnauthor=J.+Holenzauthor=J.+Kihlstromauthor=K.+Kolmodinauthor=J.+Lindstromauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstromauthor=S.+v.+Bergauthor=J.+Faltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstrom%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DBerg%26aufirst%3DS.%2Bv.%26aulast%3DFalting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28A%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7h&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7i&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7iR"><div class="casContent"><span class="casTitleNuber">7i</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lgadbfqovcPIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit7i&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Aβ reduction</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7j&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D897%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9156</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Louauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Epstein, O.; Bryan, M. C.; Cheng, A. C.; Derakhchan, K.; Dineen, T. A.; Hickman, D.; Hua, Z.; Human, J. B.; Kreiman, C. E.; Marx, I. E.; Weiss, M. M.; Qu, Y.; Wahl, R. C.; Wen, P. H.; Whittington, D. A.; Wood, S.; Zheng, X. M.; Fremeau,  Jr., R. T.; White, R. D.; Patel, V. F.</span><span> </span><span class="NLM_article-title">Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene BACE inhibitors</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span>, DOI: <span class="refDoi"> DOI: 10.1021/jm501266w</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm501266w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&author=O.+Epstein&author=M.+C.+Bryan&author=A.+C.+Cheng&author=K.+Derakhchan&author=T.+A.+Dineen&author=D.+Hickman&author=Z.+Hua&author=J.+B.+Human&author=C.+E.+Kreiman&author=I.+E.+Marx&author=M.+M.+Weiss&author=Y.+Qu&author=R.+C.+Wahl&author=P.+H.+Wen&author=D.+A.+Whittington&author=S.+Wood&author=X.+M.+Zheng&author=R.+T.+Fremeau&author=R.+D.+White&author=V.+F.+Patel&title=Lead+optimization+and+modulation+of+hERG+activity+in+a+series+of+aminooxazoline+xanthene+BACE+inhibitors&doi=10.1021%2Fjm501266w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501266w%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DO.%26atitle%3DLead%2520optimization%2520and%2520modulation%2520of%2520hERG%2520activity%2520in%2520a%2520series%2520of%2520aminooxazoline%2520xanthene%2520BACE%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26doi%3D10.1021%2Fjm501266w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mahar Doan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Passive permeability and P-glycoprotein mediated efflux differentiate CNS and non-CNS marketed drugs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=K.+M.+Mahar+Doanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkinsonauthor=J.+W.+Polli&title=Passive+permeability+and+P-glycoprotein+mediated+efflux+differentiate+CNS+and+non-CNS+marketed+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Mahar Doan Kelly M; Humphreys Joan E; Webster Lindsey O; Wring Stephen A; Shampine Larry J; Serabjit-Singh Cosette J; Adkison Kimberly K; Polli Joseph W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-37</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to determine whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochemical properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compounds for drug development.  Apparent permeability (P(app)) and Pgp substrate profiles for 93 CNS (n = 48) and non-CNS (n = 45) drugs were determined by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were positive in the calcein-AM assay when tested at 100 microM.  The CNS drug set (n = 7 of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (n = 19 of 45, 42.2%).  Analysis of 18 physicochemical properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer positive charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group (p < 0.05), properties that enhance membrane permeability.  This study on a large, diverse set of marketed compounds clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochemical properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B --> A/A --> B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_HiV1Xqt18Vf1XRtfYM0dfW6udTcc2eZPvYOnS8DAM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D&md5=b841902aa8502de47c1e1603c80e09fb</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DMahar%2BDoan%26aufirst%3DK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520permeability%2520and%2520P-glycoprotein%2520mediated%2520efflux%2520differentiate%2520CNS%2520and%2520non-CNS%2520marketed%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bissantz, C.; Kuhn, B.; Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span>.  <span class="citation_source-journal">J. Med. Chem.</span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bissantz%2C+C.%3B+Kuhn%2C+B.%3B+Stahl%2C+M.+A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions.+J.+Med.+Chem.53%2C+5061%E2%80%935084."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26volume%3D53%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hassner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorber, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcock, C.</span><span> </span><span class="NLM_article-title">Addition of iodine isocyanate to olefins. Scope and synthetic utility</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01278a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1967&pages=540-549&author=A.+Hassnerauthor=M.+E.+Lorberauthor=C.+Heathcock&title=Addition+of+iodine+isocyanate+to+olefins.+Scope+and+synthetic+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjo01278a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01278a006%26sid%3Dliteratum%253Aachs%26aulast%3DHassner%26aufirst%3DA.%26aulast%3DLorber%26aufirst%3DM.%2BE.%26aulast%3DHeathcock%26aufirst%3DC.%26atitle%3DAddition%2520of%2520iodine%2520isocyanate%2520to%2520olefins.%2520Scope%2520and%2520synthetic%2520utility%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1967%26volume%3D32%26spage%3D540%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fernandez, J. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellet, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, M. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mota, J. F.</span><span> </span><span class="NLM_article-title">Syntheses and spectral properties of β-iodoureas and 2-amino-4,4-diphenyl-2-oxazolines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1991&pages=777-780&author=J.+M.+G.+Fernandezauthor=C.+O.+Melletauthor=M.+A.+P.+Adrianauthor=J.+F.+Mota&title=Syntheses+and+spectral+properties+of+%CE%B2-iodoureas+and+2-amino-4%2C4-diphenyl-2-oxazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DJ.%2BM.%2BG.%26aulast%3DMellet%26aufirst%3DC.%2BO.%26aulast%3DAdrian%26aufirst%3DM.%2BA.%2BP.%26aulast%3DMota%26aufirst%3DJ.%2BF.%26atitle%3DSyntheses%2520and%2520spectral%2520properties%2520of%2520%25CE%25B2-iodoureas%2520and%25202-amino-4%252C4-diphenyl-2-oxazolines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1991%26volume%3D28%26spage%3D777%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><div class="note"><p class="first last">For a review, see</p></div><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling reactions of organoboron compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2456</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2456-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2456%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghanta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">Physicochemical features of the hERG channel drug binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">10120</span><span class="NLM_x">–</span> <span class="NLM_lpage">10127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=10120-10127&author=D.+Fernandezauthor=A.+Ghantaauthor=G.+W.+Kauffmanauthor=M.+C.+Sanguinetti&title=Physicochemical+features+of+the+hERG+channel+drug+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DD.%26aulast%3DGhanta%26aufirst%3DA.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DPhysicochemical%2520features%2520of%2520the%2520hERG%2520channel%2520drug%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D10120%26epage%3D10127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0ljPpnbWjmZf3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Seelig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landwojtowicz, E.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of P-glycoprotein substrates and modifiers</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2FS0928-0987%2800%2900177-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=11121731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1yiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=31-40&author=A.+Seeligauthor=E.+Landwojtowicz&title=Structure%E2%80%93activity+relationship+of+P-glycoprotein+substrates+and+modifiers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of P-glycoprotein substrates and modifiers</span></div><div class="casAuthors">Seelig, A.; Landwojtowicz, E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The air-water partition coeffs., Kaw, highly correlated with the corresponding lipid-water partition coeffs., Klw, and the crit. micelle concns., CMC, were measured for 11 compds. for which the kinetic parameters of P-glycoprotein ATPase activation (Michaelis-Menten const., Km, and maximal velocity, Vmax) had been detd. previously in inside-out vesicles of CR1R12 Chinese hamster ovary cells.  In addn., the hydrogen bond donor patterns (type I and type II) relevant for substrate recognition by P-glycoprotein were detd. from the energy-minimized three-dimensional structure of these compds.  A linear relation between the air-water partition coeff., Kaw, and the inverse of the Michaelis-Menten const., Km, was obsd. such that Km·Kaw∼1.  The maximal velocity, Vmax, was shown to decrease with the no. and strength of electron donor (hydrogen bond acceptor) groups in recognition patterns.  If two substrates are applied simultaneously to P-glycoprotein the compd. with the higher potential to form hydrogen bonds generally acts as an inhibitor.  We conclude that partitioning into the lipid membrane is the rate-limiting step for the interaction of a substrate with P-glycoprotein and that dissocn. of the P-glycoprotein-substrate complex is detd. by the no. and strength of the hydrogen bonds formed between the substrate and the transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc-z_lr6yeA7Vg90H21EOLACvtfcHk0ljPpnbWjmZf3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1yiu7w%253D&md5=df34dfdd3c1dafd241d25f2b7521bf21</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2800%2900177-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252800%252900177-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeelig%26aufirst%3DA.%26aulast%3DLandwojtowicz%26aufirst%3DE.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520P-glycoprotein%2520substrates%2520and%2520modifiers%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D12%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Coordinates for the complex of BACE1 with inhibitor <b>42</b> have been deposited in the Protein Data Bank under PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RCD">4RCD</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R.</span><span> </span><span class="NLM_article-title">Time-dependent CYP inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1517%2F17425255.3.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=17269894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=51-66&author=R.+J.+Rileyauthor=K.+Grimeauthor=R.+Weaver&title=Time-dependent+CYP+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Time-dependent CYP inhibition</span></div><div class="casAuthors">Riley, Robert J.; Grime, Ken; Weaver, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Time-dependent inhibition (TDI) of CYP refers to a change in potency during an in vitro incubation or dosing period in vivo.  Potential mechanisms include the formation of inhibitory metabolites and mechanism-based inhibition (MBI).  In vitro expts. are configured to assess TDI and MBI is inferred, at least initially.  MBI is more profound after multiple-dosing and the recovery period is independent of continued drug exposure.  Advances in in vitro-in vivo extrapolations for competitive inhibition and the potential relationship between MBI and reactive metabolite-mediated toxicity, have redirected emphasis to CYP TDI.  In contrast, with reversible inhibition, strategies for projecting the risks from TDI are less developed and the traditional I/Ki model often yields a dramatic underprediction.  This review explores the contribution of TDI to drug-drug interactions and idiosyncratic drug toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8w1eAZ9QULVg90H21EOLACvtfcHk0ljPpnbWjmZf3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D&md5=184636ac0768f51d65f407a0655233e4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17425255.3.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.3.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DWeaver%26aufirst%3DR.%26atitle%3DTime-dependent%2520CYP%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2007%26volume%3D3%26spage%3D51%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Berry, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">An Examination of IC<sub>50</sub> and IC<sub>50</sub>-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6, and CYP2C9 in human liver microsomes</span> <span class="citation_source-journal">Drug. Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.2174%2F187231208783478407" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=51-59&author=L.+M.+Berryauthor=Z.+Zhao&title=An+Examination+of+IC50+and+IC50-shift+experiments+in+assessing+time-dependent+inhibition+of+CYP3A4%2C+CYP2D6%2C+and+CYP2C9+in+human+liver+microsomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F187231208783478407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231208783478407%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DAn%2520Examination%2520of%2520IC50%2520and%2520IC50-shift%2520experiments%2520in%2520assessing%2520time-dependent%2520inhibition%2520of%2520CYP3A4%252C%2520CYP2D6%252C%2520and%2520CYP2C9%2520in%2520human%2520liver%2520microsomes%26jtitle%3DDrug.%2520Metab.%2520Lett.%26date%3D2008%26volume%3D8%26spage%3D51%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">In general, aminoxazoline xanthene compounds displayed similar PK profiles in rats and maximum effects on Aβ reduction in the CSF and brain were observed between 4 and 5 h following an oral dose in the PD assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+surrogate+for+assessing+CNS+exposure%3A+an+industrial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0ljIgC8T18TFEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520surrogate%2520for%2520assessing%2520CNS%2520exposure%253A%2520an%2520industrial%2520perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+drug+concentration+in+brain+homogenate+and+cerebral+spinal+fluid+at+steady+state+as+a+surrogate+for+unbound+concentration+in+brain+interstitial+fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0ljIgC8T18TFEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520drug%2520concentration%2520in%2520brain%2520homogenate%2520and%2520cerebral%2520spinal%2520fluid%2520at%2520steady%2520state%2520as%2520a%2520surrogate%2520for%2520unbound%2520concentration%2520in%2520brain%2520interstitial%2520fluid%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Felmlee, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mager, D. E.</span><span> </span><span class="NLM_article-title">Mechanism-based pharmacodynamic modeling</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">929</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1007%2F978-1-62703-050-2_21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=23007443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisF2ht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=929&publication_year=2012&pages=583-600&author=M.+A.+Felmleeauthor=M.+E.+Morrisauthor=D.+E.+Mager&title=Mechanism-based+pharmacodynamic+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based pharmacodynamic modeling</span></div><div class="casAuthors">Felmlee, Melanie A.; Morris, Marilyn E.; Mager, Donald E.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">929</span>
        (<span class="NLM_cas:issue">Computational Toxicology, Volume I</span>),
    <span class="NLM_cas:pages">583-600</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Pharmacodynamic modeling is based on a quant. integration of pharmacokinetics, pharmacol. systems, and (patho-) physiol. processes for understanding the intensity and time-course of drug effects on the body.  Application of such models to the anal. of meaningful exptl. data allows for the quantification and prediction of drug-system interactions for both therapeutic and adverse drug responses.  In this chapter, commonly used mechanistic pharmacodynamic models are presented with respect to their important features, operable equations, and signature profiles.  In addn., literature examples showcasing the utility of these models to adverse drug events are highlighted.  Common model types that are covered include simple direct effects, biophase distribution, indirect effects, signal transduction, and irreversible effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotNyzwxREt3LVg90H21EOLACvtfcHk0lg4AlMDuo2oww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisF2ht70%253D&md5=a459c27b92c14cbc01725c085789fa86</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-050-2_21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-050-2_21%26sid%3Dliteratum%253Aachs%26aulast%3DFelmlee%26aufirst%3DM.%2BA.%26aulast%3DMorris%26aufirst%3DM.%2BE.%26aulast%3DMager%26aufirst%3DD.%2BE.%26atitle%3DMechanism-based%2520pharmacodynamic%2520modeling%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2012%26volume%3D929%26spage%3D583%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Finlayson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">January, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharkey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. S.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2FS0014-2999%2801%2901362-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=11698075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFWhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2001&pages=147-148&author=K.+Finlaysonauthor=L.+Turnbullauthor=C.+T.+Januaryauthor=J.+Sharkeyauthor=J.+S.+Kelly&title=%5B3H%5DDofetilide+binding+to+HERG+transfected+membranes%3A+a+potential+high+throughput+preclinical+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen</span></div><div class="casAuthors">Finlayson, Keith; Turnbull, Lorna; January, Craig T.; Sharkey, John; Kelly, John S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-148</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The pharmacol. characteristics of [3H]dofetilide binding were examd. in membranes prepd. from human embryonic kidney (HEK293) cells stably expressing human ether-a-go-go related gene (HERG) K+ channels.  The class III antiarrhythmic compds. dofetilide, clofilium, 4'-[[1-[2-(6-methyl-2-pyridyl)ethyl]-4-piperidyl]carbonyl]methanesulfonanilide (E-4031), N-methyl-N-[2-[methyl-(1-methyl-1H-benzimidazol-2-yl)amino]ethyl]-4-[(methylsulfonyl)amino]benzene-sulfonamide (WAY-123,398) and d-sotalol all inhibited [3H]dofetilide binding.  In addn., the structurally unrelated compds. pimozide, terfenadine and haloperidol, all of which prolong the QT interval in man, also inhibited binding.  These data indicate that a [3H]dofetilide binding assay using HERG membranes may help identify compds. that prolong the QT interval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr09GxPknr35bVg90H21EOLACvtfcHk0lg4AlMDuo2oww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFWhs74%253D&md5=9849fe1d07c00f00be2ba076ecc7d93b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901362-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901362-0%26sid%3Dliteratum%253Aachs%26aulast%3DFinlayson%26aufirst%3DK.%26aulast%3DTurnbull%26aufirst%3DL.%26aulast%3DJanuary%26aufirst%3DC.%2BT.%26aulast%3DSharkey%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DJ.%2BS.%26atitle%3D%255B3H%255DDofetilide%2520binding%2520to%2520HERG%2520transfected%2520membranes%253A%2520a%2520potential%2520high%2520throughput%2520preclinical%2520screen%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D430%26spage%3D147%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g','cit6h','cit6i','cit6j','cit6k','cit6l','cit6m','cit6n','cit6o','cit6p','cit6q'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g','cit7h','cit7i','cit7j'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':[],'ref17':['cit17'],'ref18':['cit18'],'ref19':[],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Pallavi Sharma, M. R. Ranga Prabhath, Derek Wong, Maame Adjoa Ampem-Lassen, Shreesha V. Bhat, Luke Williams, <span class="NLM_string-name hlFld-ContribAuthor">Teresa G. Carvalho</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Biologically Active Heterospirocycles through Iterative 1,3-Dipolar Cycloaddition Pathways. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>86 </em>
                                    (1)
                                     , 1223-1230. <a href="https://doi.org/10.1021/acs.joc.0c02424" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02424</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02424%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BBiologically%252BActive%252BHeterospirocycles%252Bthrough%252BIterative%252B1%25252C3-Dipolar%252BCycloaddition%252BPathways%26aulast%3DSharma%26aufirst%3DPallavi%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D13102020%26date%3D14122020%26volume%3D86%26issue%3D1%26spage%3D1223%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Naili Luo, Shan Wang, Yue Zhang, Junhu Xin, <span class="NLM_string-name hlFld-ContribAuthor">Cunde Wang</span>. </span><span class="cited-content_cbyCitation_article-title">DBU-Promoted Cascade Selective Nucleophilic Addition/C–C Bond Cleavage/Hetero-Diels–Alder Reactions of 2-Amino-4H-chromen-4-ones with β-Nitrostyrenes and/or Aryl Aldehydes: Access to 5H-Chromeno[2,3-b]pyridin-5-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (21)
                                     , 14219-14228. <a href="https://doi.org/10.1021/acs.joc.0c01993" title="DOI URL">https://doi.org/10.1021/acs.joc.0c01993</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c01993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c01993%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDBU-Promoted%252BCascade%252BSelective%252BNucleophilic%252BAddition%25252FC%2525E2%252580%252593C%252BBond%252BCleavage%25252FHetero-Diels%2525E2%252580%252593Alder%252BReactions%252Bof%252B2-Amino-4H-chromen-4-ones%252Bwith%252B%2525CE%2525B2-Nitrostyrenes%252Band%25252For%252BAryl%252BAldehydes%25253A%252BAccess%252Bto%252B5H-Chromeno%25255B2%25252C3-b%25255Dpyridin-5-ones%26aulast%3DLuo%26aufirst%3DNaili%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18082020%26date%3D29102020%26volume%3D85%26issue%3D21%26spage%3D14219%26epage%3D14228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liping H. Pettus, Matthew P. Bourbeau, Jodi Bradley, Michael D. Bartberger, Kui Chen, Dean Hickman, Michael Johnson, Qingyian Liu, James R. Manning, Adrian Nanez, Aaron C. Siegmund, Paul H. Wen, Douglas A. Whittington, Jennifer R. Allen, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Wood</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2263-2281. <a href="https://doi.org/10.1021/acs.jmedchem.9b01034" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAM-6494%25253A%252BA%252BPotent%252Band%252BOrally%252BEfficacious%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitor%252Bwith%252Bin%252BVivo%252BSelectivity%252Bover%252BBACE2%26aulast%3DPettus%26aufirst%3DLiping%2BH.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D29062019%26date%3D18102019%26date%3D07102019%26volume%3D63%26issue%3D5%26spage%3D2263%26epage%3D2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Eriko Matsuoka, Naoya Asada, Genta Tadano, Takahiko Yamamoto, Kenji Nakahara, Kouki Fuchino, Hisanori Ito, Naoki Kanegawa, Diederik Moechars, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 5080-5095. <a href="https://doi.org/10.1021/acs.jmedchem.9b00309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BSelective%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%25253A%252BTargeting%252Bthe%252BFlap%252Bto%252BGain%252BSelectivity%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16022019%26date%3D13052019%26date%3D25042019%26volume%3D62%26issue%3D10%26spage%3D5080%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kenji Nakahara, Kouki Fuchino, Kazuo Komano, Naoya Asada, Genta Tadano, Tsuyoshi Hasegawa, Takahiko Yamamoto, Yusuke Sako, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Centrally Active 6-Substituted 5-Fluoro-1,3-dihydro-oxazine β-Secretase (BACE1) Inhibitors via Active Conformation Stabilization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (13)
                                     , 5525-5546. <a href="https://doi.org/10.1021/acs.jmedchem.8b00011" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BCentrally%252BActive%252B6-Substituted%252B5-Fluoro-1%25252C3-dihydro-oxazine%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bvia%252BActive%252BConformation%252BStabilization%26aulast%3DNakahara%26aufirst%3DKenji%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04012018%26date%3D14062018%26date%3D18052018%26volume%3D61%26issue%3D13%26spage%3D5525%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kouki Fuchino, Yasunori Mitsuoka, Moriyasu Masui, Noriyuki Kurose, Shuhei Yoshida, Kazuo Komano, Takahiko Yamamoto, Masayoshi Ogawa, Chie Unemura, Motoko Hosono, Hisanori Ito, Gaku Sakaguchi, Shigeru Ando, Shuichi Ohnishi, Yasuto Kido, Tamio Fukushima, Hirofumi Miyajima, Shuichi Hiroyama, Kiyotaka Koyabu, Deborah Dhuyvetter, Herman Borghys, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Novel 1,3-Oxazine Based β-Secretase (BACE1) Inhibitors: Incorporation of a Double Bond To Reduce P-gp Efflux Leading to Robust Aβ Reduction in the Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5122-5137. <a href="https://doi.org/10.1021/acs.jmedchem.8b00002" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BNovel%252B1%25252C3-Oxazine%252BBased%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%25253A%252BIncorporation%252Bof%252Ba%252BDouble%252BBond%252BTo%252BReduce%252BP-gp%252BEfflux%252BLeading%252Bto%252BRobust%252BA%2525CE%2525B2%252BReduction%252Bin%252Bthe%252BBrain%26aulast%3DFuchino%26aufirst%3DKouki%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D01012018%26date%3D23052018%26date%3D07052018%26volume%3D61%26issue%3D12%26spage%3D5122%26epage%3D5137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah E.  Graham</span>, <span class="hlFld-ContribAuthor ">Richard D.  Smith</span>, and <span class="hlFld-ContribAuthor ">Heather A.  Carlson</span>  . </span><span class="cited-content_cbyCitation_article-title">Predicting Displaceable Water Sites Using Mixed-Solvent Molecular Dynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (2)
                                     , 305-314. <a href="https://doi.org/10.1021/acs.jcim.7b00268" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00268%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPredicting%252BDisplaceable%252BWater%252BSites%252BUsing%252BMixed-Solvent%252BMolecular%252BDynamics%26aulast%3DGraham%26aufirst%3DSarah%2BE.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D12052017%26date%3D16012018%26date%3D26022018%26date%3D29122017%26volume%3D58%26issue%3D2%26spage%3D305%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 619-637. <a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE-1%252BInhibitors%25253A%252BFrom%252BRecent%252BSingle-Target%252BMolecules%252Bto%252BMultitarget%252BCompounds%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D08082017%26date%3D08022018%26date%3D27072017%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Steven M.    Mennen </span><span class="hlFld-ContribAuthor "> John    Stellwagen </span><span class="hlFld-ContribAuthor "> Ryan D.    White </span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Identification and Development of AM-6138: An Inhibitor of BACE1 for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 29-52. <a href="https://doi.org/10.1021/bk-2018-1307.ch002" title="DOI URL">https://doi.org/10.1021/bk-2018-1307.ch002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2018-1307.ch002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2018-1307.ch002%26sid%3Dliteratum%253Aachs%26atitle%3DPreclinical%252BIdentification%252Band%252BDevelopment%252Bof%252BAM-6138%25253A%252BAn%252BInhibitor%252Bof%252BBACE1%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DMennen%26aufirst%3DSteven%2BM.%26date%3D2018%26date%3D2018%26spage%3D29%26epage%3D52%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2018%26date%3D2018%26volume%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Bull</span>, <span class="hlFld-ContribAuthor ">Rosemary A.  Croft</span>, <span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">Robert  Doran</span>, and <span class="hlFld-ContribAuthor ">Kate F.  Morgan</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12150-12233. <a href="https://doi.org/10.1021/acs.chemrev.6b00274" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DOxetanes%25253A%252BRecent%252BAdvances%252Bin%252BSynthesis%25252C%252BReactivity%25252C%252Band%252BMedicinal%252BChemistry%26aulast%3DBull%26aufirst%3DJames%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28042016%26date%3D15092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12150%26epage%3D12233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David A.  Conlon</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Natalie, Jr.</span>, <span class="hlFld-ContribAuthor ">Nicolas  Cuniere</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Razler</span>, <span class="hlFld-ContribAuthor ">Jason  Zhu</span>, <span class="hlFld-ContribAuthor ">Nuria  de Mas</span>, <span class="hlFld-ContribAuthor ">Steven  Tymonko</span>, <span class="hlFld-ContribAuthor ">Kenneth J.  Fraunhoffer</span>, <span class="hlFld-ContribAuthor ">Eric  Sortore</span>, <span class="hlFld-ContribAuthor ">Victor W.  Rosso</span>, <span class="hlFld-ContribAuthor ">Zhongmin  Xu</span>, <span class="hlFld-ContribAuthor ">Monica L.  Adams</span>, <span class="hlFld-ContribAuthor ">Anisha  Patel</span>, <span class="hlFld-ContribAuthor ">Jun  Huang</span>, <span class="hlFld-ContribAuthor ">Hua  Gong</span>, <span class="hlFld-ContribAuthor ">David S.  Weinstein</span>, <span class="hlFld-ContribAuthor ">Fernando  Quiroz</span>, and <span class="hlFld-ContribAuthor ">Doris C.  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Practical Synthesis of Functionalized Azaxanthene-Derived Nonsteroidal Glucocorticoid Receptor Modulators. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (5)
                                     , 921-933. <a href="https://doi.org/10.1021/acs.oprd.6b00035" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00035%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BPractical%252BSynthesis%252Bof%252BFunctionalized%252BAzaxanthene-Derived%252BNonsteroidal%252BGlucocorticoid%252BReceptor%252BModulators%26aulast%3DConlon%26aufirst%3DDavid%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D05022016%26date%3D12052016%26date%3D20052016%26date%3D26042016%26volume%3D20%26issue%3D5%26spage%3D921%26epage%3D933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Remani Vasudevan  Sumesh</span>, <span class="hlFld-ContribAuthor ">Muthumani  Muthu</span>, <span class="hlFld-ContribAuthor ">Abdulrahman I.  Almansour</span>, <span class="hlFld-ContribAuthor ">Raju  Suresh Kumar</span>, <span class="hlFld-ContribAuthor ">Natarajan  Arumugam</span>, <span class="hlFld-ContribAuthor ">S.  Athimoolam</span>, <span class="hlFld-ContribAuthor ">E. Arockia  Jeya Yasmi Prabha</span>, and <span class="hlFld-ContribAuthor ">Raju Ranjith  Kumar</span>  . </span><span class="cited-content_cbyCitation_article-title">Multicomponent Dipolar Cycloaddition Strategy: Combinatorial Synthesis of Novel Spiro-Tethered Pyrazolo[3,4-b]quinoline Hybrid Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2016,</strong> <em>18 </em>
                                    (5)
                                     , 262-270. <a href="https://doi.org/10.1021/acscombsci.6b00003" title="DOI URL">https://doi.org/10.1021/acscombsci.6b00003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.6b00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.6b00003%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DMulticomponent%252BDipolar%252BCycloaddition%252BStrategy%25253A%252BCombinatorial%252BSynthesis%252Bof%252BNovel%252BSpiro-Tethered%252BPyrazolo%25255B3%25252C4-b%25255Dquinoline%252BHybrid%252BHeterocycles%26aulast%3DSumesh%26aufirst%3DRemani%2BVasudevan%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13012016%26date%3D20032016%26date%3D08042016%26date%3D09052016%26date%3D30032016%26volume%3D18%26issue%3D5%26spage%3D262%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oleg  Epstein</span>, <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Katayoun  Derakhchan</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Dineen</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Zihao  Hua</span>, <span class="hlFld-ContribAuthor ">Jason B.  Human</span>, <span class="hlFld-ContribAuthor ">Charles  Kreiman</span>, <span class="hlFld-ContribAuthor ">Isaac E.  Marx</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Xiao Mei  Zheng</span>, <span class="hlFld-ContribAuthor ">Robert T.  Fremeau, Jr.</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, and <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>  . </span><span class="cited-content_cbyCitation_article-title">Lead Optimization and Modulation of hERG Activity in a Series of Aminooxazoline Xanthene β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 9796-9810. <a href="https://doi.org/10.1021/jm501266w" title="DOI URL">https://doi.org/10.1021/jm501266w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501266w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLead%252BOptimization%252Band%252BModulation%252Bof%252BhERG%252BActivity%252Bin%252Ba%252BSeries%252Bof%252BAminooxazoline%252BXanthene%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE1%252529%252BInhibitors%26aulast%3DEpstein%26aufirst%3DOleg%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18082014%26date%3D12112014%26date%3D11122014%26volume%3D57%26issue%3D23%26spage%3D9796%26epage%3D9810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua R.  Born</span>, <span class="hlFld-ContribAuthor ">Vinoth Kumar  Chenniappan</span>, <span class="hlFld-ContribAuthor ">Danielle P.  Davis</span>, <span class="hlFld-ContribAuthor ">Jayme L.  Dahlin</span>, <span class="hlFld-ContribAuthor ">Juan J.  Marugan</span>, <span class="hlFld-ContribAuthor ">Samarjit  Patnaik</span>. </span><span class="cited-content_cbyCitation_article-title">The Impact of Assay Design on Medicinal Chemistry: Case Studies. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2021,</strong> <em>26 </em>, 247255522110262. <a href="https://doi.org/10.1177/24725552211026238" title="DOI URL">https://doi.org/10.1177/24725552211026238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/24725552211026238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F24725552211026238%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DThe%252BImpact%252Bof%252BAssay%252BDesign%252Bon%252BMedicinal%252BChemistry%25253A%252BCase%252BStudies%26aulast%3DBorn%26aufirst%3DJoshua%2BR.%26date%3D2021%26date%3D2021%26volume%3D26%26spage%3D247255522110262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingliang  Wang</span>, <span class="hlFld-ContribAuthor ">Dongping  Cheng</span>, <span class="hlFld-ContribAuthor ">Yueqi  Pu</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of azaxanthones via DDQ-mediated tandem oxidative annulation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>114 </em>, 153302. <a href="https://doi.org/10.1016/j.tetlet.2021.153302" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153302%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bazaxanthones%252Bvia%252BDDQ-mediated%252Btandem%252Boxidative%252Bannulation%26aulast%3DWang%26aufirst%3DMingliang%26date%3D2021%26volume%3D114%26spage%3D153302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Frohn</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Siegmund</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Albert  Amegadzie</span>, <span class="hlFld-ContribAuthor ">Ning  Chen</span>, <span class="hlFld-ContribAuthor ">Helming  Tan</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Allen</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Bourbeau</span>. </span><span class="cited-content_cbyCitation_article-title">The development of a structurally distinct series of BACE1 inhibitors via the (Z)-fluoro-olefin amide bioisosteric replacement. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127240. <a href="https://doi.org/10.1016/j.bmcl.2020.127240" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127240%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdevelopment%252Bof%252Ba%252Bstructurally%252Bdistinct%252Bseries%252Bof%252BBACE1%252Binhibitors%252Bvia%252Bthe%252B%252528Z%252529-fluoro-olefin%252Bamide%252Bbioisosteric%252Breplacement%26aulast%3DFrohn%26aufirst%3DMichael%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandran  Rankan</span>, <span class="hlFld-ContribAuthor ">Prabhakaran  Santhi Marimuthu</span>, <span class="hlFld-ContribAuthor ">Keshri Nath  Tiwari</span>. </span><span class="cited-content_cbyCitation_article-title">A quick and regioselective access of spirooxindole‐oxazoline by reaction of isatin and isocyanoacetate “on water”. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (6)
                                     , 2628-2633. <a href="https://doi.org/10.1002/jhet.3953" title="DOI URL">https://doi.org/10.1002/jhet.3953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3953%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DA%252Bquick%252Band%252Bregioselective%252Baccess%252Bof%252Bspirooxindole%2525E2%252580%252590oxazoline%252Bby%252Breaction%252Bof%252Bisatin%252Band%252Bisocyanoacetate%252B%2525E2%252580%25259Con%252Bwater%2525E2%252580%25259D%26aulast%3DRankan%26aufirst%3DChandran%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D6%26spage%3D2628%26epage%3D2633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Mahsima  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Najmeh  Edraki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103649. <a href="https://doi.org/10.1016/j.bioorg.2020.103649" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103649%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bsmall%252Bmolecule%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252Bdisease%25253A%252BFocusing%252Bon%252BBACE1%252Band%252Bmulti-target%252Bdirected%252Bligands%26aulast%3DIraji%26aufirst%3DAida%26date%3D2020%26volume%3D97%26spage%3D103649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Lai</span>, <span class="hlFld-ContribAuthor ">Xing‐Yan  Luo</span>, <span class="hlFld-ContribAuthor ">Hui‐Jie  Guo</span>, <span class="hlFld-ContribAuthor ">Si‐Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Xiong</span>, <span class="hlFld-ContribAuthor ">Shu‐Xia  Yang</span>, <span class="hlFld-ContribAuthor ">Li‐Mei  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Zou</span>, <span class="hlFld-ContribAuthor ">Chun‐Fen  Mo</span>, <span class="hlFld-ContribAuthor ">Yan‐Tang  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">PO‐322 exerts potent immunosuppressive effects in vitro and in vivo by selectively inhibiting SGK1 activity. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (7)
                                     , 1666-1676. <a href="https://doi.org/10.1111/bph.14926" title="DOI URL">https://doi.org/10.1111/bph.14926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14926%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DPO%2525E2%252580%252590322%252Bexerts%252Bpotent%252Bimmunosuppressive%252Beffects%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bby%252Bselectively%252Binhibiting%252BSGK1%252Bactivity%26aulast%3DLai%26aufirst%3DYi%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D7%26spage%3D1666%26epage%3D1676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Wu</span>, <span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Ming-xing  He</span>, <span class="hlFld-ContribAuthor ">Hao  Wen</span>, <span class="hlFld-ContribAuthor ">Wei  Cao</span>, <span class="hlFld-ContribAuthor ">Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of isoquinazolines
              via
              metal-free [4 + 2] cycloaddition of ynamides with nitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (36)
                                     , 8408-8416. <a href="https://doi.org/10.1039/C9OB01395D" title="DOI URL">https://doi.org/10.1039/C9OB01395D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01395D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01395D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPreparation%252Bof%252Bisoquinazolines%252Bvia%252Bmetal-free%252B%25255B4%252B%25252B%252B2%25255D%252Bcycloaddition%252Bof%252Bynamides%252Bwith%252Bnitriles%26aulast%3DWu%26aufirst%3DHao%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D36%26spage%3D8408%26epage%3D8416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Chih  Kuo</span>, <span class="hlFld-ContribAuthor ">Rajendiran  Rajesh</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Neurotherapeutics</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     , 623-652. <a href="https://doi.org/10.1080/14737175.2019.1621750" title="DOI URL">https://doi.org/10.1080/14737175.2019.1621750</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14737175.2019.1621750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14737175.2019.1621750%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Neurotherapeutics%26atitle%3DChallenges%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Brecent%252Bprogress%252Band%252Btreatment%252Bstrategies%252Bof%252Bpharmaceuticals%252Btargeting%252Bnotable%252Bpathological%252Bfactors%26aulast%3DKuo%26aufirst%3DYung-Chih%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D7%26spage%3D623%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing‐yan  Luo</span>, <span class="hlFld-ContribAuthor ">Hong  Zhou</span>, <span class="hlFld-ContribAuthor ">Si‐yu  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Xiong</span>, <span class="hlFld-ContribAuthor ">Chun‐fen  Mo</span>, <span class="hlFld-ContribAuthor ">Hui‐jie  Guo</span>, <span class="hlFld-ContribAuthor ">Yan‐tang  Wang</span>, <span class="hlFld-ContribAuthor ">Shu‐xia  Yang</span>, <span class="hlFld-ContribAuthor ">Li‐mei  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Zou</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A benzoxazole derivative PO‐296 inhibits T lymphocyte proliferation by the JAK3/STAT5 signal pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2019,</strong> <em>120 </em>
                                    (6)
                                     , 9193-9202. <a href="https://doi.org/10.1002/jcb.28195" title="DOI URL">https://doi.org/10.1002/jcb.28195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.28195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.28195%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DA%252Bbenzoxazole%252Bderivative%252BPO%2525E2%252580%252590296%252Binhibits%252BT%252Blymphocyte%252Bproliferation%252Bby%252Bthe%252BJAK3%25252FSTAT5%252Bsignal%252Bpathway%26aulast%3DLuo%26aufirst%3DXing%25E2%2580%2590yan%26date%3D2019%26date%3D2018%26volume%3D120%26issue%3D6%26spage%3D9193%26epage%3D9202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuying  Fang</span>, <span class="hlFld-ContribAuthor ">Huihao  Zhou</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 133-145. <a href="https://doi.org/10.1016/j.ejmech.2019.02.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Btetrahydroisoquinoline-benzimidazole%252Bhybrids%252Bas%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DFang%26aufirst%3DYuying%26date%3D2019%26volume%3D167%26spage%3D133%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajasekhar  Ponduri</span>, <span class="hlFld-ContribAuthor ">Pramod  Kumar</span>, <span class="hlFld-ContribAuthor ">Lakshmana RAO  Vadali</span>, <span class="hlFld-ContribAuthor ">Nagi Reddy  Modugu</span>. </span><span class="cited-content_cbyCitation_article-title">Water‐PEG‐400 Mediated an Efficient One‐Pot Eco‐Friendly Synthesis of Functionalized Isoxazole Substituted Chromeno[2, 3‐
              b
              ]pyridine‐3‐carboxylate Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (27)
                                     , 7766-7770. <a href="https://doi.org/10.1002/slct.201801089" title="DOI URL">https://doi.org/10.1002/slct.201801089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201801089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201801089%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DWater%2525E2%252580%252590PEG%2525E2%252580%252590400%252BMediated%252Ban%252BEfficient%252BOne%2525E2%252580%252590Pot%252BEco%2525E2%252580%252590Friendly%252BSynthesis%252Bof%252BFunctionalized%252BIsoxazole%252BSubstituted%252BChromeno%25255B2%25252C%2525E2%252580%2525893%2525E2%252580%252590%252Bb%252B%25255Dpyridine%2525E2%252580%2525903%2525E2%252580%252590carboxylate%252BDerivatives%26aulast%3DPonduri%26aufirst%3DRajasekhar%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D27%26spage%3D7766%26epage%3D7770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raju Suresh  Kumar</span>, <span class="hlFld-ContribAuthor ">Paulrayer  Antonisamy</span>, <span class="hlFld-ContribAuthor ">Abdulrahman I.  Almansour</span>, <span class="hlFld-ContribAuthor ">Natarajan  Arumugam</span>, <span class="hlFld-ContribAuthor ">Govindasami  Periyasami</span>, <span class="hlFld-ContribAuthor ">Mohammad  Altaf</span>, <span class="hlFld-ContribAuthor ">Ha-Rim  Kim</span>, <span class="hlFld-ContribAuthor ">Kang-Beom  Kwon</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalized spirooxindole-indolizine hybrids: Stereoselective green synthesis and evaluation of anti-inflammatory effect involving TNF-α and nitrite inhibition. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>152 </em>, 417-423. <a href="https://doi.org/10.1016/j.ejmech.2018.04.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFunctionalized%252Bspirooxindole-indolizine%252Bhybrids%25253A%252BStereoselective%252Bgreen%252Bsynthesis%252Band%252Bevaluation%252Bof%252Banti-inflammatory%252Beffect%252Binvolving%252BTNF-%2525CE%2525B1%252Band%252Bnitrite%252Binhibition%26aulast%3DKumar%26aufirst%3DRaju%2BSuresh%26date%3D2018%26volume%3D152%26spage%3D417%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan D.  Low</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Doug  Whittington</span>, <span class="hlFld-ContribAuthor ">Quifen  Xue</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Allen</span>, <span class="hlFld-ContribAuthor ">Ana E.  Minatti</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective synthesis of fused cyclopropyl-3-amino-2,4-oxazine β-amyloid cleaving enzyme (BACE) inhibitors and their biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (6)
                                     , 1111-1115. <a href="https://doi.org/10.1016/j.bmcl.2018.01.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.01.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.01.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.01.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiastereoselective%252Bsynthesis%252Bof%252Bfused%252Bcyclopropyl-3-amino-2%25252C4-oxazine%252B%2525CE%2525B2-amyloid%252Bcleaving%252Benzyme%252B%252528BACE%252529%252Binhibitors%252Band%252Btheir%252Bbiological%252Bevaluation%26aulast%3DLow%26aufirst%3DJonathan%2BD.%26date%3D2018%26volume%3D28%26issue%3D6%26spage%3D1111%26epage%3D1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolali  Alizadeh</span>, <span class="hlFld-ContribAuthor ">Reza  Mohammadi</span>, <span class="hlFld-ContribAuthor ">Fahimeh  Bayat</span>, <span class="hlFld-ContribAuthor ">Long-Guan  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Proton transfer process in synthesis of 3-acetyl-4-(substituted ethylenyl)coumarins and chromeno[3,4-c]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (16)
                                     , 2085-2091. <a href="https://doi.org/10.1016/j.tet.2018.03.015" title="DOI URL">https://doi.org/10.1016/j.tet.2018.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DProton%252Btransfer%252Bprocess%252Bin%252Bsynthesis%252Bof%252B3-acetyl-4-%252528substituted%252Bethylenyl%252529coumarins%252Band%252Bchromeno%25255B3%25252C4-c%25255Dpyridines%26aulast%3DAlizadeh%26aufirst%3DAbdolali%26date%3D2018%26volume%3D74%26issue%3D16%26spage%3D2085%26epage%3D2091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manickam  Bakthadoss</span>, <span class="hlFld-ContribAuthor ">Swarna Kumari  Meegada</span>, <span class="hlFld-ContribAuthor ">Manickam  Surendar</span>. </span><span class="cited-content_cbyCitation_article-title">Triple domino reaction for the synthesis of pyrazole/indoline linked chromenes. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (4)
                                     , 490-496. <a href="https://doi.org/10.1016/j.tet.2017.12.021" title="DOI URL">https://doi.org/10.1016/j.tet.2017.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DTriple%252Bdomino%252Breaction%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bpyrazole%25252Findoline%252Blinked%252Bchromenes%26aulast%3DBakthadoss%26aufirst%3DManickam%26date%3D2018%26volume%3D74%26issue%3D4%26spage%3D490%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh S.  Chavan</span>, <span class="hlFld-ContribAuthor ">Bapurao D.  Rupanawar</span>, <span class="hlFld-ContribAuthor ">Rohit B.  Kamble</span>, <span class="hlFld-ContribAuthor ">Anil M.  Shelke</span>, <span class="hlFld-ContribAuthor ">Gurunath  Suryavanshi</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free annulation of β-acylamino ketones: facile access to spirooxazolines and oxazolines
              via
              oxidative C–O bond formation. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2018,</strong> <em>5 </em>
                                    (4)
                                     , 544-548. <a href="https://doi.org/10.1039/C7QO00783C" title="DOI URL">https://doi.org/10.1039/C7QO00783C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7QO00783C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7QO00783C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DMetal-free%252Bannulation%252Bof%252B%2525CE%2525B2-acylamino%252Bketones%25253A%252Bfacile%252Baccess%252Bto%252Bspirooxazolines%252Band%252Boxazolines%252Bvia%252Boxidative%252BC%2525E2%252580%252593O%252Bbond%252Bformation%26aulast%3DChavan%26aufirst%3DSantosh%2BS.%26date%3D2018%26date%3D2018%26volume%3D5%26issue%3D4%26spage%3D544%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.M.  Tice</span>, <span class="hlFld-ContribAuthor ">Y.  Zheng</span>, <span class="hlFld-ContribAuthor ">S.B.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Spirocyclic Scaffolds in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 211-263. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12291-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12291-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12291-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12291-7%26sid%3Dliteratum%253Aachs%26atitle%3DSpirocyclic%252BScaffolds%252Bin%252BDrug%252BDiscovery%26aulast%3DTice%26aufirst%3DC.M.%26date%3D2017%26spage%3D211%26epage%3D263%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.W.  Stamford</span>, <span class="hlFld-ContribAuthor ">J.N.  Cumming</span>, <span class="hlFld-ContribAuthor ">J.D.  Scott</span>, <span class="hlFld-ContribAuthor ">C.O.  Strickland</span>. </span><span class="cited-content_cbyCitation_article-title">Verubecestat. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 204-251. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12453-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12453-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12453-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12453-9%26sid%3Dliteratum%253Aachs%26atitle%3DVerubecestat%26aulast%3DStamford%26aufirst%3DA.W.%26date%3D2017%26spage%3D204%26epage%3D251%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">H.J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 326-383. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13809-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13809-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B2-Secretase%252B%252528BACE%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D326%26epage%3D383%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan D.  Low</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Mark R.  Fielden</span>, <span class="hlFld-ContribAuthor ">Vijay  Gore</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">E.  Allen Sickmier</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Jonathan  Werner</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Ana E.  Minatti</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 1196-1206. <a href="https://doi.org/10.1039/C7MD00106A" title="DOI URL">https://doi.org/10.1039/C7MD00106A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00106A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00106A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDevelopment%252Bof%252B2-aminooxazoline%252B3-azaxanthene%252B%2525CE%2525B2-amyloid%252Bcleaving%252Benzyme%252B%252528BACE%252529%252Binhibitors%252Bwith%252Bimproved%252Bselectivity%252Bagainst%252BCathepsin%252BD%26aulast%3DLow%26aufirst%3DJonathan%2BD.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D1196%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea M.  Zuhl</span>, <span class="hlFld-ContribAuthor ">Charles E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Sherry  Niessen</span>, <span class="hlFld-ContribAuthor ">Kevin  Atchison</span>, <span class="hlFld-ContribAuthor ">Christopher  Houle</span>, <span class="hlFld-ContribAuthor ">David A.  Karanian</span>, <span class="hlFld-ContribAuthor ">Claude  Ambroise</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Brulet</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Beck</span>, <span class="hlFld-ContribAuthor ">Shawn D.  Doran</span>, <span class="hlFld-ContribAuthor ">Brian T.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Kieran F.  Geoghegan</span>, <span class="hlFld-ContribAuthor ">Graham M.  West</span>, <span class="hlFld-ContribAuthor ">Joshua C.  Judkins</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">David R.  Riddell</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms13042" title="DOI URL">https://doi.org/10.1038/ncomms13042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms13042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms13042%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DChemoproteomic%252Bprofiling%252Breveals%252Bthat%252Bcathepsin%252BD%252Boff-target%252Bactivity%252Bdrives%252Bocular%252Btoxicity%252Bof%252B%2525CE%2525B2-secretase%252Binhibitors%26aulast%3DZuhl%26aufirst%3DAndrea%2BM.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ya-Jun  Zheng</span>, <span class="hlFld-ContribAuthor ">Colin M.  Tice</span>. </span><span class="cited-content_cbyCitation_article-title">The utilization of spirocyclic scaffolds in novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (9)
                                     , 831-834. <a href="https://doi.org/10.1080/17460441.2016.1195367" title="DOI URL">https://doi.org/10.1080/17460441.2016.1195367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1195367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1195367%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Butilization%252Bof%252Bspirocyclic%252Bscaffolds%252Bin%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DZheng%26aufirst%3DYa-Jun%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D9%26spage%3D831%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolali  Alizadeh</span>, <span class="hlFld-ContribAuthor ">Fahimeh  Bayat</span>, <span class="hlFld-ContribAuthor ">Zhe  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of chromenopyridines containing intramolecular hydrogen bonds through a sequential three-component reaction. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2016,</strong> <em>42 </em>
                                    (6)
                                     , 5927-5936. <a href="https://doi.org/10.1007/s11164-015-2414-6" title="DOI URL">https://doi.org/10.1007/s11164-015-2414-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-015-2414-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-015-2414-6%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DEfficient%252Bsynthesis%252Bof%252Bchromenopyridines%252Bcontaining%252Bintramolecular%252Bhydrogen%252Bbonds%252Bthrough%252Ba%252Bsequential%252Bthree-component%252Breaction%26aulast%3DAlizadeh%26aufirst%3DAbdolali%26date%3D2016%26date%3D2016%26volume%3D42%26issue%3D6%26spage%3D5927%26epage%3D5936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolali  Alizadeh</span>, <span class="hlFld-ContribAuthor ">Leila  Moafi</span>. </span><span class="cited-content_cbyCitation_article-title">N
              ,
              N′
              -Bis(arylmethylidene)arylmethanediamines: Suitable Precursors for the Synthesis of 1-Pyrroline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2016,</strong> <em>99 </em>
                                    (4)
                                     , 306-309. <a href="https://doi.org/10.1002/hlca.201500251" title="DOI URL">https://doi.org/10.1002/hlca.201500251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201500251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201500251%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DN%252B%25252C%252BN%2525E2%252580%2525B2%252B-Bis%252528arylmethylidene%252529arylmethanediamines%25253A%252BSuitable%252BPrecursors%252Bfor%252Bthe%252BSynthesis%252Bof%252B1-Pyrroline%252BDerivatives%26aulast%3DAlizadeh%26aufirst%3DAbdolali%26date%3D2016%26date%3D2016%26volume%3D99%26issue%3D4%26spage%3D306%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel F.  Wyss</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, <span class="hlFld-ContribAuthor ">Corey O.  Strickland</span>, <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>. </span><span class="cited-content_cbyCitation_article-title">BACE Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 327-354. <a href="https://doi.org/10.1002/9783527683604.ch14" title="DOI URL">https://doi.org/10.1002/9783527683604.ch14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch14%26sid%3Dliteratum%253Aachs%26atitle%3DBACE%252BInhibitors%26aulast%3DWyss%26aufirst%3DDaniel%2BF.%26date%3D2016%26date%3D2016%26spage%3D327%26epage%3D354%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Guan</span>, <span class="hlFld-ContribAuthor ">Yanfeng  Hao</span>, <span class="hlFld-ContribAuthor ">Lei  Chen</span>, <span class="hlFld-ContribAuthor ">Meng-Lin  Wei</span>, <span class="hlFld-ContribAuthor ">Qin  Jiang</span>, <span class="hlFld-ContribAuthor ">Wen-Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Yan-Bo  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wei  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of neuroprotective 4-O-substituted chrysotoxine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (27)
                                     , 22827-22838. <a href="https://doi.org/10.1039/C5RA21313D" title="DOI URL">https://doi.org/10.1039/C5RA21313D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA21313D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA21313D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bneuroprotective%252B4-O-substituted%252Bchrysotoxine%252Bderivatives%252Bas%252Bpotential%252Bmultifunctional%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DGuan%26aufirst%3DLi%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D27%26spage%3D22827%26epage%3D22838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abderrahman  El Bouakher</span>, <span class="hlFld-ContribAuthor ">Hassan  Allouchi</span>, <span class="hlFld-ContribAuthor ">Isabelle  Abrunhosa-Thomas</span>, <span class="hlFld-ContribAuthor ">Yves  Troin</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>. </span><span class="cited-content_cbyCitation_article-title">Suzuki-Miyaura Reactions of Halospirooxindole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>
                                    (16)
                                     , 3450-3461. <a href="https://doi.org/10.1002/ejoc.201500268" title="DOI URL">https://doi.org/10.1002/ejoc.201500268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201500268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201500268%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSuzuki-Miyaura%252BReactions%252Bof%252BHalospirooxindole%252BDerivatives%26aulast%3DEl%2BBouakher%26aufirst%3DAbderrahman%26date%3D2015%26date%3D2015%26volume%3D2015%26issue%3D16%26spage%3D3450%26epage%3D3461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benito  Alcaide</span>, <span class="hlFld-ContribAuthor ">Pedro  Almendros</span>. </span><span class="cited-content_cbyCitation_article-title">Four-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 87-115. <a href="https://doi.org/10.1016/B978-0-08-100024-3.00004-0" title="DOI URL">https://doi.org/10.1016/B978-0-08-100024-3.00004-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100024-3.00004-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100024-3.00004-0%26sid%3Dliteratum%253Aachs%26atitle%3DFour-Membered%252BRing%252BSystems%26aulast%3DAlcaide%26aufirst%3DBenito%26date%3D2015%26spage%3D87%26epage%3D115%26pub%3DElsevier%26date%3D2015%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">James  Brown</span>, <span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective synthesis of multiply halogenated azaxanthones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (52)
                                     , 7229-7232. <a href="https://doi.org/10.1016/j.tetlet.2014.11.032" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.11.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.11.032%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRegioselective%252Bsynthesis%252Bof%252Bmultiply%252Bhalogenated%252Bazaxanthones%26aulast%3DQian%26aufirst%3DWenyuan%26date%3D2014%26volume%3D55%26issue%3D52%26spage%3D7229%26epage%3D7232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previous efforts to balance hERG inhibition and Pgp-mediated efflux.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the P2′-Neopentyloxy 4-Azaxanthenes <b>26</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) NaH, DMF, 130 °C, 55%, (ii) PPA, 140 °C, 93%; (b) (i) MeMgCl, THF, −30 °C, HCl/Et<sub>2</sub>O, (ii) I<sub>2</sub>, AgOCN, THF, −40 °C, (iii) NH<sub>3</sub>, 23 °C; (iv) chiral SFC, 29%; (c) BBr<sub>3</sub>, DCM, 0 °C, 51%; (d) neopentyl iodide, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 63%; (e) Ar-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(AmPhos)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, THF–H<sub>2</sub>O, 110 °C, 72–90%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of 4-Azaxanthenes via Late-Stage Installation of the P2′ Group<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) NaH, DMF, 130 °C, 76%, (ii) PPA, 140 °C, 85%; (b) (i) MeMgCl, THF, −30 to 0 °C, THF–CHCl<sub>3</sub>, 80 °C, (ii) I<sub>2</sub>, AgOCN, THF, −20 °C, (iii) NH<sub>3</sub>, 23 °C, (iv) chiral SFC, 13%; (c) 2-fluoro-3-pyridineboronic acid, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane–water, 70 °C, 91%; (d) R-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane–water, 80 °C, 40–59%; (e) R-CCH, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, <i>i</i>-PrNH<sub>2</sub>–DMF, 90 °C, 58–95%; (f) R-C≡C-TMS, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, TBAF, THF, 70 °C, 89% for <b>42</b>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 4-Azaxanthenes <b>33</b>–<b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) NaH, DMF, 140 °C, 83%, (ii) PPA, 140 °C, 66%; (b)  (i) MeMgBr, THF, −30 to 0 °C, CH<sub>3</sub>OH, 60 °C, 53%, (ii) I<sub>2</sub>, AgOCN, THF, −20 °C, (iii) NH<sub>3</sub>, 23 °C, (iv) chiral SFC, 28%; (c) BBr<sub>3</sub>, DCM, 0 °C, 62%; (d) (i) 2-(3,6-dihydro-2<i>H</i>-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, water, 80 °C, 70%, (ii) H<sub>2</sub> (1 atm), 10% Pd/C, MeOH, 82% of <b>18a</b>; (e) R-B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(AmPhos)<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane–water, 75–100 °C, 34–69% for <b>18b</b>, <b>18d</b>, and <b>18e</b>; (f) morpholine, Pd<sub>2</sub>(dba)<sub>3</sub>, DavePhos, LHMDS, THF, 70 °C, 51% of <b>18c</b>; (g) PhNTf<sub>2</sub>, Et<sub>3</sub>N, DCM, 67–89%; (h) 2-fluoro-3-pyridineboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane–water, 80 °C, 34–97%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of BACE1 Inhibitor <b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) (i) LiTMP, THF, −10 °C, then CO<sub>2</sub>(g), <b>20</b>, K<sub>2</sub>CO<sub>3</sub>, DMF, 140 °C, (ii) PPA, 140 °C; (b) (i) Pd(OAc)<sub>2</sub>, X-Phos, B<sub>2</sub>(pin)<sub>2</sub>, K<sub>3</sub>PO<sub>4</sub>, 1,4-dioxane, 23 °C, (ii) 30% H<sub>2</sub>O<sub>2</sub>, THF, 66%; (c) (i) 3-bromo-2-methylpropene, DBU, DCM, (ii) NIS, MeOH, (iii) MeMgCl, THF, −40 °C, (iv) LiBEt<sub>3</sub>H, THF, 9% over four steps; (d) (i) HCl/1,4-dioxane, 50 °C, (ii) I<sub>2</sub>, AgOCN, THF, −20 °C, (iii) NH<sub>3</sub>, 23 °C, 16%; (e) (i) 2-fluoro-3-pyridineboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, THF–water, 110 °C, (ii) chiral SFC, 16%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of BACE1 Inhibitor <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) BBr<sub>3</sub>, DCM, 0 °C, 99%; (b) neopentyl iodide, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 48%; (c) (i) 2-fluoro-3-pyridineboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, THF–water, sealed tube, 90 °C, (ii) chiral SFC, 24%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure of <b>42</b> with BACE1. (a) Interactions of <b>42</b> with the catalytic aspartic acids, Ser229, and Trp76 of BACE1. (b) Interaction of the P2′ oxetane unit with Arg128 in S2′.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Pharmacodynamic effect of <b>42</b> on CNS Aβ in Sprague–Dawley rats. (a) CSF Aβ reduction at 4 h. (b) Brain Aβ reduction at 4 h. (c) Time-course study at 30 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/medium/jm-2014-012676_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of BACE Inhibitors <b>1</b> and <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-23/jm5012676/20141205/images/large/jm-2014-012676_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5012676&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i74">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Small, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span> </span><span class="NLM_article-title">Alois Alzheimer and Alzeimer’s Disease: A Centennial Perspective</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1111%2Fj.1471-4159.2006.04212.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=17076655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=708-710&author=D.+H.+Smallauthor=R.+Cappai&title=Alois+Alzheimer+and+Alzeimer%E2%80%99s+Disease%3A+A+Centennial+Perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Alois Alzheimer and Alzheimer's disease: a centennial perspective</span></div><div class="casAuthors">Small, David H.; Cappai, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">708-710</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The year 2006 is the centenary of the famous presentation of Alois Alzheimer which first described the neuropathol. of Alzheimer's disease (AD).  Since this presentation, enormous progress has been made in understanding the biol. of AD.  The central role of the β-amyloid protein (Aβ) in the pathogenesis of AD and the relationship between plaque and tangle pathol. is now much better understood.  In this article, we review the current status of the amyloid hypothesis of AD and its role in the development of future therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodHVyze5z1W7Vg90H21EOLACvtfcHk0lgcm7O6fcuuYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1eju7%252FE&md5=27564c272b2bc577bbf4d568ffb7a079</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04212.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04212.x%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DD.%2BH.%26aulast%3DCappai%26aufirst%3DR.%26atitle%3DAlois%2520Alzheimer%2520and%2520Alzeimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Centennial%2520Perspective%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D708%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span> </span><span class="NLM_article-title">A century of Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=777-781&author=M.+Goedertauthor=M.+G.+Spillantini&title=A+century+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26atitle%3DA%2520century%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D777%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Van Marum, R. J.</span><span> </span><span class="NLM_article-title">Current and future therapy in Alzheimer’s Disease</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1111%2Fj.1472-8206.2008.00578.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=18485144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=265-274&author=R.+J.+Van+Marum&title=Current+and+future+therapy+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Current and future therapy in Alzheimer's disease</span></div><div class="casAuthors">van Marum, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-274</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized as one of the most important medical problems in the elderly.  As most pharmacol. research within the field of dementia is focused on Alzheimer's dementia (AD), this review will focus on pharmacol. interventions in AD.  Most disease-modifying therapies are based on the amyloid hypothesis.  In this hypothesis, the pathol. accumulation of Aβ in the brain leads to oxidative stress, neuronal destruction and finally the clin. syndrome of AD.  Following this hypothesis, secondary prevention of AD can be made by: decreasing the prodn. of Aβ, stimulation of clearance of Aβ formed or prevention of aggregation of Aβ into amyloid plaques.  First a short overview on current approved therapies for AD is given.  The main part of the review will focus on potential disease-modifying therapies for AD that are currently being studied in phase I to phase III trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYSu96SxTqLVg90H21EOLACvtfcHk0lgYFCmiB7m37w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1elsLo%253D&md5=0813e575e9440a3e1ffc0e0ee79c5e7a</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.2008.00578.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.2008.00578.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMarum%26aufirst%3DR.%2BJ.%26atitle%3DCurrent%2520and%2520future%2520therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2008%26volume%3D22%26spage%3D265%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Roberson, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">100 Years and counting: prospects for defeating Alzheimer’s Disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=781-784&author=E.+D.+Robersonauthor=L.+Mucke&title=100+Years+and+counting%3A+prospects+for+defeating+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26aulast%3DMucke%26aufirst%3DL.%26atitle%3D100%2520Years%2520and%2520counting%253A%2520prospects%2520for%2520defeating%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D781%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Catalano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henze, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyce, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krafft, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinney, G. G.</span><span> </span><span class="NLM_article-title">The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer’s Disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">608</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.2174%2F156802606776743066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=16712494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVOmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=597-608&author=S.+Catalanoauthor=E.+C.+Dodsonauthor=D.+A.+Henzeauthor=J.+G.+Joyceauthor=G.+A.+Krafftauthor=G.+G.+Kinney&title=The+role+of+amyloid-beta+derived+diffusible+ligands+%28ADDLs%29+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease</span></div><div class="casAuthors">Catalano, Susan M.; Dodson, Elizabeth C.; Henze, Darrell A.; Joyce, Joseph G.; Krafft, Grant A.; Kinney, Gene G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">597-608</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The amyloid-β (Aβ) cascade hypothesis of Alzheimer's disease (AD) has dominated research and subsequent therapeutic drug development for over two decades.  Central to this hypothesis is the observation that Aβ is elevated in AD patients and that the disease is ultimately characterized by the central deposition of insol. senile plaques.  More recent evidence, however, suggests that the presence or absence of plaque is insufficient to fully account for the deleterious role of elevated Aβ in AD.  Such studies support the basis for an alternate interpretation of the Aβ cascade hypothesis.  Namely, that sol. oligomers of Aβ (i.e., ADDLs) accumulate and cause functional deficits prior to overt neuronal cell death or plaque deposition.  Accordingly, the following review focuses on research describing the prepn. and functional activity of ADDLs in vitro and in vivo.  These studies provide the basis for an alternate, ADDL-based, view of the Aβ cascade hypothesis and accounts for the disconnect between plaque burden and cognitive deficits.  Possible therapeutic approaches aimed at lowering ADDLs in AD patients are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXQlT7tzCPc7Vg90H21EOLACvtfcHk0lgGNWRqEgWtEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVOmsbY%253D&md5=fc371b4b30370dce13f04afebe292872</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F156802606776743066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743066%26sid%3Dliteratum%253Aachs%26aulast%3DCatalano%26aufirst%3DS.%26aulast%3DDodson%26aufirst%3DE.%2BC.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJoyce%26aufirst%3DJ.%2BG.%26aulast%3DKrafft%26aufirst%3DG.%2BA.%26aulast%3DKinney%26aufirst%3DG.%2BG.%26atitle%3DThe%2520role%2520of%2520amyloid-beta%2520derived%2520diffusible%2520ligands%2520%2528ADDLs%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D597%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pimplikar, S. W.</span><span> </span><span class="NLM_article-title">Reassessing the Amyloid Cascade Hypothesis of Alzheimer’s Disease</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2Fj.biocel.2008.12.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=19124085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1261-1268&author=S.+W.+Pimplikar&title=Reassessing+the+Amyloid+Cascade+Hypothesis+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Reassessing the amyloid cascade hypothesis of Alzheimer's disease</span></div><div class="casAuthors">Pimplikar, Sanjay W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1261-1268</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Since its inception, the amyloid cascade hypothesis has dominated the field of Alzheimer's disease (AD) research and has provided the intellectual framework for therapeutic intervention.  Although the details of the hypothesis continue to evolve, its core principle has remained essentially unaltered.  It posits that the amyloid-β peptides, derived from amyloid precursor protein (APP), are the root cause of AD.  Substantial genetic and biochem. data support this view, and yet a no. of findings also run contrary to its tenets.  The presence of familial AD mutations in APP and presenilins, demonstration of Aβ toxicity, and studies in mouse models of AD all support the hypothesis, whereas the presence of Aβ plaques in normal individuals, the uncertain nature of the pathogenic Aβ species, and repeated disappointments with Aβ-centered therapeutic trials are inconsistent with the hypothesis.  The current state of knowledge does not prove nor disprove the amyloid hypothesis, but rather points to the need for its reassessment.  A view that Aβ is one of the factors, as opposed to the factor, that causes AD is more consistent with the present knowledge, and is more likely to promote comprehensive and effective therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNZoitUBRzaLVg90H21EOLACvtfcHk0lgGNWRqEgWtEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Krsb0%253D&md5=e33973b5f125c34d95cb3f1b477d3ced</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2008.12.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2008.12.015%26sid%3Dliteratum%253Aachs%26aulast%3DPimplikar%26aufirst%3DS.%2BW.%26atitle%3DReassessing%2520the%2520Amyloid%2520Cascade%2520Hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D41%26spage%3D1261%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">beta-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S.+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.+C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=beta-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3Dbeta-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE1%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as beta-secretase</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lgGDWtM1NLy5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520beta-secretase%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashier, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membraned-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashierauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membraned-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+beta-secretase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashier%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembraned-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520beta-secretase%2520activity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sinha%2C+S.%3B+Anderson%2C+J.+P.%3B+Barbour%2C+R.%3B+Basi%2C+G.+S.%3B+Caccavello%2C+R.%3B+Davis%2C+D.%3B+Doan%2C+M.%3B+Dovey%2C+H.+F.%3B+Frigon%2C+N.%3B+Hong%2C+J.%3B+Jacobson-Croak%2C+K.%3B+Jewett%2C+N.%3B+Keim%2C+P.%3B+Knops%2C+J.%3B+Lieberburg%2C+I.%3B+Power%2C+M.%3B+Tan%2C+H.%3B+Tatsuno%2C+G.%3B+Tung%2C+J.%3B+Schenk%2C+D.%3B+Seubert%2C+P.%3B+Suomensaari%2C+S.+M.%3B+Wang%2C+S.%3B+Walker%2C+D.%3B+Zhao%2C+J.%3B+McConlogue%2C+L.%3B+John%2C+V.Nature+1999%2C+402%2C+537%E2%80%93540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DJohn%26aufirst%3DV.%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span> </span><span class="NLM_article-title">Inhibition of BACE1 for therapeutic use in Alzheimer’s Disease</span> <span class="citation_source-journal">Int. J. Clin. Exp. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=20661410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptFagtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=618-628&author=X.+Luoauthor=R.+Yan&title=Inhibition+of+BACE1+for+therapeutic+use+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BACE1 for therapeutic use in Alzheimer's disease</span></div><div class="casAuthors">Luo, Xiaoyang; Yan, Riqiang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical and Experimental Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">618-628</span>CODEN:
                <span class="NLM_cas:coden">IJCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1936-2625</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  Since BACE1 was reported as the β-secretase in Alzheimer's disease (AD) over ten years ago, encouraging progress has been made toward understanding the cellular functions of BACE1.  Genetic studies have further confirmed that BACE1 is essential for processing amyloid precursor protein (APP) at the β-secretase site.  Only after this cleavage can the membrane-bound APP C-terminal fragment be subsequently cleaved by γ-secretase to release so-called AD-causing Aβ peptides.  Hence, in the past decade, a wide variety of BACE1 inhibitors have been developed for AD therapy.  This review will summarize the major historical events during the evolution of BACE1 inhibitors designed through different strategies of drug discovery.  Although BACE1 inhibitors are expected to be safe in general, careful titrn. of drug dosage to avoid undesirable side effects in BACE1-directed AD therapy is also emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUFz1x-AF9XbVg90H21EOLACvtfcHk0lgFvLdTIumfKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptFagtbo%253D&md5=0cf2745b97b31229b1de6b7db04911e2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DR.%26atitle%3DInhibition%2520of%2520BACE1%2520for%2520therapeutic%2520use%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2010%26volume%3D3%26spage%3D618%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Johnsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jönsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span> </span><span class="NLM_article-title">A mutation in <i>APP</i> protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Johnssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Johnssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+B.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+J%C3%B6nssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottir&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJohnsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BB.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJ%25C3%25B6nsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koelsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermolieff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span> </span><span class="NLM_article-title">Design of potent inhibitors for human brainmemapsin 2 (β-secretase)</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">3522</span><span class="NLM_x">–</span> <span class="NLM_lpage">3523</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja000300g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=3522-3523&author=A.+K.+Ghoshauthor=D.+Shinauthor=D.+Downsauthor=G.+Koelschauthor=X.+Linauthor=J.+Ermolieffauthor=J.+Tang&title=Design+of+potent+inhibitors+for+human+brainmemapsin+2+%28%CE%B2-secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fja000300g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja000300g%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DDowns%26aufirst%3DD.%26aulast%3DKoelsch%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DErmolieff%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26atitle%3DDesign%2520of%2520potent%2520inhibitors%2520for%2520human%2520brainmemapsin%25202%2520%2528%25CE%25B2-secretase%2529%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D3522%26epage%3D3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span> </span><span class="NLM_article-title">Design and development of BACE-1 inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=536-556&author=J.+N.+Cummingauthor=U.+Iserlohauthor=M.+E.+Kennedy&title=Design+and+development+of+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26atitle%3DDesign%2520and%2520development%2520of%2520BACE-1%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2004%26volume%3D7%26spage%3D536%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Durham, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, T. A.</span><span> </span><span class="NLM_article-title">Progress toward the discovery and development of efficacious BACE inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=776-791&author=T.+B.+Durhamauthor=T.+A.+Shepherd&title=Progress+toward+the+discovery+and+development+of+efficacious+BACE+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurham%26aufirst%3DT.%2BB.%26aulast%3DShepherd%26aufirst%3DT.%2BA.%26atitle%3DProgress%2520toward%2520the%2520discovery%2520and%2520development%2520of%2520efficacious%2520BACE%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D776%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Potent pyrrolidine- and piperidine-based BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2Fj.bmcl.2007.10.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=18023580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1Wgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=414-417&author=U.+Iserlohauthor=Y.+Wuauthor=J.+N.+Cummingauthor=J.+Panauthor=L.+Y.+Wangauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=X.+Chenauthor=E.+M.+Parkerauthor=C.+Stricklandauthor=J.+Voigt&title=Potent+pyrrolidine-+and+piperidine-based+BACE-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Potent pyrrolidine- and piperidine-based BACE-1 inhibitors</span></div><div class="casAuthors">Iserloh, U.; Wu, Y.; Cumming, J. N.; Pan, J.; Wang, L. Y.; Stamford, A. W.; Kennedy, M. E.; Kuvelkar, R.; Chen, X.; Parker, E. M.; Strickland, C.; Voigt, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">414-417</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Based on lead compd. 1 identified from the patent literature, the authors developed novel patentable BACE-1 inhibitors by introducing a cyclic amine scaffold.  Extensive SAR studies on both pyrrolidines and piperidines ultimately led to inhibitor (I), one of the most potent inhibitors synthesized to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAchFs1p0DSrVg90H21EOLACvtfcHk0lhepJuh6Kzuag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1Wgtg%253D%253D&md5=39db058f22f5ff8f12735456a6f7b70e</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.116%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DPotent%2520pyrrolidine-%2520and%2520piperidine-based%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D414%26epage%3D417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Discovery of an orally efficacious 4-phenoxypyrrolidine-based BACE-1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=418-422&author=U.+Iserlohauthor=J.+Panauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=Q.+Zhangauthor=L.+Zhangauthor=E.+M.+Parkerauthor=N.+A.+McHughauthor=L.+Favreauauthor=C.+Stricklandauthor=J.+Voigt&title=Discovery+of+an+orally+efficacious+4-phenoxypyrrolidine-based+BACE-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DMcHugh%26aufirst%3DN.%2BA.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520efficacious%25204-phenoxypyrrolidine-based%2520BACE-1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D418%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacPherson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanway, S.</span><span> </span><span class="NLM_article-title">BACE-1 inhibitors part 2: identification of hydroxy ethylamines (HEAs) with reduced peptidic character</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1017-1022&author=B.+Clarkeauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=A.+Fallerauthor=J.+Hawkinsauthor=I.+Hussainauthor=D.+MacPhersonauthor=G.+Maileauthor=R.+Maticoauthor=P.+Milnerauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=D.+Riddellauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Stanway&title=BACE-1+inhibitors+part+2%3A+identification+of+hydroxy+ethylamines+%28HEAs%29+with+reduced+peptidic+character"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMacPherson%26aufirst%3DD.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMilner%26aufirst%3DP.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DStanway%26aufirst%3DS.%26atitle%3DBACE-1%2520inhibitors%2520part%25202%253A%2520identification%2520of%2520hydroxy%2520ethylamines%2520%2528HEAs%2529%2520with%2520reduced%2520peptidic%2520character%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1017%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3664</span><span class="NLM_x">–</span> <span class="NLM_lpage">3668</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3664-3668&author=N.+Charrierauthor=B.+Clarkeauthor=L.+Cutlerauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=C.+Howesauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors.+Part+1%3A+The+need+for+improved+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors.%2520Part%25201%253A%2520The%2520need%2520for%2520improved%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3664%26epage%3D3668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6h"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors part 2: optimization of the non-prime side substituent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3669</span><span class="NLM_x">–</span> <span class="NLM_lpage">3673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3669-3673&author=N.+Charrierauthor=B.+Clarkeauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors+part+2%3A+optimization+of+the+non-prime+side+substituent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors%2520part%25202%253A%2520optimization%2520of%2520the%2520non-prime%2520side%2520substituent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3669%26epage%3D3673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6i"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Charrier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matico, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redshaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleil, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweitzer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theobald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayne, G.</span><span> </span><span class="NLM_article-title">Second generation of BACE-1 inhibitors part 3: towards non-hydroxyethylamine transition state mimetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3674</span><span class="NLM_x">–</span> <span class="NLM_lpage">3678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3674-3678&author=N.+Charrierauthor=B.+Clarkeauthor=L.+Cutlerauthor=E.+Demontauthor=C.+Dingwallauthor=R.+Dunsdonauthor=J.+Hawkinsauthor=C.+Howesauthor=J.+Hubbardauthor=I.+Hussainauthor=G.+Maileauthor=R.+Maticoauthor=J.+Mosleyauthor=A.+Naylorauthor=A.+O%E2%80%99Brienauthor=S.+Redshawauthor=P.+Rowlandauthor=V.+Soleilauthor=K.+Smithauthor=S.+Sweitzerauthor=P.+Theobaldauthor=D.+Veseyauthor=D.+Walterauthor=G.+Wayne&title=Second+generation+of+BACE-1+inhibitors+part+3%3A+towards+non-hydroxyethylamine+transition+state+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharrier%26aufirst%3DN.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DDunsdon%26aufirst%3DR.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DJ.%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DMaile%26aufirst%3DG.%26aulast%3DMatico%26aufirst%3DR.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DA.%26aulast%3DRedshaw%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSoleil%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DSweitzer%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DP.%26aulast%3DVesey%26aufirst%3DD.%26aulast%3DWalter%26aufirst%3DD.%26aulast%3DWayne%26aufirst%3DG.%26atitle%3DSecond%2520generation%2520of%2520BACE-1%2520inhibitors%2520part%25203%253A%2520towards%2520non-hydroxyethylamine%2520transition%2520state%2520mimetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3674%26epage%3D3678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6j"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Stachel, S. J.</span><span> </span><span class="NLM_article-title">Progess toward the development of a viable BACE1 inhibitor</span> <span class="citation_source-journal">Drug. Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2009&pages=101-110&author=S.+J.+Stachel&title=Progess+toward+the+development+of+a+viable+BACE1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26atitle%3DProgess%2520toward%2520the%2520development%2520of%2520a%2520viable%2520BACE1%2520inhibitor%26jtitle%3DDrug.%2520Dev.%2520Res.%26date%3D2009%26volume%3D70%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references therein.</p></div><div class="NLM_citation" id="rightTab-cit6k"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Al-Tel, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Qawasmeh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Aboudi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabri, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voelter, W.</span><span> </span><span class="NLM_article-title">Rational design and synthesis of potent dibenzazepine motifs as β-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6484</span><span class="NLM_x">–</span> <span class="NLM_lpage">6488</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9008482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6484-6488&author=T.+H.+Al-Telauthor=R.+A.+Al-Qawasmehauthor=M.+F.+Schmidtauthor=A.+Al-Aboudiauthor=S.+N.+Raoauthor=S.+S.+Sabriauthor=W.+Voelter&title=Rational+design+and+synthesis+of+potent+dibenzazepine+motifs+as+%CE%B2-secretase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1021%2Fjm9008482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9008482%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Tel%26aufirst%3DT.%2BH.%26aulast%3DAl-Qawasmeh%26aufirst%3DR.%2BA.%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DAl-Aboudi%26aufirst%3DA.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DSabri%26aufirst%3DS.%2BS.%26aulast%3DVoelter%26aufirst%3DW.%26atitle%3DRational%2520design%2520and%2520synthesis%2520of%2520potent%2520dibenzazepine%2520motifs%2520as%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6484%26epage%3D6488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Cumming, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgur, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saionz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2837</span><span class="NLM_x">–</span> <span class="NLM_lpage">2842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2837-2842&author=J.+Cummingauthor=S.+Babuauthor=Y.+Huangauthor=C.+Carrolauthor=X.+Chenauthor=L.+Favreauauthor=W.+Greenleeauthor=T.+Guoauthor=M.+Kennedyauthor=R.+Kuvelkarauthor=T.+Leauthor=G.+Liauthor=N.+McHughauthor=P.+Orthauthor=L.+Ozgurauthor=E.+Parkerauthor=K.+Saionzauthor=A.+Stamfordauthor=C.+Stricklandauthor=D.+Tadesseauthor=J.+Voigtauthor=L.+Zhangauthor=Q.+Zhang&title=Piperazine+sulfonamide+BACE1+inhibitors%3A+design%2C+synthesis%2C+and+in+vivo+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCarrol%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DKennedy%26aufirst%3DM.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLe%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMcHugh%26aufirst%3DN.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DOzgur%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DSaionz%26aufirst%3DK.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DPiperazine%2520sulfonamide%2520BACE1%2520inhibitors%253A%2520design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2837%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Al-Tel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semreen, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Qawasmeh, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Awadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaarour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Agnaf, O.</span><span> </span><span class="NLM_article-title">Design, synthesis, and qualitative structure–activity evaluations of novel β-secretase inhibitors as potential Alzheimer’s drug leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8873</span><span class="NLM_x">–</span> <span class="NLM_lpage">8385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8873-8385&author=T.+Al-Telauthor=M.+H.+Semreenauthor=R.+A.+Al-Qawasmehauthor=M.+F.+Schmidtauthor=R.+El-Awadiauthor=M.+Ardahauthor=R.+Zaarourauthor=S.+N.+Raoauthor=O.+El-Agnaf&title=Design%2C+synthesis%2C+and+qualitative+structure%E2%80%93activity+evaluations+of+novel+%CE%B2-secretase+inhibitors+as+potential+Alzheimer%E2%80%99s+drug+leads"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Tel%26aufirst%3DT.%26aulast%3DSemreen%26aufirst%3DM.%2BH.%26aulast%3DAl-Qawasmeh%26aufirst%3DR.%2BA.%26aulast%3DSchmidt%26aufirst%3DM.%2BF.%26aulast%3DEl-Awadi%26aufirst%3DR.%26aulast%3DArdah%26aufirst%3DM.%26aulast%3DZaarour%26aufirst%3DR.%26aulast%3DRao%26aufirst%3DS.%2BN.%26aulast%3DEl-Agnaf%26aufirst%3DO.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520qualitative%2520structure%25E2%2580%2593activity%2520evaluations%2520of%2520novel%2520%25CE%25B2-secretase%2520inhibitors%2520as%2520potential%2520Alzheimer%25E2%2580%2599s%2520drug%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8873%26epage%3D8385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6n"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S.</span><span> </span><span class="NLM_article-title">A potent and orally efficacious, hydroxyethylamine-based inhibitor of beta-secretase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3000148" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=886-891&author=M.+R.+Kallerauthor=S.+S.+Harriedauthor=B.+Albrechtauthor=P.+Amaranteauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=R.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+Dunnauthor=R.+Graceffaauthor=D.+Hickmanauthor=T.+Juddauthor=C.+Kreimanauthor=D.+Laauthor=P.+Lopezauthor=Y.+Luoauthor=C.+Masseauthor=H.+Monenscheinauthor=T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=T.+Williamsonauthor=S.+Woodauthor=M.+Xueauthor=B.+Yangauthor=J.+Zhangauthor=V.+Patelauthor=W.+Zhongauthor=S.+Hitchcock&title=A+potent+and+orally+efficacious%2C+hydroxyethylamine-based+inhibitor+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=10.1021%2Fml3000148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000148%26sid%3Dliteratum%253Aachs%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DAlbrecht%26aufirst%3DB.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDunn%26aufirst%3DR.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DLa%26aufirst%3DD.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMasse%26aufirst%3DC.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DZhong%26aufirst%3DW.%26aulast%3DHitchcock%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520orally%2520efficacious%252C%2520hydroxyethylamine-based%2520inhibitor%2520of%2520beta-secretase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D886%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and preparation of a potent series of β-secretase inhibitors that demonstrate robust reduction of central β-amyloid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9009</span><span class="NLM_x">–</span> <span class="NLM_lpage">9024</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300119p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9009-9024&author=M.+M.+Weissauthor=T.+Williamsonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=T.+A.+Dineenauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=C.+Rattanauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+preparation+of+a+potent+series+of+%CE%B2-secretase+inhibitors+that+demonstrate+robust+reduction+of+central+%CE%B2-amyloid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6o&amp;dbid=16384&amp;doi=10.1021%2Fjm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520a%2520potent%2520series%2520of%2520%25CE%25B2-secretase%2520inhibitors%2520that%2520demonstrate%2520robust%2520reduction%2520of%2520central%2520%25CE%25B2-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9009%26epage%3D9024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, orally efficacious hydroxyethylamine derived β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9025</span><span class="NLM_x">–</span> <span class="NLM_lpage">9044</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6p&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9025-9044&author=T.+A.+Dineenauthor=M.+M.+Weissauthor=T.+Williamsonauthor=P.+Actonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+T.+Dunnauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+synthesis+of+potent%2C+orally+efficacious+hydroxyethylamine+derived+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6pR"><div class="casContent"><span class="casTitleNuber">6p</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors</span></div><div class="casAuthors">Dineen, Thomas A.; Weiss, Matthew M.; Williamson, Toni; Acton, Paul; Babu-Khan, Safura; Bartberger, Michael D.; Brown, James; Chen, Kui; Cheng, Yuan; Citron, Martin; Croghan, Michael D.; Dunn, Robert T.; Esmay, Joel; Graceffa, Russell F.; Harried, Scott S.; Hickman, Dean; Hitchcock, Stephen A.; Horne, Daniel B.; Huang, Hongbing; Imbeah-Ampiah, Ronke; Judd, Ted; Kaller, Matthew R.; Kreiman, Charles R.; La, Daniel S.; Li, Vivian; Lopez, Patricia; Louie, Steven; Monenschein, Holger; Nguyen, Thomas T.; Pennington, Lewis D.; San Miguel, Tisha; Sickmier, E. Allen; Vargas, Hugo M.; Wahl, Robert C.; Wen, Paul H.; Whittington, Douglas A.; Wood, Stephen; Xue, Qiufen; Yang, Bryant H.; Patel, Vinod F.; Zhong, Wenge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9025-9044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords compds. (e.g., 1, I) with sufficient bioavailability and pharmacokinetic profiles to reduce central amyloid-β peptide (Aβ) levels in wild-type rats following oral dosing.  In this article, we describe further modifications of the Ph ring of the hydroxyethylamine series to afford potent, dual BACE1/CYP 3A4 inhibitors which demonstrate improved penetration into the CNS.  Several of these compds. caused robust redn. of Aβ levels in rat CSF and brain following oral dosing, and compd. II exhibited an improved cardiovascular safety profile relative to 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqApKWBnTeHErVg90H21EOLACvtfcHk0lgxf-dR4ptBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOnsbg%253D&md5=1c6ad4a5aa1583864bd778715e1453ea</span></div><a href="/servlet/linkout?suffix=cit6p&amp;dbid=16384&amp;doi=10.1021%2Fjm300118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300118s%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DActon%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520orally%2520efficacious%2520hydroxyethylamine%2520derived%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9025%26epage%3D9044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Ng, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Probst, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gailunas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brogley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neitz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiss, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konradi, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dappen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zmolek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bova, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruslim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artis, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yednock, T. A.</span><span> </span><span class="NLM_article-title">Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors</span> <span class="citation_source-journal">Biorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4674</span><span class="NLM_x">–</span> <span class="NLM_lpage">4679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6q&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2Fj.bmcl.2013.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6q&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=23856050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6q&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSgsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4674-4679&author=R.+A.+Ngauthor=+Sunauthor=S.+Minguaauthor=S.+Bowersauthor=R.+K.+Homauthor=G.+D.+Probstauthor=V.+Johnauthor=L.+Y.+Fangauthor=M.+Maillardauthor=A.+Gailunasauthor=L.+Brogleyauthor=R.+J.+Neitzauthor=J.+S.+Tungauthor=M.+A.+Pleissauthor=A.+W.+Konradiauthor=H.+L.+Shamauthor=M.+S.+Dappenauthor=M.+Adlerauthor=N.+Yaoauthor=W.+Zmolekauthor=D.+Nakamuraauthor=K.+P.+Quinnauthor=J.-M.+Sauerauthor=M.+P.+Bovaauthor=L.+Ruslimauthor=D.+R.+Artisauthor=T.+A.+Yednock&title=Design+and+synthesis+of+hydroxyethylamine+%28HEA%29+BACE-1+inhibitors%3A+prime+side+chromane-containing+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6qR"><div class="casContent"><span class="casTitleNuber">6q</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: Prime side chromane-containing inhibitors</span></div><div class="casAuthors">Ng, Raymond A.; Sun, Minghua; Bowers, Simeon; Hom, Roy K.; Probst, Gary D.; John, Varghese; Fang, Lawrence Y.; Maillard, Michel; Gailunas, Andrea; Brogley, Louis; Neitz, R. Jeffrey; Tung, Jay S.; Pleiss, Michael A.; Konradi, Andrei W.; Sham, Hing L.; Dappen, Michael S.; Adler, Marc; Yao, Nanhua; Zmolek, Wes; Nakamura, David; Quinn, Kevin P.; Sauer, John-Michael; Bova, Michael P.; Ruslim, Lany; Artis, Dean R.; Yednock, Ted A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4674-4679</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The structure activity relationship of the prime region of conformationally restricted hydroxyethylamine (HEA) BACE inhibitors is described.  Variation of the P1' region provided selectivity over Cat-D with a series of 2,2-dioxo-isothiochromanes and optimization of the P2' substituent of chromane-HEA(s) with polar substituents provided improvements in the compd.'s in vitro permeability.  Significant potency gains were obsd. with small aliph. substituents such as Me, Pr, and cyclopropyl when placed at the C-2 position of the chromane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUSWYKJenCb7Vg90H21EOLACvtfcHk0lhk7qDI5mCrbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSgsrzI&md5=e851a0654e076d7cc032f2adc58af570</span></div><a href="/servlet/linkout?suffix=cit6q&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DR.%2BA.%26aulast%3DSun%26aulast%3DMingua%26aufirst%3DS.%26aulast%3DBowers%26aufirst%3DS.%26aulast%3DHom%26aufirst%3DR.%2BK.%26aulast%3DProbst%26aufirst%3DG.%2BD.%26aulast%3DJohn%26aufirst%3DV.%26aulast%3DFang%26aufirst%3DL.%2BY.%26aulast%3DMaillard%26aufirst%3DM.%26aulast%3DGailunas%26aufirst%3DA.%26aulast%3DBrogley%26aufirst%3DL.%26aulast%3DNeitz%26aufirst%3DR.%2BJ.%26aulast%3DTung%26aufirst%3DJ.%2BS.%26aulast%3DPleiss%26aufirst%3DM.%2BA.%26aulast%3DKonradi%26aufirst%3DA.%2BW.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DDappen%26aufirst%3DM.%2BS.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DZmolek%26aufirst%3DW.%26aulast%3DNakamura%26aufirst%3DD.%26aulast%3DQuinn%26aufirst%3DK.%2BP.%26aulast%3DSauer%26aufirst%3DJ.-M.%26aulast%3DBova%26aufirst%3DM.%2BP.%26aulast%3DRuslim%26aufirst%3DL.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DYednock%26aufirst%3DT.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520hydroxyethylamine%2520%2528HEA%2529%2520BACE-1%2520inhibitors%253A%2520prime%2520side%2520chromane-containing%2520inhibitors%26jtitle%3DBiorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4674%26epage%3D4679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061197u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1124-1132&author=M.+Congreveauthor=D.+Aharonyauthor=J.+Albertauthor=O.+Callaghanauthor=J.+Campbellauthor=R.+A.+E.+Carrauthor=G.+Chessariauthor=S.+Cowanauthor=P.+D.+Edwardsauthor=M.+Fredericksonauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+the+discovery+of+aminopyridines+as+inhibitors+of+beta-secretase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1021%2Fjm061197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061197u%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DJ.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520the%2520discovery%2520of%2520aminopyridines%2520as%2520inhibitors%2520of%2520beta-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1124%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Baxter, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braeken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruinzeel, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenneman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, A. B.</span><span> </span><span class="NLM_article-title">2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): use of structure based design to convert a micromolar hit into a nanomolar lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4261</span><span class="NLM_x">–</span> <span class="NLM_lpage">4264</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0705408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4261-4264&author=E.+W.+Baxterauthor=K.+A.+Conwayauthor=L.+Kennisauthor=F.+Bischoffauthor=M.+H.+Merckenauthor=H.+L.+Winterauthor=C.+H.+Reynoldsauthor=B.+A.+Toungeauthor=C.+Luoauthor=M.+K.+Scottauthor=Y.+Huangauthor=M.+Braekenauthor=S.+M.+Pietersauthor=D.+J.+Berthelotauthor=S.+Masureauthor=W.+D.+Bruinzeelauthor=A.+D.+Jordanauthor=M.+H.+Parkerauthor=R.+E.+Boydauthor=J.+Quauthor=R.+S.+Alexanderauthor=D.+E.+Brennemanauthor=A.+B.+Reitz&title=2-Amino-3%2C4-dihydroquinazolines+as+inhibitors+of+BACE-1+%28beta-site+APP+cleaving+enzyme%29%3A+use+of+structure+based+design+to+convert+a+micromolar+hit+into+a+nanomolar+lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1021%2Fjm0705408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0705408%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DE.%2BW.%26aulast%3DConway%26aufirst%3DK.%2BA.%26aulast%3DKennis%26aufirst%3DL.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DMercken%26aufirst%3DM.%2BH.%26aulast%3DWinter%26aufirst%3DH.%2BL.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DM.%2BK.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DBraeken%26aufirst%3DM.%26aulast%3DPieters%26aufirst%3DS.%2BM.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%26aulast%3DMasure%26aufirst%3DS.%26aulast%3DBruinzeel%26aufirst%3DW.%2BD.%26aulast%3DJordan%26aufirst%3DA.%2BD.%26aulast%3DParker%26aufirst%3DM.%2BH.%26aulast%3DBoyd%26aufirst%3DR.%2BE.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DBrenneman%26aufirst%3DD.%2BE.%26aulast%3DReitz%26aufirst%3DA.%2BB.%26atitle%3D2-Amino-3%252C4-dihydroquinazolines%2520as%2520inhibitors%2520of%2520BACE-1%2520%2528beta-site%2520APP%2520cleaving%2520enzyme%2529%253A%2520use%2520of%2520structure%2520based%2520design%2520to%2520convert%2520a%2520micromolar%2520hit%2520into%2520a%2520nanomolar%2520lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4261%26epage%3D4264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Barrow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitzenberger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1002%2Fcmdc.200700038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=17458843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVyktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=995-999&author=J.+Barrowauthor=K.+Rittleauthor=P.+Ngoauthor=H.+Selnickauthor=S.+Grahamauthor=S.+Pitzenbergerauthor=G.+McGaugheyauthor=D.+Colussiauthor=M.-T.+Laiauthor=Q.+Huangauthor=K.+Tugushevaauthor=A.+Espesethauthor=A.+Simonauthor=S.+Munshiauthor=J.+Vacca&title=Design+and+synthesis+of+2%2C3%2C5-substituted+imidazolidin-4-one+inhibitors+of+BACE-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1</span></div><div class="casAuthors">Barrow, James C.; Rittle, Kenneth E.; Ngo, Phung L.; Selnick, Harold G.; Graham, Samuel L.; Pitzenberger, Steven M.; McGaughey, Georgia B.; Colussi, Dennis; Lai, Ming-Tain; Huang, Qian; Tugusheva, Katherine; Espeseth, Amy S.; Simon, Adam J.; Munshi, Sanjeev K.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">995-999</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">2,3,5-Substituted imidazolidin-4-ones (e.g. I (R1 = Me, H; R2 = Bn)) were prepd. and tested as BACE-1 inhibitors.  The illustrated I are the most potent inhibitors.  The crystal and mol. structures of I (R1 = Me; R2 = Me) in the active site of BACE-1 were detd. by x-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgoCprsegvBLVg90H21EOLACvtfcHk0lgh19QhDk9QFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVyktLc%253D&md5=e04a29f0ada03e808cbe5a10e8e57d0e</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700038%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%26aulast%3DRittle%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DP.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DPitzenberger%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DEspeseth%26aufirst%3DA.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202%252C3%252C5-substituted%2520imidazolidin-4-one%2520inhibitors%2520of%2520BACE-1%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D995%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichau, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichau&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichau%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lgqmJgTjV-mfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBell, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgqmJgTjV-mfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Swahn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plobeck, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S. v.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as BACE-1 inhibitors: the challenge to achieve in vivo brain efficacy</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1854</span><span class="NLM_x">–</span> <span class="NLM_lpage">1859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1854-1859&author=B.+Swahnauthor=J.+Holenzauthor=J.+Kihlstromauthor=K.+Kolmodinauthor=J.+Lindstromauthor=N.+Plobeckauthor=D.+Rotticciauthor=F.+Sehgelmebleauthor=M.+Sundstromauthor=S.+v.+Bergauthor=J.+Faltingauthor=B.+Georgievskaauthor=S.+Gustavssonauthor=J.+Neelissenauthor=M.+Ekauthor=L.+Olssonauthor=S.+Berg&title=Aminoimidazoles+as+BACE-1+inhibitors%3A+the+challenge+to+achieve+in+vivo+brain+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DKihlstrom%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstrom%26aufirst%3DJ.%26aulast%3DPlobeck%26aufirst%3DN.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSundstrom%26aufirst%3DM.%26aulast%3DBerg%26aufirst%3DS.%2Bv.%26aulast%3DFalting%26aufirst%3DJ.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DEk%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.%26aulast%3DBerg%26aufirst%3DS.%26atitle%3DAminoimidazoles%2520as%2520BACE-1%2520inhibitors%253A%2520the%2520challenge%2520to%2520achieve%2520in%2520vivo%2520brain%2520efficacy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1854%26epage%3D1859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strömberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9297</span><span class="NLM_x">–</span> <span class="NLM_lpage">9311</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstr%C3%B6mauthor=J.+Kihlstr%C3%B6mauthor=K.+Kolmodinauthor=J.+Lindstr%C3%B6mauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketj%C3%A4llauthor=J.+F%C3%A4ltingauthor=F.+Jeppssonauthor=K.+Str%C3%B6mbergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28A%CE%B2%29+lowering+in+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7h&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStr%25C3%25B6mberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9297%26epage%3D9311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7i&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7iR"><div class="casContent"><span class="casTitleNuber">7i</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lifhOKIEL9QhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit7i&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Aβ reduction</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7j&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D897%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span> </span><span class="NLM_article-title">Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9156</span><span class="NLM_x">–</span> <span class="NLM_lpage">9169</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9156-9169&author=H.+Huangauthor=D.+S.+Laauthor=A.+C.+Chengauthor=D.+A.+Whittingtonauthor=V.+F.+Patelauthor=K.+Chenauthor=T.+A.+Dineenauthor=O.+Epsteinauthor=R.+Graceffaauthor=D.+Hickmanauthor=Y.-H.+Kiangauthor=S.+Louieauthor=Y.+Louauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=R.+T.+Fremeau&title=Structure-+and+property-based+design+of+aminooxazoline+xanthenes+as+selective%2C+orally+efficacious%2C+and+CNS+penetrable+BACE+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm300598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300598e%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DKiang%26aufirst%3DY.-H.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DStructure-%2520and%2520property-based%2520design%2520of%2520aminooxazoline%2520xanthenes%2520as%2520selective%252C%2520orally%2520efficacious%252C%2520and%2520CNS%2520penetrable%2520BACE%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9156%26epage%3D9169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Epstein, O.; Bryan, M. C.; Cheng, A. C.; Derakhchan, K.; Dineen, T. A.; Hickman, D.; Hua, Z.; Human, J. B.; Kreiman, C. E.; Marx, I. E.; Weiss, M. M.; Qu, Y.; Wahl, R. C.; Wen, P. H.; Whittington, D. A.; Wood, S.; Zheng, X. M.; Fremeau,  Jr., R. T.; White, R. D.; Patel, V. F.</span><span> </span><span class="NLM_article-title">Lead optimization and modulation of hERG activity in a series of aminooxazoline xanthene BACE inhibitors</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span>, DOI: <span class="refDoi"> DOI: 10.1021/jm501266w</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm501266w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&author=O.+Epstein&author=M.+C.+Bryan&author=A.+C.+Cheng&author=K.+Derakhchan&author=T.+A.+Dineen&author=D.+Hickman&author=Z.+Hua&author=J.+B.+Human&author=C.+E.+Kreiman&author=I.+E.+Marx&author=M.+M.+Weiss&author=Y.+Qu&author=R.+C.+Wahl&author=P.+H.+Wen&author=D.+A.+Whittington&author=S.+Wood&author=X.+M.+Zheng&author=R.+T.+Fremeau&author=R.+D.+White&author=V.+F.+Patel&title=Lead+optimization+and+modulation+of+hERG+activity+in+a+series+of+aminooxazoline+xanthene+BACE+inhibitors&doi=10.1021%2Fjm501266w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm501266w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501266w%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DO.%26atitle%3DLead%2520optimization%2520and%2520modulation%2520of%2520hERG%2520activity%2520in%2520a%2520series%2520of%2520aminooxazoline%2520xanthene%2520BACE%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26doi%3D10.1021%2Fjm501266w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mahar Doan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shampine, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkinson, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polli, J. W.</span><span> </span><span class="NLM_article-title">Passive permeability and P-glycoprotein mediated efflux differentiate CNS and non-CNS marketed drugs</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">1029</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1124%2Fjpet.102.039255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=12438524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=1029-1037&author=K.+M.+Mahar+Doanauthor=J.+E.+Humphreysauthor=L.+O.+Websterauthor=S.+A.+Wringauthor=L.+J.+Shampineauthor=C.+J.+Serabjit-Singhauthor=K.+K.+Adkinsonauthor=J.+W.+Polli&title=Passive+permeability+and+P-glycoprotein+mediated+efflux+differentiate+CNS+and+non-CNS+marketed+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs</span></div><div class="casAuthors">Mahar Doan Kelly M; Humphreys Joan E; Webster Lindsey O; Wring Stephen A; Shampine Larry J; Serabjit-Singh Cosette J; Adkison Kimberly K; Polli Joseph W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1029-37</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Membrane permeability and P-glycoprotein (Pgp) can be limiting factors for blood-brain barrier penetration.  The objectives of this study were to determine whether there are differences in the in vitro permeability, Pgp substrate profiles, and physicochemical properties of drugs for central nervous system (CNS) and non-CNS indications, and whether these differences are useful criteria in selecting compounds for drug development.  Apparent permeability (P(app)) and Pgp substrate profiles for 93 CNS (n = 48) and non-CNS (n = 45) drugs were determined by monolayer efflux.  Calcein-AM inhibition assays were used to supplement the efflux results.  The CNS set (2 of 48, 4.2%) had a 7-fold lower incidence of passive permeability values <150 nm/s compared with the non-CNS set (13 of 45, 28.9%).  The majority of drugs (72.0%, 67 of 93) were not Pgp substrates; however, 49.5% (46 of 93) were positive in the calcein-AM assay when tested at 100 microM.  The CNS drug set (n = 7 of 48, 14.6%) had a 3-fold lower incidence of Pgp-mediated efflux than the non-CNS drug set (n = 19 of 45, 42.2%).  Analysis of 18 physicochemical properties revealed that the CNS drug set had fewer hydrogen bond donors, fewer positive charges, greater lipophilicity, lower polar surface area, and reduced flexibility compared with the non-CNS group (p < 0.05), properties that enhance membrane permeability.  This study on a large, diverse set of marketed compounds clearly demonstrates that permeability, Pgp-mediated efflux, and certain physicochemical properties are factors that differentiate CNS and non-CNS drugs.  For CNS delivery, a drug should ideally have an in vitro passive permeability >150 nm/s and not be a good (B --> A/A --> B ratio <2.5) Pgp substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_HiV1Xqt18Vf1XRtfYM0dfW6udTcc2eabAZg68c0FS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nptVKmsw%253D%253D&md5=b841902aa8502de47c1e1603c80e09fb</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039255%26sid%3Dliteratum%253Aachs%26aulast%3DMahar%2BDoan%26aufirst%3DK.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DWebster%26aufirst%3DL.%2BO.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DShampine%26aufirst%3DL.%2BJ.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26aulast%3DAdkinson%26aufirst%3DK.%2BK.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26atitle%3DPassive%2520permeability%2520and%2520P-glycoprotein%2520mediated%2520efflux%2520differentiate%2520CNS%2520and%2520non-CNS%2520marketed%2520drugs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D1029%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure–brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%80%93brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2580%2593brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bissantz, C.; Kuhn, B.; Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span>.  <span class="citation_source-journal">J. Med. Chem.</span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bissantz%2C+C.%3B+Kuhn%2C+B.%3B+Stahl%2C+M.+A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions.+J.+Med.+Chem.53%2C+5061%E2%80%935084."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26volume%3D53%26spage%3D5061%26epage%3D5084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hassner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorber, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heathcock, C.</span><span> </span><span class="NLM_article-title">Addition of iodine isocyanate to olefins. Scope and synthetic utility</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01278a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1967&pages=540-549&author=A.+Hassnerauthor=M.+E.+Lorberauthor=C.+Heathcock&title=Addition+of+iodine+isocyanate+to+olefins.+Scope+and+synthetic+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjo01278a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01278a006%26sid%3Dliteratum%253Aachs%26aulast%3DHassner%26aufirst%3DA.%26aulast%3DLorber%26aufirst%3DM.%2BE.%26aulast%3DHeathcock%26aufirst%3DC.%26atitle%3DAddition%2520of%2520iodine%2520isocyanate%2520to%2520olefins.%2520Scope%2520and%2520synthetic%2520utility%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1967%26volume%3D32%26spage%3D540%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fernandez, J. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellet, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, M. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mota, J. F.</span><span> </span><span class="NLM_article-title">Syntheses and spectral properties of β-iodoureas and 2-amino-4,4-diphenyl-2-oxazolines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1991&pages=777-780&author=J.+M.+G.+Fernandezauthor=C.+O.+Melletauthor=M.+A.+P.+Adrianauthor=J.+F.+Mota&title=Syntheses+and+spectral+properties+of+%CE%B2-iodoureas+and+2-amino-4%2C4-diphenyl-2-oxazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DJ.%2BM.%2BG.%26aulast%3DMellet%26aufirst%3DC.%2BO.%26aulast%3DAdrian%26aufirst%3DM.%2BA.%2BP.%26aulast%3DMota%26aufirst%3DJ.%2BF.%26atitle%3DSyntheses%2520and%2520spectral%2520properties%2520of%2520%25CE%25B2-iodoureas%2520and%25202-amino-4%252C4-diphenyl-2-oxazolines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1991%26volume%3D28%26spage%3D777%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><div class="note"><p class="first last">For a review, see</p></div><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling reactions of organoboron compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2456</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2456-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2456%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fernandez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghanta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span> </span><span class="NLM_article-title">Physicochemical features of the hERG channel drug binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">10120</span><span class="NLM_x">–</span> <span class="NLM_lpage">10127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=10120-10127&author=D.+Fernandezauthor=A.+Ghantaauthor=G.+W.+Kauffmanauthor=M.+C.+Sanguinetti&title=Physicochemical+features+of+the+hERG+channel+drug+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DD.%26aulast%3DGhanta%26aufirst%3DA.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26atitle%3DPhysicochemical%2520features%2520of%2520the%2520hERG%2520channel%2520drug%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D10120%26epage%3D10127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of hERG optimizations: highlights and hang-ups</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5029</span><span class="NLM_x">–</span> <span class="NLM_lpage">5046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060379l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5029-5046&author=C.+Jamiesonauthor=E.+M.+Moirauthor=Z.+Rankovicauthor=G.+Wishart&title=Medicinal+chemistry+of+hERG+optimizations%3A+highlights+and+hang-ups"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of hERG optimizations: Highlights and hang-ups</span></div><div class="casAuthors">Jamieson, Craig; Moir, Elizabeth M.; Rankovic, Zoran; Wishart, Grant</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5029-5046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  A brief summary of the in silico, in vitro, and in vivo approaches employed to measure blockade of hERG and QT prolongation is detailed.  The discussion aims to summarize the approaches engaged to circumvent activity at hERG, identified through an extensive literature survey.  The optimizations are recorded as pairs of compds., which have been categorized in terms of the tactics employed to diminish hERG activity. Examn. of the properties of the compds. within each category has enabled formulation os some empirical guidelines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv6eM5w53KebVg90H21EOLACvtfcHk0lhofb1I0uc9og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1WqsL8%253D&md5=117c84a010f877c835b7dbc945996b92</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm060379l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060379l%26sid%3Dliteratum%253Aachs%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMoir%26aufirst%3DE.%2BM.%26aulast%3DRankovic%26aufirst%3DZ.%26aulast%3DWishart%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520hERG%2520optimizations%253A%2520highlights%2520and%2520hang-ups%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5029%26epage%3D5046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Seelig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landwojtowicz, E.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of P-glycoprotein substrates and modifiers</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2FS0928-0987%2800%2900177-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=11121731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1yiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=31-40&author=A.+Seeligauthor=E.+Landwojtowicz&title=Structure%E2%80%93activity+relationship+of+P-glycoprotein+substrates+and+modifiers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of P-glycoprotein substrates and modifiers</span></div><div class="casAuthors">Seelig, A.; Landwojtowicz, E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The air-water partition coeffs., Kaw, highly correlated with the corresponding lipid-water partition coeffs., Klw, and the crit. micelle concns., CMC, were measured for 11 compds. for which the kinetic parameters of P-glycoprotein ATPase activation (Michaelis-Menten const., Km, and maximal velocity, Vmax) had been detd. previously in inside-out vesicles of CR1R12 Chinese hamster ovary cells.  In addn., the hydrogen bond donor patterns (type I and type II) relevant for substrate recognition by P-glycoprotein were detd. from the energy-minimized three-dimensional structure of these compds.  A linear relation between the air-water partition coeff., Kaw, and the inverse of the Michaelis-Menten const., Km, was obsd. such that Km·Kaw∼1.  The maximal velocity, Vmax, was shown to decrease with the no. and strength of electron donor (hydrogen bond acceptor) groups in recognition patterns.  If two substrates are applied simultaneously to P-glycoprotein the compd. with the higher potential to form hydrogen bonds generally acts as an inhibitor.  We conclude that partitioning into the lipid membrane is the rate-limiting step for the interaction of a substrate with P-glycoprotein and that dissocn. of the P-glycoprotein-substrate complex is detd. by the no. and strength of the hydrogen bonds formed between the substrate and the transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpc-z_lr6yeA7Vg90H21EOLACvtfcHk0ligc0Fa1oi4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1yiu7w%253D&md5=df34dfdd3c1dafd241d25f2b7521bf21</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0928-0987%2800%2900177-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-0987%252800%252900177-9%26sid%3Dliteratum%253Aachs%26aulast%3DSeelig%26aufirst%3DA.%26aulast%3DLandwojtowicz%26aufirst%3DE.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520P-glycoprotein%2520substrates%2520and%2520modifiers%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2000%26volume%3D12%26spage%3D31%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Coordinates for the complex of BACE1 with inhibitor <b>42</b> have been deposited in the Protein Data Bank under PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RCD">4RCD</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Riley, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grime, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, R.</span><span> </span><span class="NLM_article-title">Time-dependent CYP inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1517%2F17425255.3.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=17269894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=51-66&author=R.+J.+Rileyauthor=K.+Grimeauthor=R.+Weaver&title=Time-dependent+CYP+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Time-dependent CYP inhibition</span></div><div class="casAuthors">Riley, Robert J.; Grime, Ken; Weaver, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Time-dependent inhibition (TDI) of CYP refers to a change in potency during an in vitro incubation or dosing period in vivo.  Potential mechanisms include the formation of inhibitory metabolites and mechanism-based inhibition (MBI).  In vitro expts. are configured to assess TDI and MBI is inferred, at least initially.  MBI is more profound after multiple-dosing and the recovery period is independent of continued drug exposure.  Advances in in vitro-in vivo extrapolations for competitive inhibition and the potential relationship between MBI and reactive metabolite-mediated toxicity, have redirected emphasis to CYP TDI.  In contrast, with reversible inhibition, strategies for projecting the risks from TDI are less developed and the traditional I/Ki model often yields a dramatic underprediction.  This review explores the contribution of TDI to drug-drug interactions and idiosyncratic drug toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8w1eAZ9QULVg90H21EOLACvtfcHk0ligc0Fa1oi4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGlurY%253D&md5=184636ac0768f51d65f407a0655233e4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17425255.3.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.3.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26aulast%3DGrime%26aufirst%3DK.%26aulast%3DWeaver%26aufirst%3DR.%26atitle%3DTime-dependent%2520CYP%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2007%26volume%3D3%26spage%3D51%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Berry, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span> </span><span class="NLM_article-title">An Examination of IC<sub>50</sub> and IC<sub>50</sub>-shift experiments in assessing time-dependent inhibition of CYP3A4, CYP2D6, and CYP2C9 in human liver microsomes</span> <span class="citation_source-journal">Drug. Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.2174%2F187231208783478407" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=51-59&author=L.+M.+Berryauthor=Z.+Zhao&title=An+Examination+of+IC50+and+IC50-shift+experiments+in+assessing+time-dependent+inhibition+of+CYP3A4%2C+CYP2D6%2C+and+CYP2C9+in+human+liver+microsomes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F187231208783478407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231208783478407%26sid%3Dliteratum%253Aachs%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DZ.%26atitle%3DAn%2520Examination%2520of%2520IC50%2520and%2520IC50-shift%2520experiments%2520in%2520assessing%2520time-dependent%2520inhibition%2520of%2520CYP3A4%252C%2520CYP2D6%252C%2520and%2520CYP2C9%2520in%2520human%2520liver%2520microsomes%26jtitle%3DDrug.%2520Metab.%2520Lett.%26date%3D2008%26volume%3D8%26spage%3D51%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">In general, aminoxazoline xanthene compounds displayed similar PK profiles in rats and maximum effects on Aβ reduction in the CSF and brain were observed between 4 and 5 h following an oral dose in the PD assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, J. H.</span><span> </span><span class="NLM_article-title">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.2174%2F138920008783331077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=18220571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=46-59&author=J.+H.+Lin&title=CSF+as+a+surrogate+for+assessing+CNS+exposure%3A+an+industrial+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">CSF as a surrogate for assessing CNS exposure: an industrial perspective</span></div><div class="casAuthors">Lin, Jiunn H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-59</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  For drugs that directly act on targets in the central nervous system (CNS), sufficient drug delivery into the brain is a prerequisite for drug action.  Systemically administered drugs can reach CNS by passage across the endothelium of capillary vasculatures, the so-called blood-brain barrier (BBB).  Literature data suggest that most marketed CNS drugs have good membrane permeability and relatively high plasma unbound fraction, but are not good P-glycoprotein (P-gp) substrates.  Therefore, it is important to use the in vitro parameters of P-gp function activity, membrane permeability and plasma unbound fraction as key criteria for lead optimization during the early stage of drug discovery.  Evidence from preclin. and clin. studies suggests that drug concn. in cerebrospinal fluid (CSF) appears to be reasonably accurate in predicting unbound drug concn. in the brain.  Therefore, CSF can be used as a useful surrogate for in vivo assessment of CNS exposure and provides an important basis for the selection of drug candidates for entry into development.  However, it is important to point out that CSF drug concn. is not always an accurate surrogate for predicting unbound drug concn. in the brain.  Depending on the physicochem. properties of drugs and the site/timing of CSF sampling, the unbound drug concn. at the biophase within the brain could differ significantly from the corresponding CSF drug concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrft1JtBu-LmrVg90H21EOLACvtfcHk0ligc0Fa1oi4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSitbo%253D&md5=cfea50f80a3bcf592477e8ecb8825084</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.2174%2F138920008783331077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008783331077%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BH.%26atitle%3DCSF%2520as%2520a%2520surrogate%2520for%2520assessing%2520CNS%2520exposure%253A%2520an%2520industrial%2520perspective%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D46%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span> <span class="citation_source-journal">Drug. Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+drug+concentration+in+brain+homogenate+and+cerebral+spinal+fluid+at+steady+state+as+a+surrogate+for+unbound+concentration+in+brain+interstitial+fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0ligc0Fa1oi4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520drug%2520concentration%2520in%2520brain%2520homogenate%2520and%2520cerebral%2520spinal%2520fluid%2520at%2520steady%2520state%2520as%2520a%2520surrogate%2520for%2520unbound%2520concentration%2520in%2520brain%2520interstitial%2520fluid%26jtitle%3DDrug.%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Felmlee, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mager, D. E.</span><span> </span><span class="NLM_article-title">Mechanism-based pharmacodynamic modeling</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">929</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1007%2F978-1-62703-050-2_21" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=23007443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BC3sXisF2ht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=929&publication_year=2012&pages=583-600&author=M.+A.+Felmleeauthor=M.+E.+Morrisauthor=D.+E.+Mager&title=Mechanism-based+pharmacodynamic+modeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based pharmacodynamic modeling</span></div><div class="casAuthors">Felmlee, Melanie A.; Morris, Marilyn E.; Mager, Donald E.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">929</span>
        (<span class="NLM_cas:issue">Computational Toxicology, Volume I</span>),
    <span class="NLM_cas:pages">583-600</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Pharmacodynamic modeling is based on a quant. integration of pharmacokinetics, pharmacol. systems, and (patho-) physiol. processes for understanding the intensity and time-course of drug effects on the body.  Application of such models to the anal. of meaningful exptl. data allows for the quantification and prediction of drug-system interactions for both therapeutic and adverse drug responses.  In this chapter, commonly used mechanistic pharmacodynamic models are presented with respect to their important features, operable equations, and signature profiles.  In addn., literature examples showcasing the utility of these models to adverse drug events are highlighted.  Common model types that are covered include simple direct effects, biophase distribution, indirect effects, signal transduction, and irreversible effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotNyzwxREt3LVg90H21EOLACvtfcHk0lgkKUPn8jNtgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXisF2ht70%253D&md5=a459c27b92c14cbc01725c085789fa86</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2F978-1-62703-050-2_21&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-62703-050-2_21%26sid%3Dliteratum%253Aachs%26aulast%3DFelmlee%26aufirst%3DM.%2BA.%26aulast%3DMorris%26aufirst%3DM.%2BE.%26aulast%3DMager%26aufirst%3DD.%2BE.%26atitle%3DMechanism-based%2520pharmacodynamic%2520modeling%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2012%26volume%3D929%26spage%3D583%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Finlayson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">January, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharkey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. S.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5012676&amp;key=10.1016%2FS0014-2999%2801%2901362-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5012676&amp;key=11698075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5012676&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFWhs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2001&pages=147-148&author=K.+Finlaysonauthor=L.+Turnbullauthor=C.+T.+Januaryauthor=J.+Sharkeyauthor=J.+S.+Kelly&title=%5B3H%5DDofetilide+binding+to+HERG+transfected+membranes%3A+a+potential+high+throughput+preclinical+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen</span></div><div class="casAuthors">Finlayson, Keith; Turnbull, Lorna; January, Craig T.; Sharkey, John; Kelly, John S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-148</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The pharmacol. characteristics of [3H]dofetilide binding were examd. in membranes prepd. from human embryonic kidney (HEK293) cells stably expressing human ether-a-go-go related gene (HERG) K+ channels.  The class III antiarrhythmic compds. dofetilide, clofilium, 4'-[[1-[2-(6-methyl-2-pyridyl)ethyl]-4-piperidyl]carbonyl]methanesulfonanilide (E-4031), N-methyl-N-[2-[methyl-(1-methyl-1H-benzimidazol-2-yl)amino]ethyl]-4-[(methylsulfonyl)amino]benzene-sulfonamide (WAY-123,398) and d-sotalol all inhibited [3H]dofetilide binding.  In addn., the structurally unrelated compds. pimozide, terfenadine and haloperidol, all of which prolong the QT interval in man, also inhibited binding.  These data indicate that a [3H]dofetilide binding assay using HERG membranes may help identify compds. that prolong the QT interval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr09GxPknr35bVg90H21EOLACvtfcHk0lgkKUPn8jNtgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFWhs74%253D&md5=9849fe1d07c00f00be2ba076ecc7d93b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2801%2901362-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252801%252901362-0%26sid%3Dliteratum%253Aachs%26aulast%3DFinlayson%26aufirst%3DK.%26aulast%3DTurnbull%26aufirst%3DL.%26aulast%3DJanuary%26aufirst%3DC.%2BT.%26aulast%3DSharkey%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DJ.%2BS.%26atitle%3D%255B3H%255DDofetilide%2520binding%2520to%2520HERG%2520transfected%2520membranes%253A%2520a%2520potential%2520high%2520throughput%2520preclinical%2520screen%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D430%26spage%3D147%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RCD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RCD','PDB','4RCD'); return false;">PDB: 4RCD</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i68"><a href="/doi/suppl/10.1021/jm5012676">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80733"></div></div></div></div></div><hr /></hr><p class="last">General information, experimental data and characterization, X-ray crystal structure information. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5012676/suppl_file/jm5012676_si_001.pdf">jm5012676_si_001.pdf (509.29 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession code for the X-ray cocrystal of BACE1 + compound <b>42</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4RCD">4RCD</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5012676&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm5012676%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5012676" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998a233eca3d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
